data_1efe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1efe _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 5.04 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.4699999999999998 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.96 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 3.4100000000000001 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.97 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 2.3399999999999999 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 2.1299999999999999 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.71 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.5099999999999998 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 3.3900000000000001 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 7' ' ' CYS . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.5800000000000001 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.9099999999999999 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 1.3100000000000001 110.81 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.8600000000000001 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.6000000000000001 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.9299999999999999 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.8 111.646 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.8999999999999999 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.6699999999999999 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.6699999999999999 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 3.1600000000000001 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 5.3499999999999996 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 4.0499999999999998 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 4.0 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.7699999999999996 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.8099999999999996 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 9.6099999999999994 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 8.2699999999999996 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.75 109.878 179.112 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.906 -0.405 . . . . 5.6600000000000001 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.6200000000000001 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.8899999999999999 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 3.0099999999999998 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 2.2200000000000002 110.154 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.9199999999999999 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.73 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.1699999999999999 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 2.1400000000000001 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.6499999999999999 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.6699999999999999 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.96999999999999997 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.3700000000000001 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.79 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.79 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.8300000000000001 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 1.48 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.0699999999999998 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 2.3199999999999998 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 2.6099999999999999 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.9300000000000002 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 5.04 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.4699999999999998 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.96 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 3.4100000000000001 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.97 110.258 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 2.3399999999999999 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 2.1299999999999999 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.71 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.5099999999999998 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 3.3900000000000001 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.5800000000000001 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.9099999999999999 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 111.159 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.8600000000000001 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.6000000000000001 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.8 110.524 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.8999999999999999 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.6699999999999999 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.6699999999999999 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 3.1600000000000001 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 5.3499999999999996 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.412 ' CE1' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 3.0800000000000001 110.314 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 4.0499999999999998 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 4.0 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.7699999999999996 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.8099999999999996 110.734 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 9.6099999999999994 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 8.2699999999999996 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.75 109.718 179.851 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.51 -0.552 . . . . 5.6600000000000001 109.51 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.6200000000000001 109.414 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.8899999999999999 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 26' ' ' TYR . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 3.0099999999999998 110.787 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 2.2200000000000002 111.668 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.9199999999999999 111.713 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.73 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.1699999999999999 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 2.1400000000000001 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.6499999999999999 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.6699999999999999 110.144 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.96999999999999997 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.3700000000000001 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.79 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.79 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.8300000000000001 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 1.48 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.0699999999999998 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 2.3199999999999998 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 2.6099999999999999 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.9300000000000002 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 5.04 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.4699999999999998 111.51 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.96 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 3.4100000000000001 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.97 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 2.3399999999999999 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 2.1299999999999999 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.71 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.5099999999999998 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 3.3900000000000001 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.5800000000000001 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.9099999999999999 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 1.3100000000000001 112.141 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.8600000000000001 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.6000000000000001 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.8 110.671 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.8999999999999999 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.6699999999999999 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.6699999999999999 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 3.1600000000000001 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 5.3499999999999996 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 3.0800000000000001 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 4.0499999999999998 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 4.0 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.7699999999999996 109.55 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.8099999999999996 113.962 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 9.6099999999999994 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 8.2699999999999996 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.75 109.937 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttm . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.218 0.532 . . . . 5.6600000000000001 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.6200000000000001 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.8899999999999999 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 3.0099999999999998 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 2.2200000000000002 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.9199999999999999 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.73 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.1699999999999999 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 2.1400000000000001 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.6499999999999999 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.6699999999999999 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.96999999999999997 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.3700000000000001 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.79 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.79 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.8300000000000001 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 1.48 110.23 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.0699999999999998 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 2.3199999999999998 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 2.6099999999999999 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.9300000000000002 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 5.04 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.4699999999999998 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.96 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 3.4100000000000001 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.97 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 2.3399999999999999 109.414 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 2.1299999999999999 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.71 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.5099999999999998 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 3.3900000000000001 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.5800000000000001 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.9099999999999999 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 1.3100000000000001 110.012 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.8600000000000001 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.6000000000000001 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.9299999999999999 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.8 110.925 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.8999999999999999 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.6699999999999999 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.6699999999999999 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 3.1600000000000001 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 5.3499999999999996 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 3.0800000000000001 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 4.0499999999999998 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 4.0 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.7699999999999996 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.8099999999999996 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 9.6099999999999994 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 8.2699999999999996 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.75 111.89 -179.826 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.435 -0.58 . . . . 5.6600000000000001 109.435 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.6200000000000001 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.8899999999999999 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 41' ' ' ILE . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 3.0099999999999998 109.584 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 2.2200000000000002 111.186 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.9199999999999999 111.445 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.73 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.1699999999999999 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 2.1400000000000001 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.6499999999999999 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.6699999999999999 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.96999999999999997 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.3700000000000001 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.79 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.79 110.72 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.8300000000000001 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 1.48 109.593 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.0699999999999998 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 2.3199999999999998 109.969 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 2.6099999999999999 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.9300000000000002 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 5.04 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.4699999999999998 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.96 108.427 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 3.4100000000000001 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.97 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 2.3399999999999999 110.531 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 2.1299999999999999 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.71 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.5099999999999998 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 3.3900000000000001 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.5800000000000001 110.569 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.9099999999999999 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 1.3100000000000001 111.106 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD21 ' CZ ' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.8600000000000001 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.6000000000000001 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.9299999999999999 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.8 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.8999999999999999 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.6699999999999999 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.6699999999999999 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 3.1600000000000001 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 5.3499999999999996 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.415 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 3.0800000000000001 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 4.0499999999999998 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 4.0 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.7699999999999996 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.8099999999999996 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 9.6099999999999994 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 8.2699999999999996 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.75 110.106 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.142 0.496 . . . . 5.6600000000000001 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.6200000000000001 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.8899999999999999 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 58' ' ' TYR . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 3.0099999999999998 109.349 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.2200000000000002 110.1 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.9199999999999999 110.336 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.73 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.1699999999999999 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 2.1400000000000001 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.6499999999999999 110.164 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.6699999999999999 109.992 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.96999999999999997 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.3700000000000001 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.79 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.79 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.8300000000000001 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 1.48 109.971 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.0699999999999998 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 2.3199999999999998 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 2.6099999999999999 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.9300000000000002 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 5.04 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.4699999999999998 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.96 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 3.4100000000000001 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.97 110.433 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 2.3399999999999999 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 2.1299999999999999 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.71 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.5099999999999998 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 3.3900000000000001 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.5800000000000001 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.9099999999999999 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 1.3100000000000001 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.8600000000000001 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.6000000000000001 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.9299999999999999 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.8 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.8999999999999999 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.6699999999999999 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.6699999999999999 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 3.1600000000000001 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 5.3499999999999996 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 3.0800000000000001 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 4.0499999999999998 110.224 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 4.0 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.7699999999999996 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.8099999999999996 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 9.6099999999999994 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 8.2699999999999996 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.4 t80 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.75 109.995 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mptt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.369 -0.604 . . . . 5.6600000000000001 109.369 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.6200000000000001 108.915 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.8899999999999999 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 58' ' ' TYR . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 3.0099999999999998 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 2.2200000000000002 110.675 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.9199999999999999 110.91 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.73 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.1699999999999999 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 2.1400000000000001 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.6499999999999999 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.6699999999999999 111.411 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.96999999999999997 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.3700000000000001 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.79 110.905 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.79 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.8300000000000001 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 1.48 109.7 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.0699999999999998 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 2.3199999999999998 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CZ ' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 2.6099999999999999 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.9300000000000002 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 5.04 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.4699999999999998 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.96 109.273 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 3.4100000000000001 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.97 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 2.3399999999999999 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 2.1299999999999999 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.71 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.5099999999999998 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 3.3900000000000001 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.5800000000000001 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.9099999999999999 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 1.3100000000000001 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.8600000000000001 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.6000000000000001 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.9299999999999999 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.8 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.8999999999999999 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.6699999999999999 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.6699999999999999 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 3.1600000000000001 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 5.3499999999999996 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 3.0800000000000001 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 4.0499999999999998 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 4.0 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.7699999999999996 109.987 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.8099999999999996 113.08 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 9.6099999999999994 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 8.2699999999999996 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.75 110.472 -179.686 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.87 -0.789 . . . . 5.6600000000000001 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.6200000000000001 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.8899999999999999 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 3.0099999999999998 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 2.2200000000000002 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.9199999999999999 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.73 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.1699999999999999 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 2.1400000000000001 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.6499999999999999 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.6699999999999999 109.67 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.96999999999999997 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.3700000000000001 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.79 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.79 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.8300000000000001 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 1.48 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.0699999999999998 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 2.3199999999999998 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 2.6099999999999999 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.9300000000000002 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 5.04 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.4699999999999998 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.96 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 3.4100000000000001 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.97 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 2.3399999999999999 109.379 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 2.1299999999999999 109.509 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.71 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.5099999999999998 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 3.3900000000000001 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.5800000000000001 110.52 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.9099999999999999 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 1.3100000000000001 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.8600000000000001 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.6000000000000001 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.9299999999999999 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.8 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.8999999999999999 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.6699999999999999 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.6699999999999999 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 3.1600000000000001 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 5.3499999999999996 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 3.0800000000000001 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 4.0499999999999998 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 4.0 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.7699999999999996 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.8099999999999996 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 9.6099999999999994 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 8.2699999999999996 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.75 110.23 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.131 0.491 . . . . 5.6600000000000001 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.6200000000000001 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.8899999999999999 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG23 ' CE1' ' A' ' 58' ' ' TYR . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 3.0099999999999998 109.331 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 2.2200000000000002 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.9199999999999999 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.73 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.1699999999999999 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 2.1400000000000001 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.6499999999999999 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.6699999999999999 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.96999999999999997 109.447 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.3700000000000001 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.79 110.507 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.79 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.8300000000000001 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 1.48 110.189 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.0699999999999998 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 2.3199999999999998 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.413 ' CE1' HG23 ' A' ' 41' ' ' ILE . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 2.6099999999999999 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.9300000000000002 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 5.04 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.4699999999999998 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.96 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 3.4100000000000001 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.97 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 2.3399999999999999 109.012 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 2.1299999999999999 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.71 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.5099999999999998 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 3.3900000000000001 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.5800000000000001 110.13 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.9099999999999999 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 1.3100000000000001 111.442 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.8600000000000001 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.6000000000000001 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.9299999999999999 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.8 110.604 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.8999999999999999 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.6699999999999999 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.6699999999999999 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 3.1600000000000001 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 5.3499999999999996 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 3.0800000000000001 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 4.0499999999999998 110.236 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 4.0 110.624 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.7699999999999996 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.8099999999999996 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 9.6099999999999994 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 8.2699999999999996 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.75 109.678 179.303 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.227 0.537 . . . . 5.6600000000000001 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.6200000000000001 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.8899999999999999 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 41' ' ' ILE . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 3.0099999999999998 110.081 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 2.2200000000000002 110.572 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.9199999999999999 111.24 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.73 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.1699999999999999 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 2.1400000000000001 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.6499999999999999 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.6699999999999999 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.96999999999999997 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.3700000000000001 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.79 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.79 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.8300000000000001 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 1.48 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.0699999999999998 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 2.3199999999999998 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 2.6099999999999999 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.9300000000000002 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 5.04 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.4699999999999998 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.96 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 3.4100000000000001 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.97 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 2.3399999999999999 110.011 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 2.1299999999999999 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.5099999999999998 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 3.3900000000000001 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 ' HB2' ' CA ' ' A' ' 7' ' ' CYS . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.5800000000000001 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.9099999999999999 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 1.3100000000000001 110.188 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.8600000000000001 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.6000000000000001 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.9299999999999999 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.8 110.34 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.8999999999999999 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.6699999999999999 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.6699999999999999 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 3.1600000000000001 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 5.3499999999999996 109.823 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 3.0800000000000001 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 4.0499999999999998 109.364 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 4.0 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.7699999999999996 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.8099999999999996 111.625 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 9.6099999999999994 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 8.2699999999999996 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.75 109.47 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.059 0.457 . . . . 5.6600000000000001 110.965 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.6200000000000001 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.8899999999999999 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 41' ' ' ILE . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 3.0099999999999998 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 2.2200000000000002 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.9199999999999999 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.73 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.1699999999999999 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 2.1400000000000001 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.6499999999999999 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.6699999999999999 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.96999999999999997 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.3700000000000001 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.79 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.79 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.8300000000000001 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 1.48 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.0699999999999998 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 2.3199999999999998 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 2.6099999999999999 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.9300000000000002 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 5.04 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.4699999999999998 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.96 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 3.4100000000000001 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.438 ' CE1' HG13 ' A' ' 49' ' ' ILE . 52.4 m-70 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.97 109.664 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 2.3399999999999999 109.65 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 2.1299999999999999 109.23 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.71 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.5099999999999998 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 3.3900000000000001 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.5800000000000001 111.043 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.9099999999999999 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 1.3100000000000001 111.279 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.8600000000000001 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.6000000000000001 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.9299999999999999 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.8 110.452 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.8999999999999999 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.6699999999999999 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.6699999999999999 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 3.1600000000000001 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 5.3499999999999996 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 3.0800000000000001 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.411 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 4.0499999999999998 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 4.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.7699999999999996 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.8099999999999996 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 9.6099999999999994 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 8.2699999999999996 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.75 110.042 -179.286 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.937 -0.394 . . . . 5.6600000000000001 109.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.6200000000000001 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.8899999999999999 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 3.0099999999999998 109.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 2.2200000000000002 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.9199999999999999 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.73 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.1699999999999999 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 2.1400000000000001 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.6499999999999999 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 HG13 ' CE1' ' A' ' 5' ' ' HIS . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.6699999999999999 110.013 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.96999999999999997 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.3700000000000001 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.79 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.79 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.8300000000000001 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 1.48 109.506 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.0699999999999998 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 2.3199999999999998 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 2.6099999999999999 110.682 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.441 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.9300000000000002 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 5.04 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.4699999999999998 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.96 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 3.4100000000000001 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.97 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 2.3399999999999999 110.174 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 2.1299999999999999 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.71 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.5099999999999998 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 3.3900000000000001 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.5800000000000001 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.9099999999999999 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 1.3100000000000001 111.791 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.8600000000000001 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.6000000000000001 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.9299999999999999 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.8 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.8999999999999999 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.6699999999999999 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.6699999999999999 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 3.1600000000000001 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 5.3499999999999996 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 3.0800000000000001 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 4.0499999999999998 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 4.0 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.7699999999999996 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.8099999999999996 111.531 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 9.6099999999999994 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 8.2699999999999996 110.506 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.75 111.215 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.317 0.58 . . . . 5.6600000000000001 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.6200000000000001 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.8899999999999999 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 3.0099999999999998 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 2.2200000000000002 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.9199999999999999 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.73 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 2.1400000000000001 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.6499999999999999 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.6699999999999999 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.96999999999999997 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.3700000000000001 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.79 109.709 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.79 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.8300000000000001 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 1.48 109.626 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.0699999999999998 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 2.3199999999999998 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 2.6099999999999999 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.9300000000000002 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 5.04 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.4699999999999998 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.96 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 3.4100000000000001 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.97 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 2.3399999999999999 109.73 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 2.1299999999999999 110.261 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.71 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.5099999999999998 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 3.3900000000000001 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.5800000000000001 110.75 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.9099999999999999 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 110.74 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.8600000000000001 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.6000000000000001 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.9299999999999999 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.8 110.968 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.8999999999999999 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.6699999999999999 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.6699999999999999 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 3.1600000000000001 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 5.3499999999999996 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 3.0800000000000001 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 4.0499999999999998 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 4.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.7699999999999996 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.8099999999999996 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 9.6099999999999994 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 8.2699999999999996 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.75 110.222 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.351 -0.611 . . . . 5.6600000000000001 109.351 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' ILE . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.6200000000000001 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.8899999999999999 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 3.0099999999999998 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 2.2200000000000002 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.9199999999999999 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.73 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 2.1400000000000001 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.6499999999999999 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.6699999999999999 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.96999999999999997 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.3700000000000001 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.79 110.233 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.79 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.8300000000000001 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 1.48 109.312 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.0699999999999998 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 2.3199999999999998 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 2.6099999999999999 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.9300000000000002 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 5.04 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.4699999999999998 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.96 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 3.4100000000000001 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.97 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 2.3399999999999999 109.812 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 2.1299999999999999 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.71 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.5099999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 3.3900000000000001 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 110.481 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.9099999999999999 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 111.358 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 HD23 ' CG ' ' A' ' 26' ' ' TYR . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.8600000000000001 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.6000000000000001 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.9299999999999999 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.8 111.062 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.8999999999999999 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.6699999999999999 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.6699999999999999 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 3.1600000000000001 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 5.3499999999999996 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 3.0800000000000001 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 4.0499999999999998 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 4.0 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.7699999999999996 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.8099999999999996 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 9.6099999999999994 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 8.2699999999999996 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.75 110.699 -179.073 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.111 0.482 . . . . 5.6600000000000001 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.6200000000000001 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.8899999999999999 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 3.0099999999999998 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 2.2200000000000002 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.9199999999999999 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.73 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.1699999999999999 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 2.1400000000000001 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.6499999999999999 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.6699999999999999 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.96999999999999997 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.3700000000000001 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.79 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.79 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.8300000000000001 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 1.48 109.725 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.0699999999999998 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 2.3199999999999998 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 2.6099999999999999 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.9300000000000002 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 5.04 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.4699999999999998 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.96 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 3.4100000000000001 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.97 109.927 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 2.3399999999999999 109.5 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 2.1299999999999999 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.71 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.5099999999999998 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 3.3900000000000001 110.516 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.5800000000000001 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.9099999999999999 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 1.3100000000000001 110.944 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.8600000000000001 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.6000000000000001 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.9299999999999999 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.8 111.125 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.8999999999999999 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.6699999999999999 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.6699999999999999 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 3.1600000000000001 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 5.3499999999999996 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 3.0800000000000001 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 4.0499999999999998 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 4.0 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.7699999999999996 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.8099999999999996 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 9.6099999999999994 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 8.2699999999999996 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.75 109.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 tptt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.013 0.435 . . . . 5.6600000000000001 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.6200000000000001 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.8899999999999999 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 3.0099999999999998 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 2.2200000000000002 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.9199999999999999 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.73 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.1699999999999999 111.526 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 2.1400000000000001 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.6499999999999999 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.6699999999999999 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.96999999999999997 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.3700000000000001 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.79 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.79 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.8300000000000001 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 1.48 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.0699999999999998 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 2.3199999999999998 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 2.6099999999999999 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.9300000000000002 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 5.04 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.4699999999999998 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.96 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 3.4100000000000001 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.97 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 2.1299999999999999 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.71 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.5099999999999998 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 3.3900000000000001 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.5800000000000001 110.558 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.9099999999999999 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 1.3100000000000001 111.03 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.8600000000000001 110.91 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.6000000000000001 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.9299999999999999 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.8 110.959 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.8999999999999999 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.6699999999999999 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.6699999999999999 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 3.1600000000000001 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 5.3499999999999996 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 3.0800000000000001 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 4.0499999999999998 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 4.0 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.7699999999999996 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.8099999999999996 110.109 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 9.6099999999999994 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 8.2699999999999996 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.75 111.035 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.6 tttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.249 -0.649 . . . . 5.6600000000000001 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.6200000000000001 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.8899999999999999 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 3.0099999999999998 111.025 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 2.2200000000000002 111.119 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.9199999999999999 110.961 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.73 111.639 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.1699999999999999 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 2.1400000000000001 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.6499999999999999 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.6699999999999999 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.96999999999999997 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.3700000000000001 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.79 110.893 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.79 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.8300000000000001 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 1.48 109.552 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.0699999999999998 110.006 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 2.3199999999999998 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 2.6099999999999999 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.9300000000000002 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 5.04 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.4699999999999998 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.96 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 3.4100000000000001 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.97 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 2.1299999999999999 109.615 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.71 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.5099999999999998 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 3.3900000000000001 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.5800000000000001 110.562 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.9099999999999999 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 1.3100000000000001 110.498 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.8600000000000001 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.6000000000000001 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.9299999999999999 111.244 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.8 110.948 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.8999999999999999 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.6699999999999999 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.6699999999999999 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 3.1600000000000001 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 5.3499999999999996 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 4.0499999999999998 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 4.0 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.7699999999999996 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.8099999999999996 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 9.6099999999999994 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 8.2699999999999996 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.75 111.619 -179.241 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.601 -0.518 . . . . 5.6600000000000001 109.601 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.6200000000000001 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.8899999999999999 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 3.0099999999999998 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 2.2200000000000002 110.653 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.9199999999999999 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.73 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.1699999999999999 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 2.1400000000000001 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.6499999999999999 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.6699999999999999 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.96999999999999997 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.3700000000000001 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.79 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.79 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.8300000000000001 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 1.48 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.0699999999999998 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 2.3199999999999998 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 2.6099999999999999 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.9300000000000002 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 5.04 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.4699999999999998 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.96 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 3.4100000000000001 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.97 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 2.3399999999999999 109.849 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 2.1299999999999999 110.87 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.71 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.5099999999999998 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 3.3900000000000001 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.5800000000000001 110.878 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 1.3100000000000001 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.8600000000000001 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.6000000000000001 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.9299999999999999 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.8 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.8999999999999999 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.6699999999999999 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.6699999999999999 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 3.1600000000000001 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 5.3499999999999996 112.713 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.407 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 3.0800000000000001 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 4.0499999999999998 110.62 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 4.0 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.7699999999999996 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.8099999999999996 111.873 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 9.6099999999999994 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 8.2699999999999996 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.75 109.667 178.471 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.163 0.506 . . . . 5.6600000000000001 110.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.6200000000000001 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.8899999999999999 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 3.0099999999999998 110.987 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 2.2200000000000002 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.9199999999999999 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.73 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.1699999999999999 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 2.1400000000000001 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.6499999999999999 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.6699999999999999 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.96999999999999997 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.3700000000000001 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.79 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.79 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.8300000000000001 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 1.48 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.0699999999999998 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 2.3199999999999998 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 2.6099999999999999 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.9300000000000002 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 5.04 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.4699999999999998 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.96 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 3.4100000000000001 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.97 110.434 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 2.3399999999999999 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 2.1299999999999999 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.71 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.5099999999999998 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 3.3900000000000001 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.5800000000000001 110.656 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.9099999999999999 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 1.3100000000000001 112.898 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.8600000000000001 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.6000000000000001 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.9299999999999999 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.8 110.851 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.8999999999999999 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.6699999999999999 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.6699999999999999 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 3.1600000000000001 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 5.3499999999999996 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 3.0800000000000001 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 4.0499999999999998 110.099 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 4.0 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.7699999999999996 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.8099999999999996 110.771 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 9.6099999999999994 109.909 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 8.2699999999999996 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.75 110.008 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.145 0.498 . . . . 5.6600000000000001 109.701 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.6200000000000001 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.8899999999999999 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 3.0099999999999998 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 2.2200000000000002 109.136 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.9199999999999999 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.73 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.1699999999999999 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 2.1400000000000001 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.6499999999999999 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.6699999999999999 109.925 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.96999999999999997 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.3700000000000001 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.79 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.79 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.8300000000000001 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 1.48 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.0699999999999998 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 2.3199999999999998 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 2.6099999999999999 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.9300000000000002 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 5.04 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.4699999999999998 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.96 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 3.4100000000000001 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.97 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 2.3399999999999999 110.623 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 2.1299999999999999 110.278 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.71 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.5099999999999998 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 3.3900000000000001 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.5800000000000001 110.153 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.9099999999999999 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 1.3100000000000001 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.8600000000000001 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.6000000000000001 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.9299999999999999 111.553 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.8 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.8999999999999999 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.6699999999999999 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.6699999999999999 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 3.1600000000000001 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 5.3499999999999996 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 3.0800000000000001 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 4.0499999999999998 109.14 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 4.0 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.7699999999999996 110.039 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.8099999999999996 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 9.6099999999999994 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 8.2699999999999996 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.75 111.462 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.752 -0.462 . . . . 5.6600000000000001 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.6200000000000001 109.986 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.8899999999999999 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 3.0099999999999998 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 2.2200000000000002 110.961 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.9199999999999999 110.497 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.73 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.1699999999999999 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 2.1400000000000001 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.6499999999999999 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.6699999999999999 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.96999999999999997 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.3700000000000001 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.79 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.79 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.8300000000000001 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 1.48 109.37 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.0699999999999998 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 2.3199999999999998 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 2.6099999999999999 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.9300000000000002 110.05 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 5.04 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.4699999999999998 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.96 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 3.4100000000000001 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.97 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 2.3399999999999999 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 2.1299999999999999 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.71 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.5099999999999998 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 3.3900000000000001 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HB2' ' CA ' ' A' ' 7' ' ' CYS . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.5800000000000001 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.9099999999999999 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 1.3100000000000001 110.81 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.8600000000000001 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.6000000000000001 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.9299999999999999 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.8 111.646 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.8999999999999999 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.6699999999999999 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.6699999999999999 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 3.1600000000000001 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 5.3499999999999996 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 3.0800000000000001 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 4.0499999999999998 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 4.0 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.7699999999999996 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.8099999999999996 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 9.6099999999999994 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 8.2699999999999996 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -90.07 113.1 55.95 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.75 109.878 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.63 52.84 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.113 1.059 . . . . 7.2800000000000002 110.734 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.53 -113.68 0.85 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.04 -1.624 . . . . 5.4900000000000002 109.04 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t0 50.03 41.64 23.58 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.61 -0.935 . . . . 6.6200000000000001 111.77 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.4 t 41.7 55.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 121.13 0.49 . . . . 5.2699999999999996 112.196 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.98 161.02 31.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.53 -0.731 . . . . 5.6600000000000001 109.906 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.6200000000000001 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.8899999999999999 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 3.0099999999999998 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 2.2200000000000002 110.154 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.9199999999999999 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.73 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.1699999999999999 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 2.1400000000000001 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.6499999999999999 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.6699999999999999 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.96999999999999997 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.3700000000000001 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.79 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.79 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.8300000000000001 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 1.48 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.0699999999999998 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 2.3199999999999998 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 2.6099999999999999 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.9300000000000002 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 5.04 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.4699999999999998 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.96 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 3.4100000000000001 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.97 110.258 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 2.3399999999999999 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 2.1299999999999999 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.71 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.5099999999999998 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 3.3900000000000001 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.5800000000000001 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.9099999999999999 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 111.159 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.8600000000000001 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.6000000000000001 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.9299999999999999 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.8 110.524 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.8999999999999999 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.6699999999999999 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.6699999999999999 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 3.1600000000000001 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 5.3499999999999996 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.412 ' CE1' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 3.0800000000000001 110.314 -179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 4.0499999999999998 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 4.0 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.7699999999999996 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.8099999999999996 110.734 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 9.6099999999999994 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 8.2699999999999996 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -76.06 146.02 78.09 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.75 109.718 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.25 -46.64 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.484 1.255 . . . . 7.2800000000000002 111.012 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.17 -111.74 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.545 -1.422 . . . . 5.4900000000000002 109.545 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -162.19 126.87 3.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.691 -0.887 . . . . 6.6200000000000001 110.198 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.41 -49.96 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.749 . . . . 5.2699999999999996 109.304 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -152.75 154.73 35.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 5.6600000000000001 109.51 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.6200000000000001 109.414 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.8899999999999999 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 26' ' ' TYR . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 3.0099999999999998 110.787 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 2.2200000000000002 111.668 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.9199999999999999 111.713 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.73 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.1699999999999999 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 2.1400000000000001 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.6499999999999999 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.6699999999999999 110.144 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.96999999999999997 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.3700000000000001 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.79 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.79 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.8300000000000001 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 1.48 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.0699999999999998 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 2.3199999999999998 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 2.6099999999999999 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.9300000000000002 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 5.04 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.4699999999999998 111.51 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.96 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 3.4100000000000001 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.97 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 2.3399999999999999 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 2.1299999999999999 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.71 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.5099999999999998 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 3.3900000000000001 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.5800000000000001 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.9099999999999999 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 1.3100000000000001 112.141 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.8600000000000001 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.6000000000000001 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.8 110.671 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.8999999999999999 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.6699999999999999 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.6699999999999999 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 3.1600000000000001 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 5.3499999999999996 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 3.0800000000000001 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 4.0499999999999998 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 4.0 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.7699999999999996 109.55 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.8099999999999996 113.962 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 9.6099999999999994 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 8.2699999999999996 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.68 168.98 11.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.75 109.937 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.76 -50.63 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.274 1.144 . . . . 7.2800000000000002 110.312 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 68.32 0.55 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.964 -1.254 . . . . 5.4900000000000002 109.964 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 38' ' ' LYS . 66.6 m-20 -76.95 146.88 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.991 . . . . 6.6200000000000001 109.465 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t 58.91 -80.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.76 -0.588 . . . . 5.2699999999999996 110.281 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 36' ' ' ASP . 25.4 mttm -80.51 114.29 19.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.059 -1.025 . . . . 5.6600000000000001 109.85 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.6200000000000001 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.8899999999999999 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 3.0099999999999998 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 2.2200000000000002 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.9199999999999999 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.73 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.1699999999999999 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 2.1400000000000001 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.6499999999999999 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.6699999999999999 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.96999999999999997 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.3700000000000001 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.79 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.79 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.8300000000000001 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 1.48 110.23 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.0699999999999998 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 2.3199999999999998 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 2.6099999999999999 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.9300000000000002 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 5.04 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.4699999999999998 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.96 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 3.4100000000000001 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.409 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.97 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 2.3399999999999999 109.414 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 2.1299999999999999 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.71 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.5099999999999998 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 3.3900000000000001 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.5800000000000001 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.9099999999999999 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 1.3100000000000001 110.012 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.8600000000000001 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.6000000000000001 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.9299999999999999 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.8 110.925 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.8999999999999999 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.6699999999999999 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.6699999999999999 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 3.1600000000000001 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 5.3499999999999996 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 3.0800000000000001 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 4.0499999999999998 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 4.0 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.7699999999999996 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.8099999999999996 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 9.6099999999999994 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 8.2699999999999996 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 98.6 m-85 -77.91 -42.77 2.27 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.75 111.89 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 33' ' ' TYR . 53.7 Cg_endo -81.14 160.1 20.49 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 122.721 0.853 . . . . 7.2800000000000002 110.531 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.18 132.2 5.8 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.401 -1.479 . . . . 5.4900000000000002 109.401 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -153.81 -179.96 8.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.87 -0.782 . . . . 6.6200000000000001 110.763 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p 40.63 28.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 112.759 0.651 . . . . 5.2699999999999996 112.759 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -161.32 29.86 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.296 -0.878 . . . . 5.6600000000000001 109.435 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.6200000000000001 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.8899999999999999 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 41' ' ' ILE . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 3.0099999999999998 109.584 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 2.2200000000000002 111.186 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.9199999999999999 111.445 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.73 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.1699999999999999 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 2.1400000000000001 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.6499999999999999 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.6699999999999999 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.96999999999999997 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.3700000000000001 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.79 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.79 110.72 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.8300000000000001 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 1.48 109.593 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.0699999999999998 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 2.3199999999999998 109.969 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 2.6099999999999999 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.9300000000000002 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 5.04 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.4699999999999998 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.96 108.427 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 3.4100000000000001 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.97 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 2.3399999999999999 110.531 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 2.1299999999999999 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.71 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.5099999999999998 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 3.3900000000000001 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.5800000000000001 110.569 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.9099999999999999 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 1.3100000000000001 111.106 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD21 ' CZ ' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.8600000000000001 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.6000000000000001 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.9299999999999999 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.8 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.8999999999999999 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.6699999999999999 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.6699999999999999 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 3.1600000000000001 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 5.3499999999999996 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.415 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 3.0800000000000001 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 4.0499999999999998 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 4.0 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.7699999999999996 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.8099999999999996 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 9.6099999999999994 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 8.2699999999999996 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 -152.86 144.88 16.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.75 110.106 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -85.38 75.27 3.41 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 123.413 1.217 . . . . 7.2800000000000002 110.912 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.62 80.17 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.345 -1.102 . . . . 5.4900000000000002 110.345 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.26 117.56 20.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.473 -1.016 . . . . 6.6200000000000001 110.04 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.9 t -71.82 -39.8 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.555 -0.716 . . . . 5.2699999999999996 109.985 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -145.94 159.98 42.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 5.6600000000000001 110.341 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.6200000000000001 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.8899999999999999 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 58' ' ' TYR . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 3.0099999999999998 109.349 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 2.2200000000000002 110.1 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.9199999999999999 110.336 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.73 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.1699999999999999 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 2.1400000000000001 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.6499999999999999 110.164 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.6699999999999999 109.992 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.96999999999999997 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.3700000000000001 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.79 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.79 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.8300000000000001 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 1.48 109.971 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.0699999999999998 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 2.3199999999999998 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 2.6099999999999999 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.9300000000000002 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 5.04 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.4699999999999998 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.96 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 3.4100000000000001 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.97 110.433 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 2.3399999999999999 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 2.1299999999999999 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.71 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.5099999999999998 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 3.3900000000000001 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.5800000000000001 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.9099999999999999 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 1.3100000000000001 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.8600000000000001 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.6000000000000001 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.9299999999999999 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.8 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.8999999999999999 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.6699999999999999 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.6699999999999999 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 3.1600000000000001 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 5.3499999999999996 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 3.0800000000000001 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 4.0499999999999998 110.224 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 4.0 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.7699999999999996 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.8099999999999996 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 9.6099999999999994 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 8.2699999999999996 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' CD1' ' HD2' ' A' ' 34' ' ' PRO . 14.4 t80 -161.12 140.0 7.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.75 109.995 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 46.4 Cg_endo -70.58 96.28 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.139 1.073 . . . . 7.2800000000000002 111.468 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.25 -58.09 4.85 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.885 -1.286 . . . . 5.4900000000000002 109.885 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 38' ' ' LYS . 19.0 t0 53.74 42.11 31.89 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.396 -1.061 . . . . 6.6200000000000001 110.977 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.1 t 55.08 -86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.855 -0.528 . . . . 5.2699999999999996 110.358 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 mptt -80.7 113.17 18.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.141 -0.975 . . . . 5.6600000000000001 109.369 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.6200000000000001 108.915 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.8899999999999999 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.415 HD11 ' CZ ' ' A' ' 58' ' ' TYR . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 3.0099999999999998 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 2.2200000000000002 110.675 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.9199999999999999 110.91 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.73 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.1699999999999999 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 2.1400000000000001 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.6499999999999999 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.6699999999999999 111.411 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.96999999999999997 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.3700000000000001 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.79 110.905 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.79 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.8300000000000001 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 1.48 109.7 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.0699999999999998 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 2.3199999999999998 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CZ ' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 2.6099999999999999 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.9300000000000002 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 5.04 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.4699999999999998 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.96 109.273 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 3.4100000000000001 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.97 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 2.3399999999999999 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 2.1299999999999999 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.71 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.5099999999999998 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 3.3900000000000001 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.5800000000000001 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.9099999999999999 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 1.3100000000000001 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.8600000000000001 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.6000000000000001 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.9299999999999999 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.8 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.8999999999999999 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.6699999999999999 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.6699999999999999 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 3.1600000000000001 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 5.3499999999999996 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 3.0800000000000001 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 4.0499999999999998 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 4.0 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.7699999999999996 109.987 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.8099999999999996 113.08 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 9.6099999999999994 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 8.2699999999999996 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 13.8 t80 -154.74 144.22 15.27 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.75 110.472 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 42.3 Cg_endo -70.53 -53.95 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.317 1.167 . . . . 7.2800000000000002 110.543 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 104.85 0.17 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.155 -1.178 . . . . 5.4900000000000002 110.155 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 38' ' ' LYS . 93.2 m-20 -75.56 154.36 36.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.961 . . . . 6.6200000000000001 109.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.9 t 65.33 -64.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 109.738 -0.467 . . . . 5.2699999999999996 109.738 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' ASP . 19.9 tptm -78.58 154.2 30.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 5.6600000000000001 108.87 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.6200000000000001 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.8899999999999999 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 3.0099999999999998 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 2.2200000000000002 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.9199999999999999 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.73 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.1699999999999999 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 2.1400000000000001 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.6499999999999999 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.6699999999999999 109.67 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.96999999999999997 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.3700000000000001 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.79 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.79 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.8300000000000001 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 1.48 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.0699999999999998 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 2.3199999999999998 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 2.6099999999999999 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.9300000000000002 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 5.04 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.4699999999999998 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.96 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 3.4100000000000001 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.97 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 2.3399999999999999 109.379 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 2.1299999999999999 109.509 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.71 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.5099999999999998 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 3.3900000000000001 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.5800000000000001 110.52 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.9099999999999999 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 1.3100000000000001 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.8600000000000001 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.6000000000000001 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.9299999999999999 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.8 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.8999999999999999 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.6699999999999999 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.6699999999999999 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 3.1600000000000001 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 5.3499999999999996 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 3.0800000000000001 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 4.0499999999999998 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 4.0 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.7699999999999996 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.8099999999999996 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 9.6099999999999994 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 8.2699999999999996 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -77.7 -55.64 1.23 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.75 110.23 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.22 71.62 5.08 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.159 1.084 . . . . 7.2800000000000002 110.299 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.83 104.63 0.29 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.203 -1.559 . . . . 5.4900000000000002 109.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -80.03 105.0 10.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.579 -0.954 . . . . 6.6200000000000001 110.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -153.56 -162.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.65 -0.656 . . . . 5.2699999999999996 109.834 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -76.6 141.5 41.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.391 -0.818 . . . . 5.6600000000000001 110.432 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.6200000000000001 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.8899999999999999 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG23 ' CE1' ' A' ' 58' ' ' TYR . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 3.0099999999999998 109.331 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 2.2200000000000002 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.9199999999999999 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.73 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.1699999999999999 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 2.1400000000000001 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.6499999999999999 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.6699999999999999 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.96999999999999997 109.447 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.3700000000000001 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.79 110.507 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.79 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.8300000000000001 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 1.48 110.189 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.0699999999999998 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 2.3199999999999998 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' CE1' HG23 ' A' ' 41' ' ' ILE . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 2.6099999999999999 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.9300000000000002 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 5.04 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.4699999999999998 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.96 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 3.4100000000000001 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.97 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 2.3399999999999999 109.012 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 2.1299999999999999 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.71 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.5099999999999998 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 3.3900000000000001 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.5800000000000001 110.13 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.9099999999999999 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 1.3100000000000001 111.442 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.8600000000000001 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.6000000000000001 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.9299999999999999 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.8 110.604 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.8999999999999999 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.6699999999999999 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.6699999999999999 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 3.1600000000000001 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 5.3499999999999996 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 3.0800000000000001 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 4.0499999999999998 110.236 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 4.0 110.624 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.7699999999999996 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.8099999999999996 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 9.6099999999999994 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 8.2699999999999996 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -85.53 139.64 35.83 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.75 109.678 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.83 80.84 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.189 1.1 . . . . 7.2800000000000002 110.371 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.61 85.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.32 -1.512 . . . . 5.4900000000000002 109.32 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 38' ' ' LYS . 86.8 m-20 -74.4 156.74 36.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -1.007 . . . . 6.6200000000000001 109.739 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t 64.19 -65.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 122.134 -0.354 . . . . 5.2699999999999996 110.938 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' ASP . 3.7 pttt -79.82 149.73 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.839 . . . . 5.6600000000000001 110.287 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.6200000000000001 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.8899999999999999 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 41' ' ' ILE . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 3.0099999999999998 110.081 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 2.2200000000000002 110.572 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.9199999999999999 111.24 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.73 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.1699999999999999 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 2.1400000000000001 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.6499999999999999 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.6699999999999999 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.96999999999999997 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.3700000000000001 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.79 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.79 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.8300000000000001 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 1.48 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.0699999999999998 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 2.3199999999999998 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 2.6099999999999999 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.9300000000000002 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 5.04 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.4699999999999998 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.96 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 3.4100000000000001 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.97 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 2.3399999999999999 110.011 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 2.1299999999999999 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.5099999999999998 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 3.3900000000000001 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 ' HB2' ' CA ' ' A' ' 7' ' ' CYS . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.5800000000000001 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.9099999999999999 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 1.3100000000000001 110.188 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.8600000000000001 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.6000000000000001 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.9299999999999999 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.8 110.34 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.8999999999999999 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.6699999999999999 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.6699999999999999 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 3.1600000000000001 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 5.3499999999999996 109.823 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 3.0800000000000001 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 4.0499999999999998 109.364 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 4.0 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.7699999999999996 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.8099999999999996 111.625 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 9.6099999999999994 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 8.2699999999999996 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.457 ' CD1' ' HD2' ' A' ' 34' ' ' PRO . 15.2 t80 -150.64 149.12 25.17 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.75 109.47 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 43.6 Cg_endo -79.94 74.7 5.42 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.083 1.044 . . . . 7.2800000000000002 111.025 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.09 79.52 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.159 -1.576 . . . . 5.4900000000000002 109.159 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -154.85 167.62 29.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.704 -0.88 . . . . 6.6200000000000001 109.742 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.86 113.54 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.483 -0.76 . . . . 5.2699999999999996 109.814 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -86.9 103.2 15.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.73 -0.606 . . . . 5.6600000000000001 110.965 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.6200000000000001 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.8899999999999999 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 41' ' ' ILE . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 3.0099999999999998 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 2.2200000000000002 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.9199999999999999 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.73 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.1699999999999999 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 2.1400000000000001 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.6499999999999999 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.6699999999999999 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.96999999999999997 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.3700000000000001 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.79 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.79 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.8300000000000001 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 1.48 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.0699999999999998 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 2.3199999999999998 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 2.6099999999999999 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.9300000000000002 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 5.04 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.4699999999999998 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.96 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 3.4100000000000001 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.438 ' CE1' HG13 ' A' ' 49' ' ' ILE . 52.4 m-70 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.97 109.664 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 2.3399999999999999 109.65 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 2.1299999999999999 109.23 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.71 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.5099999999999998 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 3.3900000000000001 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.5800000000000001 111.043 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.9099999999999999 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 1.3100000000000001 111.279 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.8600000000000001 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.6000000000000001 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.9299999999999999 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.8 110.452 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.8999999999999999 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.6699999999999999 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.6699999999999999 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.441 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 3.1600000000000001 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 5.3499999999999996 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 3.0800000000000001 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.411 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 4.0499999999999998 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 4.0 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.7699999999999996 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.8099999999999996 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 9.6099999999999994 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 8.2699999999999996 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -148.07 151.91 38.77 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.75 110.042 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.12 139.57 8.36 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.313 1.165 . . . . 7.2800000000000002 110.583 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.57 21.17 45.0 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.679 -0.969 . . . . 5.4900000000000002 110.679 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -78.01 150.02 33.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.212 -1.17 . . . . 6.6200000000000001 110.335 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.9 t -155.14 67.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.867 -0.79 . . . . 5.2699999999999996 108.867 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -160.02 158.04 29.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.562 -0.711 . . . . 5.6600000000000001 109.937 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.6200000000000001 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.8899999999999999 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 3.0099999999999998 109.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 2.2200000000000002 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.9199999999999999 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.73 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.1699999999999999 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 2.1400000000000001 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.6499999999999999 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 HG13 ' CE1' ' A' ' 5' ' ' HIS . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.6699999999999999 110.013 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.96999999999999997 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.3700000000000001 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.79 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.79 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.8300000000000001 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 1.48 109.506 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.0699999999999998 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 2.3199999999999998 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 2.6099999999999999 110.682 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.441 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.9300000000000002 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 5.04 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.4699999999999998 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.96 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 3.4100000000000001 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.97 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 2.3399999999999999 110.174 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 2.1299999999999999 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.71 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.5099999999999998 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 3.3900000000000001 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.5800000000000001 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.9099999999999999 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 1.3100000000000001 111.791 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.8600000000000001 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.6000000000000001 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.9299999999999999 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.8 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.8999999999999999 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.6699999999999999 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.6699999999999999 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 3.1600000000000001 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 5.3499999999999996 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 3.0800000000000001 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 4.0499999999999998 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 4.0 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.7699999999999996 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.8099999999999996 111.531 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 9.6099999999999994 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 8.2699999999999996 110.506 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.62 82.64 2.37 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.75 111.215 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.25 63.72 8.79 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.174 1.091 . . . . 7.2800000000000002 109.82 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.35 56.33 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.03 -0.828 . . . . 5.4900000000000002 111.03 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.18 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.246 -1.15 . . . . 6.6200000000000001 110.873 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t 57.39 -80.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.747 -0.595 . . . . 5.2699999999999996 111.467 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -76.72 80.54 3.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.959 . . . . 5.6600000000000001 109.557 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.6200000000000001 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.8899999999999999 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 3.0099999999999998 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 2.2200000000000002 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.9199999999999999 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.73 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.1699999999999999 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 2.1400000000000001 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.6499999999999999 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.6699999999999999 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.96999999999999997 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.3700000000000001 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.79 109.709 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.79 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.8300000000000001 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 1.48 109.626 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.0699999999999998 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 2.3199999999999998 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 2.6099999999999999 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.9300000000000002 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 5.04 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.4699999999999998 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.96 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 3.4100000000000001 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.97 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 2.3399999999999999 109.73 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 2.1299999999999999 110.261 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.71 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.5099999999999998 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 3.3900000000000001 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.5800000000000001 110.75 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.9099999999999999 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 110.74 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.8600000000000001 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.6000000000000001 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.9299999999999999 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.8 110.968 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.8999999999999999 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.6699999999999999 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.6699999999999999 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 3.1600000000000001 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 5.3499999999999996 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 3.0800000000000001 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 4.0499999999999998 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 4.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.7699999999999996 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.8099999999999996 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 9.6099999999999994 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 8.2699999999999996 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.54 90.55 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.75 110.222 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.24 -179.31 5.33 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.47 1.247 . . . . 7.2800000000000002 110.43 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.77 110.38 3.02 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.89 -1.284 . . . . 5.4900000000000002 109.89 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 49.96 49.95 19.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.526 -0.985 . . . . 6.6200000000000001 110.745 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.83 148.78 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.701 -0.625 . . . . 5.2699999999999996 110.201 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -70.0 -36.25 75.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.695 -0.628 . . . . 5.6600000000000001 109.351 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' ILE . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.6200000000000001 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.8899999999999999 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 3.0099999999999998 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 2.2200000000000002 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.9199999999999999 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.73 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 2.1400000000000001 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.6499999999999999 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.6699999999999999 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.96999999999999997 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.3700000000000001 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.79 110.233 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.79 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.8300000000000001 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 1.48 109.312 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.0699999999999998 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 2.3199999999999998 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 2.6099999999999999 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.9300000000000002 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 5.04 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.4699999999999998 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.96 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 3.4100000000000001 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.97 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 2.3399999999999999 109.812 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 2.1299999999999999 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.71 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.5099999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 3.3900000000000001 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.5800000000000001 110.481 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.9099999999999999 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 111.358 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD23 ' CG ' ' A' ' 26' ' ' TYR . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.8600000000000001 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.6000000000000001 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.9299999999999999 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.8 111.062 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.8999999999999999 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.6699999999999999 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.6699999999999999 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 3.1600000000000001 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 5.3499999999999996 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 3.0800000000000001 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 4.0499999999999998 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 4.0 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.7699999999999996 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.8099999999999996 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 9.6099999999999994 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 8.2699999999999996 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -150.06 97.03 3.44 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.75 110.699 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.0 62.13 4.19 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.284 1.15 . . . . 7.2800000000000002 110.159 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.14 21.64 41.04 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.388 -1.085 . . . . 5.4900000000000002 110.388 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.83 114.56 18.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.308 -1.113 . . . . 6.6200000000000001 110.284 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t 54.83 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.734 -0.604 . . . . 5.2699999999999996 111.194 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -146.67 173.32 12.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 5.6600000000000001 110.06 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.6200000000000001 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.8899999999999999 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 3.0099999999999998 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 2.2200000000000002 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.9199999999999999 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.73 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.1699999999999999 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 2.1400000000000001 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.6499999999999999 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.6699999999999999 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.96999999999999997 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.3700000000000001 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.79 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.79 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.8300000000000001 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 1.48 109.725 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.0699999999999998 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 2.3199999999999998 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 2.6099999999999999 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.9300000000000002 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 5.04 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.4699999999999998 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.96 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 3.4100000000000001 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.97 109.927 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 2.3399999999999999 109.5 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 2.1299999999999999 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.71 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.5099999999999998 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 3.3900000000000001 110.516 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.5800000000000001 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.9099999999999999 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 1.3100000000000001 110.944 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.8600000000000001 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.6000000000000001 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.9299999999999999 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.8 111.125 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.8999999999999999 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.6699999999999999 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.6699999999999999 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 3.1600000000000001 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 5.3499999999999996 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 3.0800000000000001 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 4.0499999999999998 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 4.0 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.7699999999999996 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.8099999999999996 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 9.6099999999999994 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 8.2699999999999996 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.44 66.5 15.82 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.75 109.944 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 38' ' ' LYS . 47.9 Cg_endo -71.79 -165.26 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 O-C-N 123.292 1.153 . . . . 7.2800000000000002 110.184 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.61 -10.09 60.73 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.336 -0.935 . . . . 5.4900000000000002 110.777 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.2 40.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.956 -1.32 . . . . 6.6200000000000001 111.998 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p 37.47 59.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.592 0 N-CA-C 112.934 0.716 . . . . 5.2699999999999996 112.934 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 42.1 tptt -77.79 82.86 4.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 5.6600000000000001 109.994 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.6200000000000001 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.8899999999999999 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 3.0099999999999998 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 2.2200000000000002 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.9199999999999999 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.73 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.1699999999999999 111.526 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 2.1400000000000001 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.6499999999999999 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.6699999999999999 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.96999999999999997 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.3700000000000001 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.79 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.79 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.8300000000000001 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 1.48 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.0699999999999998 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 2.3199999999999998 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 2.6099999999999999 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.9300000000000002 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 5.04 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.4699999999999998 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.96 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 3.4100000000000001 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.97 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 2.1299999999999999 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.71 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.5099999999999998 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 3.3900000000000001 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.5800000000000001 110.558 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.9099999999999999 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 1.3100000000000001 111.03 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.8600000000000001 110.91 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.6000000000000001 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.9299999999999999 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.8 110.959 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.8999999999999999 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.6699999999999999 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.6699999999999999 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 3.1600000000000001 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 5.3499999999999996 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 3.0800000000000001 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 4.0499999999999998 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 4.0 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.7699999999999996 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.8099999999999996 110.109 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 9.6099999999999994 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 8.2699999999999996 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -77.93 -54.37 1.33 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.75 111.035 -179.391 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.4 Cg_endo -72.46 133.24 20.39 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.195 1.103 . . . . 7.2800000000000002 110.289 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.25 37.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.41 -1.476 . . . . 5.4900000000000002 109.41 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 50.0 38.29 16.13 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.349 -1.089 . . . . 6.6200000000000001 110.727 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.0 t 55.32 170.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.828 -0.545 . . . . 5.2699999999999996 110.014 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -70.0 -39.96 75.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.015 -1.053 . . . . 5.6600000000000001 109.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.6200000000000001 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.8899999999999999 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 3.0099999999999998 111.025 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 2.2200000000000002 111.119 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.9199999999999999 110.961 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.73 111.639 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.1699999999999999 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 2.1400000000000001 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.6499999999999999 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.6699999999999999 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.96999999999999997 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.3700000000000001 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.79 110.893 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.79 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.8300000000000001 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 1.48 109.552 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.0699999999999998 110.006 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 2.3199999999999998 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 2.6099999999999999 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.9300000000000002 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 5.04 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.4699999999999998 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.96 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 3.4100000000000001 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.97 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 2.1299999999999999 109.615 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.71 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.5099999999999998 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 3.3900000000000001 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.5800000000000001 110.562 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.9099999999999999 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 1.3100000000000001 110.498 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.8600000000000001 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.6000000000000001 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.9299999999999999 111.244 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.8 110.948 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.8999999999999999 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.6699999999999999 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.6699999999999999 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 3.1600000000000001 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 5.3499999999999996 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 3.0800000000000001 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 4.0499999999999998 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 4.0 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.7699999999999996 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.8099999999999996 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 9.6099999999999994 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 8.2699999999999996 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 1.8 m-85 -78.44 -54.78 1.14 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.75 111.619 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.8 Cg_endo -69.92 -168.67 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 122.988 0.993 . . . . 7.2800000000000002 110.988 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.66 -74.59 0.9 Allowed Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.446 -1.062 . . . . 5.4900000000000002 110.446 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 52.54 56.67 7.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.343 -1.092 . . . . 6.6200000000000001 110.963 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.9 t 57.87 169.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.644 -0.66 . . . . 5.2699999999999996 110.314 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -145.7 -174.06 4.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 5.6600000000000001 109.601 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.6200000000000001 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.8899999999999999 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 3.0099999999999998 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 2.2200000000000002 110.653 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.9199999999999999 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.73 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.1699999999999999 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 2.1400000000000001 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.6499999999999999 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.6699999999999999 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.96999999999999997 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.3700000000000001 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.79 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.79 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.8300000000000001 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 1.48 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.0699999999999998 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 2.3199999999999998 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 2.6099999999999999 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.9300000000000002 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 5.04 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.4699999999999998 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.96 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 3.4100000000000001 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.97 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 2.3399999999999999 109.849 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 2.1299999999999999 110.87 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.71 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.5099999999999998 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 3.3900000000000001 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.5800000000000001 110.878 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.9099999999999999 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 1.3100000000000001 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.8600000000000001 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.6000000000000001 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.9299999999999999 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.8 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.8999999999999999 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.6699999999999999 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.6699999999999999 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 3.1600000000000001 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 5.3499999999999996 112.713 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.407 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 3.0800000000000001 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 4.0499999999999998 110.62 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 4.0 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.7699999999999996 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.8099999999999996 111.873 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 9.6099999999999994 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 8.2699999999999996 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -154.15 61.7 3.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.75 109.667 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.06 -23.94 7.29 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.519 1.273 . . . . 7.2800000000000002 111.4 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.45 39.99 3.55 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.706 -1.758 . . . . 5.4900000000000002 108.706 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -80.75 68.05 6.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.761 -0.846 . . . . 6.6200000000000001 112.026 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 80.5 t 52.69 -89.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.248 -0.907 . . . . 5.2699999999999996 111.266 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -79.75 146.84 32.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.818 -1.176 . . . . 5.6600000000000001 110.048 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.6200000000000001 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.8899999999999999 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 3.0099999999999998 110.987 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 2.2200000000000002 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.9199999999999999 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.73 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.1699999999999999 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 2.1400000000000001 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.6499999999999999 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.6699999999999999 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.96999999999999997 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.3700000000000001 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.79 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.79 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.8300000000000001 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 1.48 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.0699999999999998 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 2.3199999999999998 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 2.6099999999999999 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.9300000000000002 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 5.04 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.4699999999999998 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.96 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 3.4100000000000001 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.97 110.434 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 2.3399999999999999 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 2.1299999999999999 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.71 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.5099999999999998 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 3.3900000000000001 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.5800000000000001 110.656 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.9099999999999999 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 1.3100000000000001 112.898 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.8600000000000001 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.6000000000000001 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.9299999999999999 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.8 110.851 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.8999999999999999 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.6699999999999999 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.6699999999999999 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 3.1600000000000001 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 5.3499999999999996 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 3.0800000000000001 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 4.0499999999999998 110.099 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 4.0 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.7699999999999996 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.8099999999999996 110.771 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 9.6099999999999994 109.909 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 8.2699999999999996 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.03 103.69 1.91 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.75 110.008 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.72 -79.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.234 1.123 . . . . 7.2800000000000002 111.091 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.96 40.04 1.7 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.184 -1.167 . . . . 5.4900000000000002 110.184 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 50.44 -176.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.38 -1.07 . . . . 6.6200000000000001 111.479 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t 45.95 -90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.774 -0.579 . . . . 5.2699999999999996 111.894 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -81.17 116.43 21.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.903 -1.123 . . . . 5.6600000000000001 109.701 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.6200000000000001 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.8899999999999999 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 3.0099999999999998 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 2.2200000000000002 109.136 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.9199999999999999 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.73 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.1699999999999999 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 2.1400000000000001 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.6499999999999999 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.6699999999999999 109.925 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.96999999999999997 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.3700000000000001 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.79 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.79 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.8300000000000001 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 1.48 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.0699999999999998 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 2.3199999999999998 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 2.6099999999999999 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.9300000000000002 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 5.04 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.4699999999999998 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.96 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 3.4100000000000001 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.97 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 2.3399999999999999 110.623 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 2.1299999999999999 110.278 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.71 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.5099999999999998 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 3.3900000000000001 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.5800000000000001 110.153 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.9099999999999999 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 1.3100000000000001 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.8600000000000001 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.6000000000000001 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.9299999999999999 111.553 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.8 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.8999999999999999 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.6699999999999999 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.6699999999999999 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 3.1600000000000001 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 5.3499999999999996 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 3.0800000000000001 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 4.0499999999999998 109.14 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 4.0 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.7699999999999996 110.039 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.8099999999999996 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 9.6099999999999994 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 8.2699999999999996 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.9 OUTLIER -76.12 -50.6 2.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.75 111.462 -179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.2 Cg_endo -70.04 -27.07 25.61 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 122.943 0.97 . . . . 7.2800000000000002 110.585 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.31 106.47 0.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.667 -1.373 . . . . 5.4900000000000002 109.667 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -77.42 155.89 31.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.667 -0.902 . . . . 6.6200000000000001 109.955 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.2 p 39.21 33.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 112.348 0.499 . . . . 5.2699999999999996 112.348 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -150.31 116.16 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.674 . . . . 5.6600000000000001 109.752 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.6200000000000001 109.986 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.8899999999999999 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 3.0099999999999998 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 2.2200000000000002 110.961 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.9199999999999999 110.497 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.73 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.1699999999999999 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 2.1400000000000001 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.6499999999999999 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.6699999999999999 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.96999999999999997 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.3700000000000001 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.79 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.79 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.8300000000000001 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 1.48 109.37 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.0699999999999998 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 2.3199999999999998 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 2.6099999999999999 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.9300000000000002 110.05 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 4.65 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.16 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.31 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 2.99 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.56 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 1.84 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 1.38 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.5 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.26 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 2.63 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 42' ' ' VAL . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.07 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.43 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 0.64 110.81 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.31 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.19 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.38 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 14' ' ' ALA . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.3 111.646 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.9 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.04 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.42 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 2.65 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 4.5 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 2.39 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 3.59 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 3.69 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.38 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.57 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 8.82 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 7.82 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.61 109.878 179.112 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.906 -0.405 . . . . 5.23 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.15 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.61 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 2.49 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 11' ' ' LEU . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 1.72 110.154 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.92 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.25 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.17 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 1.59 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.19 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.19 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.9 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.04 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.25 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.43 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.58 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 0.86 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.07 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 1.93 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 1.87 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.56 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 4.65 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.16 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.31 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 2.99 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.56 110.258 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 1.84 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 1.38 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.5 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.26 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 2.63 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.07 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.43 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 0.64 111.159 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.31 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.19 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.38 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' ALA . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.3 110.524 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.9 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.04 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.42 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 2.65 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 4.5 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 2.39 110.314 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 3.59 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 3.69 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.38 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.57 110.734 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 8.82 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 7.82 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.61 109.718 179.851 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.51 -0.552 . . . . 5.23 109.51 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HB2' HG22 ' A' ' 42' ' ' VAL . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.15 109.414 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.61 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 2.49 110.787 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' HB2' ' A' ' 39' ' ' ARG . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 1.72 111.668 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.92 111.713 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.25 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.17 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 1.59 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.19 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.19 110.144 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.9 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.04 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.25 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.43 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.58 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.86 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.07 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 1.93 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 1.87 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.56 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 4.65 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.16 111.51 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.31 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 2.99 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.56 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 1.84 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 1.38 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.5 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.26 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 2.63 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.07 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.43 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.64 112.141 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.31 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.19 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.38 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 14' ' ' ALA . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.3 110.671 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.9 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.04 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.42 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 2.65 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 4.5 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 2.39 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 3.59 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 3.69 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' C ' HG22 ' A' ' 30' ' ' THR . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.38 109.55 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.57 113.962 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 8.82 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 7.82 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.61 109.937 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttm . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.218 0.532 . . . . 5.23 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.15 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.61 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 2.49 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 1.72 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.92 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.25 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.17 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 1.59 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.19 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.19 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.9 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.04 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.25 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.43 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.58 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD11 HD23 ' A' ' 6' ' ' LEU . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 0.86 110.23 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.07 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 1.93 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 1.87 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.56 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 4.65 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.16 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.31 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 2.99 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.56 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.659 ' CD1' HD11 ' A' ' 55' ' ' LEU . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 1.84 109.414 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 1.38 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.5 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.26 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 2.63 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.07 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.43 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 6' ' ' LEU . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 0.64 110.012 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.31 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.19 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.38 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' ALA . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.3 110.925 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.9 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.04 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.42 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 2.65 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 4.5 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 2.39 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 3.59 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 3.69 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.38 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.57 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 8.82 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 7.82 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.61 111.89 -179.826 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.435 -0.58 . . . . 5.23 109.435 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.15 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.61 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 2.49 109.584 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 43' ' ' GLU . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 1.72 111.186 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 42' ' ' VAL . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.92 111.445 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.25 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.17 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 1.59 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.19 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.19 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.9 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.04 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.25 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.43 110.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.58 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD11 ' CD1' ' A' ' 6' ' ' LEU . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.86 109.593 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.07 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 53' ' ' TYR . 81.5 m-20 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 1.93 109.969 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 1.87 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.56 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 4.65 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.16 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 49' ' ' ILE . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.31 108.427 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 2.99 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.56 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 14' ' ' ALA . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 1.84 110.531 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 1.38 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.5 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.26 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 2.63 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 42' ' ' VAL . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.07 110.569 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.43 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.64 111.106 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.31 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.19 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.38 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.3 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.9 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.04 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.42 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 2.65 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 4.5 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 2.39 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 3.59 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 3.69 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.38 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.57 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 8.82 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 7.82 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.61 110.106 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.142 0.496 . . . . 5.23 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.15 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.61 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 2.49 109.349 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 43' ' ' GLU . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 1.72 110.1 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 42' ' ' VAL . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.92 110.336 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.25 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.17 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 1.59 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.19 110.164 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ASN . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.19 109.992 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.9 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.04 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.25 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.43 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.58 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 0.86 109.971 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.07 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 1.93 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 1.87 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 4.65 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.16 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.31 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 2.99 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.56 110.433 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 1.84 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 1.38 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.5 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.26 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 2.63 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.07 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.43 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 0.64 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.31 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.19 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.38 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.3 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.9 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.04 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.42 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 2.65 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 27' ' ' THR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 4.5 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 2.39 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 3.59 110.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 3.69 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.38 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.57 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 8.82 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 7.82 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.4 t80 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.61 109.995 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mptt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.369 -0.604 . . . . 5.23 109.369 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 41' ' ' ILE . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.15 108.915 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.61 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' A' ' 39' ' ' ARG . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 2.49 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 43' ' ' GLU . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 1.72 110.675 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 42' ' ' VAL . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.92 110.91 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.25 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.17 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 1.59 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.19 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.19 111.411 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.9 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.04 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 55' ' ' LEU . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.25 110.905 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.43 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.58 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 52' ' ' LEU . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 0.86 109.7 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.07 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 1.93 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 1.87 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.56 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 4.65 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.16 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' ILE . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.31 109.273 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 2.99 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.56 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 1.84 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 1.38 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.5 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.26 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 2.63 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.07 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.43 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 0.64 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.31 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.19 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.38 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.3 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.9 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.04 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.42 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 2.65 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 4.5 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 2.39 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 3.59 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 3.69 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' C ' HG22 ' A' ' 30' ' ' THR . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.38 109.987 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.57 113.08 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 8.82 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 7.82 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.61 110.472 -179.686 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.87 -0.789 . . . . 5.23 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.15 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.61 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 2.49 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 1.72 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.92 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.25 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.17 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 1.59 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.19 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 3' ' ' ASN . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.19 109.67 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.9 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.04 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.25 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.43 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.58 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.86 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.07 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 1.93 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 1.87 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.56 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 4.65 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.16 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.31 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 2.99 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.56 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD11 HD11 ' A' ' 55' ' ' LEU . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 1.84 109.379 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 1.38 109.509 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.5 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.26 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 2.63 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.07 110.52 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.43 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 0.64 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.31 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.19 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.38 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.3 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.9 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.04 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.42 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 2.65 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 4.5 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 2.39 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 3.59 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 3.69 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.38 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.57 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 8.82 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 7.82 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.61 110.23 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.131 0.491 . . . . 5.23 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.15 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.61 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 2.49 109.331 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.92 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.25 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.17 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 1.59 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.19 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.19 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' A' ' 6' ' ' LEU . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.9 109.447 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.04 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 55' ' ' LEU . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.25 110.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.43 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.58 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 52' ' ' LEU . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 0.86 110.189 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.07 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 1.93 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 1.87 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.56 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 4.65 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.16 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.31 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 2.99 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.56 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 14' ' ' ALA . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 1.38 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.5 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.26 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 2.63 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.07 110.13 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.43 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 0.64 111.442 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.31 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.19 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.38 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.3 110.604 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.9 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.04 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.42 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 2.65 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 4.5 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 2.39 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 27' ' ' THR . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 3.59 110.236 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 3.69 110.624 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.38 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.57 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 8.82 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 7.82 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.61 109.678 179.303 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.227 0.537 . . . . 5.23 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.15 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.61 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 2.49 110.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 43' ' ' GLU . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 1.72 110.572 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 42' ' ' VAL . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.92 111.24 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.25 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.17 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 1.59 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.19 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.19 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.9 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.04 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.25 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.43 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.58 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.86 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.07 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 1.93 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 1.87 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.56 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 4.65 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.16 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.31 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 2.99 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.56 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 1.84 110.011 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 1.38 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.5 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.26 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 2.63 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' HG13 ' A' ' 42' ' ' VAL . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.07 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.43 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 0.64 110.188 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.31 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.19 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.38 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 14' ' ' ALA . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.3 110.34 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.9 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.04 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.42 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 2.65 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 27' ' ' THR . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 4.5 109.823 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 2.39 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' PHE . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 3.59 109.364 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 3.69 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.38 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.57 111.625 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 8.82 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 7.82 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.61 109.47 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.059 0.457 . . . . 5.23 110.965 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.15 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.61 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 42' ' ' VAL . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 2.49 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 1.72 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.92 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.25 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.17 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 1.59 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.19 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.19 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.9 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.04 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.25 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.43 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.58 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 0.86 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.07 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 1.93 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 1.87 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.56 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 4.65 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.16 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.31 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 2.99 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.56 109.664 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.69 ' CD1' HD11 ' A' ' 55' ' ' LEU . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 1.84 109.65 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.418 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 1.38 109.23 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.5 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.26 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 2.63 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 6' ' ' LEU . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.07 111.043 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.43 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 0.64 111.279 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.31 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.19 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.38 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' ALA . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.3 110.452 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.9 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.04 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.42 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 2.65 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 4.5 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 2.39 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.416 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 3.59 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 3.69 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.38 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.57 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 8.82 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 7.82 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.61 110.042 -179.286 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.937 -0.394 . . . . 5.23 109.937 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.15 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.61 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' TYR . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 2.49 109.971 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 1.72 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.92 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.25 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.17 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 1.59 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.19 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.19 110.013 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.9 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.04 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.25 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.43 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.58 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 6' ' ' LEU . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.86 109.506 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.07 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 1.93 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 1.87 110.682 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 4.65 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.16 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.31 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 2.99 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.56 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.742 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 1.84 110.174 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 1.38 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.26 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 2.63 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.07 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.43 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 0.64 111.791 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.31 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.19 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.38 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.3 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.9 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.04 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.42 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 2.65 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 4.5 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 2.39 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 3.59 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 3.69 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.38 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.57 111.531 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 8.82 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 7.82 110.506 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.61 111.215 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.317 0.58 . . . . 5.23 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.15 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.61 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 2.49 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 1.72 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.92 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.25 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.17 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 1.59 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.19 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.19 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.9 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.04 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' LEU . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.25 109.709 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.43 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.58 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' LEU . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 0.86 109.626 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.07 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 1.93 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 1.87 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.56 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 4.65 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.16 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.31 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 2.99 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.56 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 11' ' ' LEU . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 1.84 109.73 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 1.38 110.261 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.5 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.26 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 2.63 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 6' ' ' LEU . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.07 110.75 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.43 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.64 110.74 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.31 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.19 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.38 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 14' ' ' ALA . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.3 110.968 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.9 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.04 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.42 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 2.65 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 4.5 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 2.39 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 3.59 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 3.69 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.38 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.57 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 8.82 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 7.82 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.61 110.222 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.351 -0.611 . . . . 5.23 109.351 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' ILE . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.15 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.61 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 2.49 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 1.72 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.92 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.25 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.17 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 1.59 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.19 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.19 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.9 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.04 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HA ' HD12 ' A' ' 55' ' ' LEU . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.25 110.233 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.43 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.58 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 52' ' ' LEU . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 0.86 109.312 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.07 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 1.93 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 1.87 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.56 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 4.65 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.16 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.31 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 2.99 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.56 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.678 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 1.84 109.812 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 1.38 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.5 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.26 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 2.63 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 15' ' ' LEU . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.07 110.481 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.43 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.64 111.358 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 11' ' ' LEU . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.31 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.19 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.38 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.3 111.062 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.9 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.04 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.42 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 2.65 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 4.5 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 2.39 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 3.59 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 3.69 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.38 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.57 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 8.82 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 7.82 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.61 110.699 -179.073 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.111 0.482 . . . . 5.23 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.15 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.61 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 2.49 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 1.72 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.92 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.25 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.17 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 1.59 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.19 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.19 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.9 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.04 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.25 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.43 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.58 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 6' ' ' LEU . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 0.86 109.725 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.07 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 1.93 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 1.87 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.56 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 4.65 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.16 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.31 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 2.99 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 46' ' ' CYS . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.56 109.927 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 1.84 109.5 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 1.38 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.5 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.26 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 2.63 110.516 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.07 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.43 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 0.64 110.944 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.31 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.19 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.38 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.3 111.125 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.9 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.04 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.42 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 2.65 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 4.5 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 2.39 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 3.59 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 3.69 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.38 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.57 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 8.82 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 7.82 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.61 109.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 tptt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.013 0.435 . . . . 5.23 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.15 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.61 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 2.49 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 1.72 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.92 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.25 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.17 111.526 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 1.59 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.19 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.19 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.9 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.04 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.25 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.43 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.58 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.86 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.07 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 1.93 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 1.87 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.56 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 4.65 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.16 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.31 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 2.99 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.56 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 1.84 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 1.38 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.5 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.26 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 2.63 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.834 ' CD2' HG23 ' A' ' 42' ' ' VAL . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.07 110.558 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.43 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 0.64 111.03 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.658 HD23 HD22 ' A' ' 55' ' ' LEU . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.31 110.91 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.19 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.38 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.696 HG22 HD12 ' A' ' 52' ' ' LEU . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.3 110.959 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.9 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.04 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.42 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 2.65 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 4.5 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 2.39 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 3.59 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 3.69 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.38 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.57 110.109 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 8.82 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 7.82 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.61 111.035 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.6 tttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.249 -0.649 . . . . 5.23 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.15 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.61 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 41' ' ' ILE . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 2.49 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.834 HG23 ' CD2' ' A' ' 11' ' ' LEU . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 1.72 111.119 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' N ' HG13 ' A' ' 42' ' ' VAL . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.92 110.961 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' OE1' HG23 ' A' ' 41' ' ' ILE . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.25 111.639 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.17 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 1.59 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.19 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.19 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.9 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.04 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 18' ' ' VAL . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.25 110.893 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.43 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.58 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 15' ' ' LEU . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.86 109.552 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 18' ' ' VAL . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.07 110.006 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 1.93 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 1.87 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.56 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 4.65 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.16 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.31 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 2.99 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.56 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 1.84 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 1.38 109.615 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.5 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.26 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 2.63 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.701 HD21 HG13 ' A' ' 42' ' ' VAL . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.07 110.562 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.43 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' HD11 ' A' ' 17' ' ' LEU . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 0.64 110.498 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.31 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.19 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 ' HG2' ' A' ' 13' ' ' GLU . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.38 111.244 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 14' ' ' ALA . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.3 110.948 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.9 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.04 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.42 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 2.65 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 4.5 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 2.39 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 3.59 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 3.69 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.38 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.57 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 8.82 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 7.82 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.61 111.619 -179.241 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.601 -0.518 . . . . 5.23 109.601 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.15 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.61 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 2.49 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 HD21 ' A' ' 11' ' ' LEU . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 1.72 110.653 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.92 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.25 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.17 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 1.59 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.19 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.19 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.9 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.04 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.25 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.43 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.58 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 0.86 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.07 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 1.93 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 1.87 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.56 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 4.65 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.16 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.31 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 2.99 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.56 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 11' ' ' LEU . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 1.84 109.849 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 1.38 110.87 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.5 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.26 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 2.63 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 6' ' ' LEU . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.07 110.878 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.43 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 0.64 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.31 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.19 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.38 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.3 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.9 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.04 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.42 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 2.65 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.781 ' HB3' HG23 ' A' ' 27' ' ' THR . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 4.5 112.713 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 41' ' ' ILE . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 2.39 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' PHE . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 3.59 110.62 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 3.69 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.38 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 30' ' ' THR . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.57 111.873 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 8.82 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 7.82 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.61 109.667 178.471 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.163 0.506 . . . . 5.23 110.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.15 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.61 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.443 HD13 ' OH ' ' A' ' 26' ' ' TYR . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 2.49 110.987 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 1.72 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.92 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.25 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.17 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 1.59 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.19 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.9 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.04 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.25 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.43 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.58 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 0.86 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.07 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 1.93 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 1.87 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.56 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 4.65 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.16 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.31 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 2.99 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.56 110.434 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 1.84 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 1.38 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.5 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.26 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 2.63 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 42' ' ' VAL . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.07 110.656 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.43 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 0.64 112.898 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 11' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.31 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.19 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.38 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.3 110.851 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.9 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.04 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.42 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 2.65 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 4.5 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 2.39 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' THR . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 3.59 110.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 3.69 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.38 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 31' ' ' ARG . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.57 110.771 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 30' ' ' THR . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 8.82 109.909 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 7.82 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.61 110.008 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.145 0.498 . . . . 5.23 109.701 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.15 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.61 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 2.49 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 11' ' ' LEU . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 1.72 109.136 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.92 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.25 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.17 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 1.59 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.19 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.19 109.925 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.9 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.04 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.25 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.43 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.58 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 0.86 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.07 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.93 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 1.87 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.56 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 4.65 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.16 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.31 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 2.99 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.56 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD13 HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 1.84 110.623 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 1.38 110.278 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.5 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.26 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 2.63 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.07 110.153 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.43 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.607 ' OE2' HD11 ' A' ' 17' ' ' LEU . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 0.64 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.31 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.19 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 ' OE2' ' A' ' 13' ' ' GLU . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.38 111.553 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.3 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.9 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.04 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.42 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 2.65 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 4.5 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 2.39 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 27' ' ' THR . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 3.59 109.14 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 3.69 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.38 110.039 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.57 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 8.82 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 7.82 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.61 111.462 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.752 -0.462 . . . . 5.23 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.717 ' HD2' HG11 ' A' ' 42' ' ' VAL . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.15 109.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.61 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 2.49 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.717 HG11 ' HD2' ' A' ' 39' ' ' ARG . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 1.72 110.961 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' N ' HG23 ' A' ' 42' ' ' VAL . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.92 110.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.25 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.17 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 1.59 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.19 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.19 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.9 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.04 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.25 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.43 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.58 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD13 ' A' ' 6' ' ' LEU . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 0.86 109.37 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.07 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 1.93 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 1.87 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.56 110.05 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 4.65 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.16 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.31 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 2.99 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.56 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 1.84 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 1.38 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.5 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.26 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 2.63 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 42' ' ' VAL . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.07 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.43 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 0.64 110.81 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.31 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.19 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.38 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 14' ' ' ALA . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.3 111.646 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.9 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.04 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.42 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 2.65 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 4.5 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 2.39 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 3.59 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 3.69 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.38 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.57 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 8.82 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 7.82 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -90.07 113.1 55.95 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.61 109.878 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.63 52.84 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.113 1.059 . . . . 6.7 110.734 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.53 -113.68 0.85 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.04 -1.624 . . . . 5.33 109.04 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t0 50.03 41.64 23.58 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.61 -0.935 . . . . 6.62 111.77 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 37' ' ' VAL . 48.4 t 41.7 55.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 121.13 0.49 . . . . 4.89 112.196 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.98 161.02 31.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.53 -0.731 . . . . 5.23 109.906 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.15 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.61 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 2.49 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 11' ' ' LEU . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 1.72 110.154 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.92 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.25 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.17 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 1.59 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.19 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.19 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.9 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.04 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.25 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.43 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.58 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 0.86 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.07 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 1.93 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 1.87 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.56 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 4.65 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.16 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.31 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 2.99 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.56 110.258 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 1.84 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 1.38 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.5 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.26 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 2.63 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.07 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.43 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 0.64 111.159 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.31 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.19 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.38 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' ALA . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.3 110.524 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.9 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.04 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.42 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 2.65 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 4.5 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 2.39 110.314 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 3.59 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 3.69 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.38 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 34' ' ' PRO . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.57 110.734 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 8.82 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 7.82 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -76.06 146.02 78.09 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.61 109.718 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 30' ' ' THR . 45.1 Cg_endo -71.25 -46.64 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.484 1.255 . . . . 6.7 111.012 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.17 -111.74 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.545 -1.422 . . . . 5.33 109.545 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -162.19 126.87 3.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.691 -0.887 . . . . 6.62 110.198 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 38' ' ' LYS . 61.7 t -71.41 -49.96 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.749 . . . . 4.89 109.304 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 37' ' ' VAL . 48.5 mttp -152.75 154.73 35.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 5.23 109.51 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HB2' HG22 ' A' ' 42' ' ' VAL . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.15 109.414 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.61 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 2.49 110.787 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' HB2' ' A' ' 39' ' ' ARG . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 1.72 111.668 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.92 111.713 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.25 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.17 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 1.59 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.19 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.19 110.144 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.9 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.04 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.25 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.43 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.58 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.86 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.07 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 1.93 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 1.87 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.56 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 4.65 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.16 111.51 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.31 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 2.99 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.56 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 1.84 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 1.38 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.5 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.26 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 2.63 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.07 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.43 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.64 112.141 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.31 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.19 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.38 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 14' ' ' ALA . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.3 110.671 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.9 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.04 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.42 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 2.65 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 4.5 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 2.39 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 3.59 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 3.69 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' C ' HG22 ' A' ' 30' ' ' THR . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.38 109.55 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.57 113.962 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 8.82 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 7.82 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.68 168.98 11.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.61 109.937 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.76 -50.63 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.274 1.144 . . . . 6.7 110.312 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 68.32 0.55 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.964 -1.254 . . . . 5.33 109.964 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 38' ' ' LYS . 66.6 m-20 -76.95 146.88 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.991 . . . . 6.62 109.465 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t 58.91 -80.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.76 -0.588 . . . . 4.89 110.281 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 36' ' ' ASP . 25.4 mttm -80.51 114.29 19.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.059 -1.025 . . . . 5.23 109.85 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.15 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.61 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 2.49 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 1.72 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.92 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.25 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.17 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 1.59 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.19 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.19 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.9 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.04 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.25 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.43 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.58 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD11 HD23 ' A' ' 6' ' ' LEU . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 0.86 110.23 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.07 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 1.93 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 1.87 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.56 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 4.65 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.16 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.31 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 2.99 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.56 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.659 ' CD1' HD11 ' A' ' 55' ' ' LEU . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 1.84 109.414 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 1.38 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.5 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.26 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 2.63 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.07 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.43 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 6' ' ' LEU . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 0.64 110.012 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.31 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.19 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.38 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' ALA . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.3 110.925 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.9 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.04 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.42 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 2.65 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 4.5 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 2.39 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 3.59 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 3.69 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.38 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.57 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 8.82 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 7.82 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 98.6 m-85 -77.91 -42.77 2.27 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.61 111.89 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 33' ' ' TYR . 53.7 Cg_endo -81.14 160.1 20.49 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 122.721 0.853 . . . . 6.7 110.531 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.18 132.2 5.8 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.401 -1.479 . . . . 5.33 109.401 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.553 ' O ' HG12 ' A' ' 37' ' ' VAL . 36.1 p-10 -153.81 -179.96 8.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.87 -0.782 . . . . 6.62 110.763 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ASP . 9.9 p 40.63 28.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 112.759 0.651 . . . . 4.89 112.759 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -161.32 29.86 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.296 -0.878 . . . . 5.23 109.435 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.15 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.61 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 2.49 109.584 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 43' ' ' GLU . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 1.72 111.186 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 42' ' ' VAL . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.92 111.445 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.25 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.17 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 1.59 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.19 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.19 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.9 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.04 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.25 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.43 110.72 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.58 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD11 ' CD1' ' A' ' 6' ' ' LEU . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.86 109.593 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.07 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 53' ' ' TYR . 81.5 m-20 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 1.93 109.969 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 1.87 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.56 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 4.65 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.16 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 49' ' ' ILE . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.31 108.427 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 2.99 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.56 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 14' ' ' ALA . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 1.84 110.531 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 1.38 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.5 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.26 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 2.63 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 42' ' ' VAL . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.07 110.569 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.43 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.64 111.106 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.31 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.19 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.38 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.3 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.9 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.04 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.42 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 2.65 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 4.5 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 2.39 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 3.59 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 3.69 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.38 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.57 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 8.82 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 7.82 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 -152.86 144.88 16.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.61 110.106 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -85.38 75.27 3.41 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 123.413 1.217 . . . . 6.7 110.912 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.62 80.17 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.345 -1.102 . . . . 5.33 110.345 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.26 117.56 20.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.473 -1.016 . . . . 6.62 110.04 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 38' ' ' LYS . 94.9 t -71.82 -39.8 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.555 -0.716 . . . . 4.89 109.985 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 37' ' ' VAL . 94.1 mttt -145.94 159.98 42.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 5.23 110.341 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.15 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.61 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 2.49 109.349 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 43' ' ' GLU . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 1.72 110.1 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 42' ' ' VAL . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.92 110.336 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.25 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.17 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 1.59 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.19 110.164 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ASN . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.19 109.992 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.9 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.04 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.25 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.43 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.58 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 0.86 109.971 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.07 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 1.93 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 1.87 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 4.65 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.16 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.31 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 2.99 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.56 110.433 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 1.84 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 1.38 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.5 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.26 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 2.63 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.07 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.43 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 0.64 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.31 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.19 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.38 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.3 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.9 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.04 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.42 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 2.65 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 27' ' ' THR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 4.5 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 2.39 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 3.59 110.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 3.69 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.38 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.57 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 8.82 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 7.82 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 36' ' ' ASP . 14.4 t80 -161.12 140.0 7.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.61 109.995 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.58 96.28 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.139 1.073 . . . . 6.7 111.468 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.25 -58.09 4.85 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.885 -1.286 . . . . 5.33 109.885 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 19.0 t0 53.74 42.11 31.89 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.396 -1.061 . . . . 6.62 110.977 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.1 t 55.08 -86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.855 -0.528 . . . . 4.89 110.358 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 mptt -80.7 113.17 18.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.141 -0.975 . . . . 5.23 109.369 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 41' ' ' ILE . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.15 108.915 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.61 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' A' ' 39' ' ' ARG . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 2.49 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 43' ' ' GLU . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 1.72 110.675 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 42' ' ' VAL . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.92 110.91 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.25 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.17 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 1.59 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.19 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.19 111.411 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.9 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.04 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 55' ' ' LEU . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.25 110.905 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.43 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.58 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 52' ' ' LEU . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 0.86 109.7 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.07 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 1.93 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 1.87 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.56 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 4.65 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.16 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' ILE . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.31 109.273 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 2.99 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.56 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 1.84 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 1.38 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.5 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.26 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 2.63 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.07 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.43 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 0.64 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.31 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.19 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.38 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.3 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.9 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.04 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.42 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 2.65 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 4.5 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 2.39 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 3.59 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 3.69 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' C ' HG22 ' A' ' 30' ' ' THR . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.38 109.987 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.57 113.08 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 8.82 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 7.82 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 13.8 t80 -154.74 144.22 15.27 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.61 110.472 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 42.3 Cg_endo -70.53 -53.95 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.317 1.167 . . . . 6.7 110.543 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 104.85 0.17 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.155 -1.178 . . . . 5.33 110.155 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 93.2 m-20 -75.56 154.36 36.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.961 . . . . 6.62 109.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 40.9 t 65.33 -64.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 109.738 -0.467 . . . . 4.89 109.738 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' ASP . 19.9 tptm -78.58 154.2 30.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 5.23 108.87 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.15 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.61 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 2.49 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 1.72 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.92 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.25 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.17 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 1.59 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.19 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 3' ' ' ASN . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.19 109.67 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.9 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.04 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.25 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.43 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.58 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.86 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.07 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 1.93 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 1.87 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.56 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 4.65 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.16 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.31 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 2.99 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.56 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD11 HD11 ' A' ' 55' ' ' LEU . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 1.84 109.379 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 1.38 109.509 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.5 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.26 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 2.63 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.07 110.52 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.43 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 0.64 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.31 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.19 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.38 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.3 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.9 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.04 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.42 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 2.65 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 4.5 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 2.39 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 3.59 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 3.69 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.38 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.57 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 8.82 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 7.82 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -77.7 -55.64 1.23 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.61 110.23 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.22 71.62 5.08 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.159 1.084 . . . . 6.7 110.299 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.83 104.63 0.29 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.203 -1.559 . . . . 5.33 109.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' C ' HG13 ' A' ' 37' ' ' VAL . 50.5 t0 -80.03 105.0 10.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.579 -0.954 . . . . 6.62 110.056 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG13 ' C ' ' A' ' 36' ' ' ASP . 28.1 m -153.56 -162.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.65 -0.656 . . . . 4.89 109.834 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -76.6 141.5 41.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.391 -0.818 . . . . 5.23 110.432 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.15 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.61 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 2.49 109.331 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.92 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.25 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.17 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 1.59 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.19 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.19 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' A' ' 6' ' ' LEU . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.9 109.447 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.04 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 55' ' ' LEU . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.25 110.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.43 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.58 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 52' ' ' LEU . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 0.86 110.189 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.07 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 1.93 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 1.87 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.56 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 4.65 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.16 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.31 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 2.99 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.56 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 14' ' ' ALA . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 1.38 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.5 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.26 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 2.63 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.07 110.13 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.43 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 0.64 111.442 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.31 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.19 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.38 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.3 110.604 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.9 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.04 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.42 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 2.65 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 4.5 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 2.39 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 27' ' ' THR . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 3.59 110.236 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 3.69 110.624 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.38 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.57 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 8.82 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 7.82 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -85.53 139.64 35.83 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.61 109.678 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.83 80.84 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.189 1.1 . . . . 6.7 110.371 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.61 85.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.32 -1.512 . . . . 5.33 109.32 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 38' ' ' LYS . 86.8 m-20 -74.4 156.74 36.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -1.007 . . . . 6.62 109.739 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t 64.19 -65.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 122.134 -0.354 . . . . 4.89 110.938 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' ASP . 3.7 pttt -79.82 149.73 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.839 . . . . 5.23 110.287 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.15 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.61 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 2.49 110.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 43' ' ' GLU . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 1.72 110.572 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 42' ' ' VAL . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.92 111.24 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.25 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.17 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 1.59 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.19 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.19 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.9 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.04 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.25 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.43 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.58 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.86 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.07 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 1.93 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 1.87 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.56 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 4.65 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.16 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.31 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 2.99 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.56 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 1.84 110.011 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 1.38 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.5 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.26 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 2.63 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' HG13 ' A' ' 42' ' ' VAL . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.07 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.43 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 0.64 110.188 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.31 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.19 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.38 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 14' ' ' ALA . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.3 110.34 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.9 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.04 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.42 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 2.65 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 27' ' ' THR . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 4.5 109.823 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 2.39 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' PHE . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 3.59 109.364 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 3.69 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.38 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.57 111.625 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 8.82 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 7.82 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CD1' ' HD2' ' A' ' 34' ' ' PRO . 15.2 t80 -150.64 149.12 25.17 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.61 109.47 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HB3' HG21 ' A' ' 30' ' ' THR . 43.6 Cg_endo -79.94 74.7 5.42 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.083 1.044 . . . . 6.7 111.025 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.09 79.52 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.159 -1.576 . . . . 5.33 109.159 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -154.85 167.62 29.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.704 -0.88 . . . . 6.62 109.742 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.86 113.54 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.483 -0.76 . . . . 4.89 109.814 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -86.9 103.2 15.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.73 -0.606 . . . . 5.23 110.965 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.15 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.61 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 42' ' ' VAL . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 2.49 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 1.72 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.92 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.25 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.17 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 1.59 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.19 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.19 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.9 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.04 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.25 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.43 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.58 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 0.86 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.07 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 1.93 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 1.87 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.56 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 4.65 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.16 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.31 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 2.99 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.56 109.664 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.69 ' CD1' HD11 ' A' ' 55' ' ' LEU . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 1.84 109.65 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.418 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 1.38 109.23 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.5 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.26 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 2.63 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 6' ' ' LEU . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.07 111.043 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.43 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 0.64 111.279 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.31 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.19 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.38 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' ALA . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.3 110.452 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.9 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.04 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.42 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 2.65 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 4.5 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 2.39 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.416 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 3.59 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 3.69 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.38 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.57 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 8.82 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 7.82 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -148.07 151.91 38.77 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.61 110.042 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.12 139.57 8.36 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.313 1.165 . . . . 6.7 110.583 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.57 21.17 45.0 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.679 -0.969 . . . . 5.33 110.679 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' C ' HG23 ' A' ' 37' ' ' VAL . 96.2 m-20 -78.01 150.02 33.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.212 -1.17 . . . . 6.62 110.335 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 36' ' ' ASP . 91.9 t -155.14 67.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.867 -0.79 . . . . 4.89 108.867 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -160.02 158.04 29.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.562 -0.711 . . . . 5.23 109.937 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.15 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.61 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' TYR . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 2.49 109.971 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 1.72 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.92 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.25 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.17 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 1.59 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.19 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.19 110.013 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.9 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.04 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.25 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.43 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.58 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 6' ' ' LEU . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.86 109.506 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.07 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 1.93 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 1.87 110.682 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 4.65 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.16 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.31 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 2.99 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.56 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.742 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 1.84 110.174 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 1.38 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.26 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 2.63 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.07 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.43 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 0.64 111.791 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.31 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.19 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.38 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.3 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.9 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.04 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.42 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 2.65 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 4.5 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 2.39 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 3.59 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 3.69 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.38 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.57 111.531 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 8.82 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 7.82 110.506 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.62 82.64 2.37 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.61 111.215 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.25 63.72 8.79 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.174 1.091 . . . . 6.7 109.82 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.35 56.33 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.03 -0.828 . . . . 5.33 111.03 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.18 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.246 -1.15 . . . . 6.62 110.873 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t 57.39 -80.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.747 -0.595 . . . . 4.89 111.467 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -76.72 80.54 3.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.959 . . . . 5.23 109.557 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.15 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.61 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 2.49 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 1.72 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.92 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.25 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.17 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 1.59 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.19 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.19 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.9 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.04 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' LEU . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.25 109.709 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.43 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.58 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' LEU . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 0.86 109.626 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.07 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 1.93 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 1.87 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.56 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 4.65 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.16 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.31 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 2.99 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.56 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 11' ' ' LEU . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 1.84 109.73 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 1.38 110.261 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.5 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.26 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 2.63 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 6' ' ' LEU . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.07 110.75 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.43 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.64 110.74 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.31 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.19 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.38 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 14' ' ' ALA . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.3 110.968 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.9 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.04 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.42 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 2.65 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 4.5 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 2.39 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 3.59 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 3.69 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.38 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.57 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 8.82 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 7.82 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.54 90.55 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.61 110.222 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.24 -179.31 5.33 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.47 1.247 . . . . 6.7 110.43 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.77 110.38 3.02 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.89 -1.284 . . . . 5.33 109.89 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 49.96 49.95 19.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.526 -0.985 . . . . 6.62 110.745 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 39' ' ' ARG . 65.4 t -75.83 148.78 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.701 -0.625 . . . . 4.89 110.201 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -70.0 -36.25 75.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.695 -0.628 . . . . 5.23 109.351 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' H ' HG12 ' A' ' 37' ' ' VAL . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.15 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.61 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 2.49 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 1.72 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.92 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.25 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.17 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 1.59 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.19 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.19 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.9 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.04 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HA ' HD12 ' A' ' 55' ' ' LEU . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.25 110.233 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.43 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.58 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 52' ' ' LEU . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 0.86 109.312 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.07 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 1.93 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 1.87 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.56 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 4.65 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.16 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.31 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 2.99 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.56 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.678 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 1.84 109.812 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 1.38 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.5 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.26 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 2.63 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 15' ' ' LEU . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.07 110.481 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.43 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.64 111.358 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 11' ' ' LEU . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.31 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.19 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.38 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.3 111.062 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.9 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.04 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.42 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 2.65 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 4.5 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 2.39 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 3.59 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 3.69 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.38 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.57 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 8.82 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 7.82 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -150.06 97.03 3.44 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.61 110.699 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.0 62.13 4.19 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.284 1.15 . . . . 6.7 110.159 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.14 21.64 41.04 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.388 -1.085 . . . . 5.33 110.388 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.83 114.56 18.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.308 -1.113 . . . . 6.62 110.284 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t 54.83 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.734 -0.604 . . . . 4.89 111.194 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -146.67 173.32 12.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 5.23 110.06 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.15 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.61 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 2.49 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 1.72 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.92 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.25 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.17 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 1.59 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.19 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.19 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.9 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.04 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.25 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.43 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.58 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 6' ' ' LEU . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 0.86 109.725 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.07 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 1.93 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 1.87 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.56 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 4.65 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.16 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.31 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 2.99 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 46' ' ' CYS . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.56 109.927 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 1.84 109.5 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 1.38 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.5 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.26 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 2.63 110.516 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.07 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.43 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 0.64 110.944 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.31 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.19 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.38 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.3 111.125 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.9 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.04 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.42 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 2.65 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 4.5 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 2.39 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 3.59 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 3.69 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.38 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.57 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 8.82 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 7.82 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.44 66.5 15.82 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.61 109.944 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 38' ' ' LYS . 47.9 Cg_endo -71.79 -165.26 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 O-C-N 123.292 1.153 . . . . 6.7 110.184 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.61 -10.09 60.73 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.336 -0.935 . . . . 5.33 110.777 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' C ' HG12 ' A' ' 37' ' ' VAL . 81.7 m-20 -87.2 40.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.956 -1.32 . . . . 6.62 111.998 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG12 ' C ' ' A' ' 36' ' ' ASP . 12.7 p 37.47 59.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.592 0 N-CA-C 112.934 0.716 . . . . 4.89 112.934 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 42.1 tptt -77.79 82.86 4.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 5.23 109.994 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.15 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.61 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 2.49 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 1.72 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.92 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.25 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.17 111.526 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 1.59 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.19 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.19 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.9 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.04 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.25 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.43 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.58 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.86 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.07 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 1.93 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 1.87 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.56 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 4.65 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.16 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.31 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 2.99 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.56 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 1.84 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 1.38 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.5 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.26 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 2.63 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.834 ' CD2' HG23 ' A' ' 42' ' ' VAL . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.07 110.558 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.43 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 0.64 111.03 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.658 HD23 HD22 ' A' ' 55' ' ' LEU . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.31 110.91 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.19 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.38 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.696 HG22 HD12 ' A' ' 52' ' ' LEU . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.3 110.959 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.9 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.04 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.42 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 2.65 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 4.5 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 2.39 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 3.59 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 3.69 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.38 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 37' ' ' VAL . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.57 110.109 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 8.82 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 7.82 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -77.93 -54.37 1.33 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.61 111.035 -179.391 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.4 Cg_endo -72.46 133.24 20.39 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.195 1.103 . . . . 6.7 110.289 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.25 37.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.41 -1.476 . . . . 5.33 109.41 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 50.0 38.29 16.13 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.349 -1.089 . . . . 6.62 110.727 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 38' ' ' LYS . 42.0 t 55.32 170.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.828 -0.545 . . . . 4.89 110.014 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' N ' HG12 ' A' ' 37' ' ' VAL . 56.6 tttt -70.0 -39.96 75.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.015 -1.053 . . . . 5.23 109.249 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.15 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.61 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' ILE . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 2.49 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.834 HG23 ' CD2' ' A' ' 11' ' ' LEU . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 1.72 111.119 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' N ' HG13 ' A' ' 42' ' ' VAL . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.92 110.961 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' OE1' HG23 ' A' ' 41' ' ' ILE . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.25 111.639 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.17 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 1.59 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.19 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.19 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.9 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.04 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 18' ' ' VAL . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.25 110.893 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.43 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.58 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 15' ' ' LEU . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.86 109.552 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 18' ' ' VAL . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.07 110.006 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 1.93 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 1.87 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.56 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 4.65 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.16 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.31 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 2.99 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.56 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 1.84 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 1.38 109.615 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.5 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.26 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 2.63 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.701 HD21 HG13 ' A' ' 42' ' ' VAL . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.07 110.562 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.43 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' HD11 ' A' ' 17' ' ' LEU . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 0.64 110.498 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.31 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.19 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 ' HG2' ' A' ' 13' ' ' GLU . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.38 111.244 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 14' ' ' ALA . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.3 110.948 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.9 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.04 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.42 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 2.65 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 4.5 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 2.39 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 3.59 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 3.69 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.38 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.57 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 8.82 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 7.82 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 1.8 m-85 -78.44 -54.78 1.14 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.61 111.619 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.8 Cg_endo -69.92 -168.67 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 122.988 0.993 . . . . 6.7 110.988 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.66 -74.59 0.9 Allowed Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.446 -1.062 . . . . 5.33 110.446 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 52.54 56.67 7.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.343 -1.092 . . . . 6.62 110.963 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 38' ' ' LYS . 40.9 t 57.87 169.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.644 -0.66 . . . . 4.89 110.314 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 37' ' ' VAL . 90.0 mttt -145.7 -174.06 4.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 5.23 109.601 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.15 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.61 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 2.49 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 HD21 ' A' ' 11' ' ' LEU . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 1.72 110.653 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.92 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.25 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.17 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 1.59 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.19 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.19 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.9 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.04 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.25 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.43 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.58 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 0.86 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.07 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 1.93 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 1.87 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.56 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 4.65 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.16 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.31 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 2.99 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.56 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 11' ' ' LEU . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 1.84 109.849 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 1.38 110.87 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.5 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.26 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 2.63 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 6' ' ' LEU . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.07 110.878 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.43 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 0.64 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.31 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.19 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.38 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.3 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.9 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.04 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.42 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 2.65 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.781 ' HB3' HG23 ' A' ' 27' ' ' THR . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 4.5 112.713 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 41' ' ' ILE . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 2.39 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' PHE . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 3.59 110.62 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 3.69 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.38 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 30' ' ' THR . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.57 111.873 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 8.82 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 7.82 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -154.15 61.7 3.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.61 109.667 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.06 -23.94 7.29 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.519 1.273 . . . . 6.7 111.4 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.45 39.99 3.55 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.706 -1.758 . . . . 5.33 108.706 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -80.75 68.05 6.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.761 -0.846 . . . . 6.62 112.026 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 80.5 t 52.69 -89.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.248 -0.907 . . . . 4.89 111.266 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -79.75 146.84 32.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.818 -1.176 . . . . 5.23 110.048 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.15 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.61 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.443 HD13 ' OH ' ' A' ' 26' ' ' TYR . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 2.49 110.987 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 1.72 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.92 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.25 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.17 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 1.59 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.19 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.9 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.04 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.25 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.43 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.58 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 0.86 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.07 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 1.93 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 1.87 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.56 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 4.65 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.16 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.31 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 2.99 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.56 110.434 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 1.84 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 1.38 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.5 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.26 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 2.63 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 42' ' ' VAL . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.07 110.656 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.43 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 0.64 112.898 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 11' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.31 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.19 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.38 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.3 110.851 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.9 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.04 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.42 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 2.65 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 4.5 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 2.39 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' THR . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 3.59 110.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 3.69 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.38 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 31' ' ' ARG . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.57 110.771 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 30' ' ' THR . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 8.82 109.909 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 7.82 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.03 103.69 1.91 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.61 110.008 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.72 -79.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.234 1.123 . . . . 6.7 111.091 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.96 40.04 1.7 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.184 -1.167 . . . . 5.33 110.184 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 50.44 -176.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.38 -1.07 . . . . 6.62 111.479 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' A' ' 38' ' ' LYS . 74.0 t 45.95 -90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.774 -0.579 . . . . 4.89 111.894 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HG3' HG12 ' A' ' 37' ' ' VAL . 80.8 mttt -81.17 116.43 21.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.903 -1.123 . . . . 5.23 109.701 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.15 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.61 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 2.49 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 11' ' ' LEU . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 1.72 109.136 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.92 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.25 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.17 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 1.59 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.19 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.19 109.925 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.9 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.04 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.25 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.43 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.58 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 0.86 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.07 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.93 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 1.87 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.56 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 4.65 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.16 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.31 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 2.99 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.56 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD13 HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 1.84 110.623 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 1.38 110.278 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.5 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.26 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 2.63 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.07 110.153 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.43 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.607 ' OE2' HD11 ' A' ' 17' ' ' LEU . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 0.64 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.31 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.19 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 ' OE2' ' A' ' 13' ' ' GLU . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.38 111.553 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.3 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.9 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.04 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.42 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 2.65 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 4.5 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 2.39 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 27' ' ' THR . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 3.59 109.14 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 3.69 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HG3' ' A' ' 34' ' ' PRO . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.38 110.039 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.57 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 8.82 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 7.82 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.9 OUTLIER -76.12 -50.6 2.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.61 111.462 -179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.2 Cg_endo -70.04 -27.07 25.61 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 122.943 0.97 . . . . 6.7 110.585 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.31 106.47 0.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.667 -1.373 . . . . 5.33 109.667 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.7 p-10 -77.42 155.89 31.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.667 -0.902 . . . . 6.62 109.955 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 36' ' ' ASP . 8.2 p 39.21 33.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 112.348 0.499 . . . . 4.89 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -150.31 116.16 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.674 . . . . 5.23 109.752 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.717 ' HD2' HG11 ' A' ' 42' ' ' VAL . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.15 109.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.61 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 2.49 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.717 HG11 ' HD2' ' A' ' 39' ' ' ARG . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 1.72 110.961 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' N ' HG23 ' A' ' 42' ' ' VAL . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.92 110.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.25 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.17 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 1.59 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.19 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.19 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.9 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.04 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.25 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.43 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.58 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD13 ' A' ' 6' ' ' LEU . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 0.86 109.37 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.07 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 1.93 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 1.87 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.56 110.05 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 4.65 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.16 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.31 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 2.99 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.56 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 1.84 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 1.38 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.5 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.26 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 2.63 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 42' ' ' VAL . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.07 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.43 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 0.64 110.81 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.31 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.19 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.38 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 14' ' ' ALA . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.3 111.646 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.9 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.04 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.42 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 2.65 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 4.5 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 2.39 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 3.59 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 3.69 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.38 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.57 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 8.82 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 7.82 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.61 109.878 179.112 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.906 -0.405 . . . . 5.23 109.906 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.15 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.61 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 2.49 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 11' ' ' LEU . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 1.72 110.154 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.92 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.25 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.17 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 1.59 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.19 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.19 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.9 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.04 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.25 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.43 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.58 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 0.86 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.07 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 1.93 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 1.87 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.56 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 4.65 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.16 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.31 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 2.99 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.404 ' CE1' HG13 ' A' ' 49' ' ' ILE . 90.8 m-70 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.56 110.258 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 1.84 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 1.38 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.5 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.26 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 2.63 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.07 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.43 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 0.64 111.159 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.31 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.19 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.38 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' ALA . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.3 110.524 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.9 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.04 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.42 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 2.65 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 4.5 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 2.39 110.314 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 3.59 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 3.69 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.38 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.57 110.734 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 8.82 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 7.82 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.61 109.718 179.851 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.5 mttp . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.51 -0.552 . . . . 5.23 109.51 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HB2' HG22 ' A' ' 42' ' ' VAL . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.15 109.414 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.61 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 2.49 110.787 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' HB2' ' A' ' 39' ' ' ARG . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 1.72 111.668 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.92 111.713 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.25 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.17 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 1.59 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.19 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 5' ' ' HIS . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.19 110.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.9 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.04 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.25 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.43 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.58 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.86 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.07 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 1.93 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 1.87 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.56 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 4.65 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.16 111.51 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.31 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 2.99 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.56 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 1.84 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 1.38 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.5 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.26 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 2.63 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.07 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.43 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.64 112.141 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.31 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.19 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.38 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 14' ' ' ALA . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.3 110.671 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.9 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.04 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.42 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 2.65 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 4.5 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 2.39 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 3.59 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 3.69 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' C ' HG22 ' A' ' 30' ' ' THR . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.38 109.55 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.57 113.962 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 8.82 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 7.82 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.61 109.937 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttm . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.218 0.532 . . . . 5.23 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.15 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.61 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 2.49 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 1.72 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.92 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.25 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.17 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 1.59 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.19 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.19 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.9 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.04 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.25 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.43 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.58 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD11 HD23 ' A' ' 6' ' ' LEU . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 0.86 110.23 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.07 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 1.93 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 1.87 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.56 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 4.65 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.16 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.31 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 2.99 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.56 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.659 ' CD1' HD11 ' A' ' 55' ' ' LEU . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 1.84 109.414 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 1.38 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.5 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.26 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 2.63 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.07 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.43 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 6' ' ' LEU . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 0.64 110.012 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.31 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.19 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.38 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' ALA . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.3 110.925 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.9 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.04 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.42 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 2.65 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 4.5 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 2.39 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 3.59 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 3.69 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.38 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.57 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 8.82 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 7.82 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.61 111.89 -179.826 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.435 -0.58 . . . . 5.23 109.435 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.15 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.61 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 2.49 109.584 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 43' ' ' GLU . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 1.72 111.186 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 42' ' ' VAL . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.92 111.445 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.25 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.17 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 1.59 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.19 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.19 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.9 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.04 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.25 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.43 110.72 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.58 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD11 ' CD1' ' A' ' 6' ' ' LEU . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.86 109.593 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.07 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 1.93 109.969 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 1.87 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.56 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 4.65 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.16 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 49' ' ' ILE . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.31 108.427 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 2.99 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.56 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 14' ' ' ALA . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 1.84 110.531 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 1.38 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.5 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.26 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 2.63 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 42' ' ' VAL . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.07 110.569 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.43 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.64 111.106 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.31 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.19 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.38 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.3 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.9 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.04 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.42 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 2.65 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 4.5 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 2.39 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 3.59 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 3.69 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.38 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.57 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 8.82 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 7.82 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.61 110.106 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.142 0.496 . . . . 5.23 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.15 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.61 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 2.49 109.349 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 43' ' ' GLU . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 1.72 110.1 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 42' ' ' VAL . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.92 110.336 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.25 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.17 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 1.59 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.19 110.164 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ASN . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.19 109.992 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.9 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.04 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.25 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.43 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.58 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 0.86 109.971 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.07 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 1.93 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 1.87 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 4.65 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.16 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.31 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 2.99 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.56 110.433 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 1.84 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 1.38 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.5 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.26 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 2.63 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.07 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.43 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 0.64 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.31 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.19 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.38 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.3 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.9 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.04 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.42 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 2.65 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 27' ' ' THR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 4.5 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 2.39 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 3.59 110.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 3.69 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.38 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.57 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 8.82 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 7.82 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.4 t80 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.61 109.995 179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mptt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.369 -0.604 . . . . 5.23 109.369 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 41' ' ' ILE . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.15 108.915 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.61 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' A' ' 39' ' ' ARG . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 2.49 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 43' ' ' GLU . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 1.72 110.675 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 42' ' ' VAL . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.92 110.91 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.25 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.17 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 1.59 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.19 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.19 111.411 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.9 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.04 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 55' ' ' LEU . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.25 110.905 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.43 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.58 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 52' ' ' LEU . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 0.86 109.7 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.07 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 1.93 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 1.87 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.56 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 4.65 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.16 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' ILE . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.31 109.273 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 2.99 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.56 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 1.84 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 1.38 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.5 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.26 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 2.63 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.07 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.43 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 0.64 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.31 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.19 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.38 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.3 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.9 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.04 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.42 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 2.65 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 4.5 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 2.39 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 3.59 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 3.69 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' C ' HG22 ' A' ' 30' ' ' THR . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.38 109.987 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.57 113.08 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 8.82 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 7.82 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.61 110.472 -179.686 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.9 tptm . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.87 -0.789 . . . . 5.23 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.15 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.61 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 2.49 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 1.72 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.92 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.25 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.17 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 1.59 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.19 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 3' ' ' ASN . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.19 109.67 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.9 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.04 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.25 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.43 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.58 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.86 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.07 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 1.93 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 1.87 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.56 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 4.65 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.16 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.31 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 2.99 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.56 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.697 HD11 HD11 ' A' ' 55' ' ' LEU . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 1.84 109.379 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 1.38 109.509 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.5 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.26 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 2.63 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.07 110.52 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.43 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 0.64 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.31 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.19 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.38 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.3 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.9 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.04 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.42 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 2.65 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 4.5 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 2.39 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 3.59 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 3.69 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.38 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.57 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 8.82 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 7.82 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.61 110.23 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.131 0.491 . . . . 5.23 110.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.15 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.61 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 2.49 109.331 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.92 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.25 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.17 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 1.59 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.19 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.19 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' A' ' 6' ' ' LEU . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.9 109.447 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.04 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 55' ' ' LEU . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.25 110.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.43 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.58 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 52' ' ' LEU . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 0.86 110.189 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.07 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 1.93 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 1.87 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.56 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 4.65 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.16 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.31 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 2.99 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.56 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 14' ' ' ALA . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 1.38 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.5 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.26 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 2.63 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.07 110.13 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.43 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 0.64 111.442 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.31 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.19 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.38 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.3 110.604 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.9 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.04 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.42 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 2.65 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 4.5 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 2.39 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 27' ' ' THR . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 3.59 110.236 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 3.69 110.624 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.38 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.57 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 8.82 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 7.82 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.61 109.678 179.303 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 pttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.227 0.537 . . . . 5.23 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.15 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.61 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 2.49 110.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 43' ' ' GLU . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 1.72 110.572 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 42' ' ' VAL . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.92 111.24 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.25 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.17 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 1.59 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.19 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.19 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.9 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.04 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.25 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.43 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.58 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.86 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.07 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 1.93 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 1.87 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.56 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 4.65 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.16 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.31 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 2.99 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.56 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 1.84 110.011 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 1.38 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.5 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.26 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 2.63 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' HG13 ' A' ' 42' ' ' VAL . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.07 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.43 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 0.64 110.188 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.31 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.19 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.38 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 14' ' ' ALA . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.3 110.34 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.9 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.04 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.42 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 2.65 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 27' ' ' THR . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 4.5 109.823 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 2.39 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' PHE . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 3.59 109.364 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 3.69 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.38 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.57 111.625 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 8.82 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 7.82 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.61 109.47 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.059 0.457 . . . . 5.23 110.965 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.15 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.61 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 42' ' ' VAL . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 2.49 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 1.72 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.92 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.25 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.17 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 1.59 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.19 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.19 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.9 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.04 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.25 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.43 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.58 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 0.86 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.07 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 1.93 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 1.87 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.56 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 4.65 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.16 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.31 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 2.99 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.472 ' CE1' HG13 ' A' ' 49' ' ' ILE . 52.4 m-70 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.56 109.664 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.69 ' CD1' HD11 ' A' ' 55' ' ' LEU . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 1.84 109.65 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.418 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 1.38 109.23 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.5 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.26 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 2.63 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 6' ' ' LEU . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.07 111.043 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.43 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 0.64 111.279 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.31 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.19 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.38 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' ALA . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.3 110.452 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.9 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.04 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.42 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 2.65 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 4.5 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 2.39 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.416 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 3.59 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 3.69 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.38 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.57 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 8.82 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 7.82 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.61 110.042 -179.286 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.937 -0.394 . . . . 5.23 109.937 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.15 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.61 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' TYR . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 2.49 109.971 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 1.72 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.92 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.25 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.17 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 1.59 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.19 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.472 HG13 ' CE1' ' A' ' 5' ' ' HIS . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.19 110.013 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.9 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.04 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.25 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.43 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.58 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 6' ' ' LEU . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.86 109.506 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.07 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 1.93 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 1.87 110.682 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 4.65 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.16 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.31 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 2.99 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.56 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.742 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 1.84 110.174 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 1.38 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.26 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 2.63 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.07 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.43 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 0.64 111.791 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.31 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.19 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.38 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.3 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.9 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.04 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.42 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 2.65 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 4.5 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 2.39 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 3.59 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 3.69 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.38 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.57 111.531 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 8.82 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 7.82 110.506 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.61 111.215 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.317 0.58 . . . . 5.23 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.15 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.61 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 2.49 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 1.72 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.92 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.25 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.17 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 1.59 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.19 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.19 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.9 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.04 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' LEU . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.25 109.709 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.43 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.58 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' LEU . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 0.86 109.626 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.07 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 1.93 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 1.87 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.56 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 4.65 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.16 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.31 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 2.99 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.56 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 11' ' ' LEU . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 1.84 109.73 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 1.38 110.261 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.5 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.26 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 2.63 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 6' ' ' LEU . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.07 110.75 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.43 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.64 110.74 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.31 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.19 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.38 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 14' ' ' ALA . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.3 110.968 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.9 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.04 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.42 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 2.65 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 4.5 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 2.39 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 3.59 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 3.69 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.38 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.57 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 8.82 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 7.82 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.61 110.222 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.351 -0.611 . . . . 5.23 109.351 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 41' ' ' ILE . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.15 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.61 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 2.49 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 1.72 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.92 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.25 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.17 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 1.59 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.19 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.19 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.9 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.04 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HA ' HD12 ' A' ' 55' ' ' LEU . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.25 110.233 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.43 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.58 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 52' ' ' LEU . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 0.86 109.312 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.07 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 1.93 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 1.87 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.56 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 4.65 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.16 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.31 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 2.99 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.56 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.678 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 1.84 109.812 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 1.38 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.5 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.26 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 2.63 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 15' ' ' LEU . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.07 110.481 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.43 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.64 111.358 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 11' ' ' LEU . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.31 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.19 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.38 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.3 111.062 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.9 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.04 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.42 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 2.65 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 4.5 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 2.39 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 3.59 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 3.69 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.38 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.57 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 8.82 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 7.82 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.61 110.699 -179.073 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.111 0.482 . . . . 5.23 110.06 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.15 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.61 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 2.49 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 1.72 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.92 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.25 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.17 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 1.59 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.19 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.19 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.9 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.04 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.25 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.43 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.58 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 6' ' ' LEU . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 0.86 109.725 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.07 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 1.93 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 1.87 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.56 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 4.65 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.16 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.31 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 2.99 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 46' ' ' CYS . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.56 109.927 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 10' ' ' HIS . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 1.84 109.5 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 1.38 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.5 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.26 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.491 ' CD2' HD23 ' A' ' 6' ' ' LEU . 68.9 t60 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 2.63 110.516 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.07 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.43 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 0.64 110.944 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.31 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.19 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.38 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.3 111.125 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.9 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.04 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.42 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 2.65 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 4.5 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 2.39 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 3.59 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 3.69 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.38 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.57 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 8.82 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 7.82 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.61 109.944 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 tptt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.013 0.435 . . . . 5.23 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.15 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.61 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 2.49 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 1.72 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.92 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.25 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.17 111.526 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 1.59 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.19 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.19 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.9 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.04 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.25 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.43 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.58 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.86 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.07 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 1.93 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 1.87 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.56 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 4.65 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.16 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.31 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 2.99 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.56 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 1.84 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 1.38 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.5 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.26 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 2.63 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.834 ' CD2' HG23 ' A' ' 42' ' ' VAL . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.07 110.558 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.43 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 0.64 111.03 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.658 HD23 HD22 ' A' ' 55' ' ' LEU . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.31 110.91 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.19 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.38 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.696 HG22 HD12 ' A' ' 52' ' ' LEU . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.3 110.959 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.9 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.04 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.42 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 2.65 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 4.5 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 2.39 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 3.59 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 3.69 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.38 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.57 110.109 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 8.82 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 7.82 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.61 111.035 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.6 tttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.249 -0.649 . . . . 5.23 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.15 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.61 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 41' ' ' ILE . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 2.49 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.834 HG23 ' CD2' ' A' ' 11' ' ' LEU . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 1.72 111.119 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' N ' HG13 ' A' ' 42' ' ' VAL . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.92 110.961 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' OE1' HG23 ' A' ' 41' ' ' ILE . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.25 111.639 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.17 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 1.59 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.19 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.19 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.9 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.04 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 18' ' ' VAL . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.25 110.893 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.43 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.58 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 15' ' ' LEU . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.86 109.552 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 18' ' ' VAL . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.07 110.006 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 1.93 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 1.87 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.56 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 4.65 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.16 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.31 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 2.99 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.56 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 1.84 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 1.38 109.615 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.5 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.26 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 2.63 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.701 HD21 HG13 ' A' ' 42' ' ' VAL . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.07 110.562 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.43 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' HD11 ' A' ' 17' ' ' LEU . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 0.64 110.498 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.31 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.19 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 ' HG2' ' A' ' 13' ' ' GLU . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.38 111.244 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 14' ' ' ALA . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.3 110.948 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.9 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.04 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.42 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 2.65 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 4.5 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 2.39 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 3.59 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 3.69 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.38 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.57 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 8.82 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 7.82 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.61 111.619 -179.241 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.0 mttt . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.601 -0.518 . . . . 5.23 109.601 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.15 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.61 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 2.49 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 HD21 ' A' ' 11' ' ' LEU . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 1.72 110.653 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.92 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.25 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.17 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 1.59 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.19 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.19 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.9 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.04 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.25 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.43 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.58 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 0.86 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.07 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 1.93 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 1.87 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.56 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 4.65 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.16 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.31 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 2.99 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.56 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 11' ' ' LEU . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 1.84 109.849 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 1.38 110.87 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.5 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.26 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 2.63 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 6' ' ' LEU . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.07 110.878 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.43 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 0.64 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.31 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.19 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.38 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.3 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.9 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.04 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.42 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 2.65 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.781 ' HB3' HG23 ' A' ' 27' ' ' THR . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 4.5 112.713 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 41' ' ' ILE . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 2.39 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' PHE . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 3.59 110.62 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 3.69 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.38 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 30' ' ' THR . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.57 111.873 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 8.82 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 7.82 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.61 109.667 178.471 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.163 0.506 . . . . 5.23 110.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.15 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.61 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.443 HD13 ' OH ' ' A' ' 26' ' ' TYR . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 2.49 110.987 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 1.72 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.92 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.25 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.17 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 1.59 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.19 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.9 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.04 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.25 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.43 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.58 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 0.86 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.07 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 1.93 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 1.87 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.56 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 4.65 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.16 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.31 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 2.99 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.425 ' CE1' HG13 ' A' ' 49' ' ' ILE . 96.6 m-70 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.56 110.434 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 1.84 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 1.38 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.5 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.26 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 2.63 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 42' ' ' VAL . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.07 110.656 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.43 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 0.64 112.898 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 11' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.31 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.19 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.38 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.3 110.851 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.9 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.04 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.42 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 2.65 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 4.5 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 2.39 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' THR . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 3.59 110.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 3.69 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.38 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 31' ' ' ARG . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.57 110.771 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 30' ' ' THR . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 8.82 109.909 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 7.82 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.61 110.008 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.145 0.498 . . . . 5.23 109.701 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.15 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.61 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 2.49 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 11' ' ' LEU . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 1.72 109.136 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.92 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.25 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.17 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 1.59 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.19 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' CE1' ' A' ' 5' ' ' HIS . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.19 109.925 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.9 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.04 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.25 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.43 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.58 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 0.86 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.07 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.93 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 1.87 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.56 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 4.65 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.16 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.31 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 2.99 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.56 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD13 HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 1.84 110.623 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 1.38 110.278 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.5 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.26 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 2.63 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.07 110.153 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.43 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.607 ' OE2' HD11 ' A' ' 17' ' ' LEU . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 0.64 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.31 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.19 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 ' OE2' ' A' ' 13' ' ' GLU . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.38 111.553 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.3 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.9 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.04 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.42 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 2.65 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 4.5 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 2.39 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 27' ' ' THR . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 3.59 109.14 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 3.69 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.38 110.039 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.57 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 8.82 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 7.82 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.61 111.462 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.752 -0.462 . . . . 5.23 109.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.717 ' HD2' HG11 ' A' ' 42' ' ' VAL . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.15 109.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.61 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 2.49 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.717 HG11 ' HD2' ' A' ' 39' ' ' ARG . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 1.72 110.961 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' N ' HG23 ' A' ' 42' ' ' VAL . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.92 110.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.25 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.17 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 1.59 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.19 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.19 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.9 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.04 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.25 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.43 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.58 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD13 ' A' ' 6' ' ' LEU . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 0.86 109.37 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.07 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 1.93 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 1.87 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.56 110.05 179.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.23 0.538 . . . . 4.65 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.98 161.1 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.554 -0.716 . . . . 4.16 110.562 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -151.18 84.51 1.32 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.535 -0.728 . . . . 3.31 109.864 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -83.46 169.3 15.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.786 -0.572 . . . . 2.99 109.838 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -73.12 136.84 44.91 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.043 -0.663 . . . . 1.56 109.31 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.2 mt -72.86 89.18 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.545 -0.722 . . . . 1.84 109.794 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 m -150.31 179.65 7.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.684 -0.635 . . . . 1.38 110.262 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.04 -140.16 39.48 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.24 -1.144 . . . . 1.5 110.24 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.7 m -71.99 -31.03 65.85 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.436 -1.037 . . . . 2.26 111.41 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.56 -36.17 82.91 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.477 -0.764 . . . . 2.63 111.112 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 42' ' ' VAL . 63.5 tp -59.98 -50.05 75.28 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.396 -0.815 . . . . 2.07 110.806 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.96 -45.52 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.733 -0.84 . . . . 1.43 108.733 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -59.99 -40.02 87.7 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.53 0.681 . . . . 2.23 109.256 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.47 -40.43 93.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.827 -0.546 . . . . 0.64 110.81 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.02 -49.99 75.5 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.83 . . . . 1.31 111.5 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -62.77 -40.03 96.04 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.334 -0.854 . . . . 3.19 110.272 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -70.05 -40.44 75.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.539 -0.725 . . . . 1.38 111.247 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 14' ' ' ALA . 84.1 t -73.56 -40.03 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.46 -0.775 . . . . 1.3 111.646 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.4 m -70.03 -34.46 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.379 -0.826 . . . . 1.27 110.922 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.3 -79.24 0.42 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.295 -1.122 . . . . 1.5 110.295 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -57.32 150.01 19.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.372 -1.075 . . . . 3.9 110.562 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -105.91 20.47 18.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.604 -0.685 . . . . 5.04 110.72 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.05 3.8 35.61 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.187 -1.006 . . . . 2.42 111.324 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -77.38 133.09 38.79 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 118.911 1.356 . . . . 2.65 110.451 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -75.63 -29.63 59.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 4.5 112.02 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 56.8 t80 56.88 39.94 29.21 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.175 -0.953 . . . . 2.39 110.76 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.7 p -85.1 114.59 56.84 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 3.59 110.456 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -88.89 -163.07 0.14 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 O-C-N 123.203 1.107 . . . . 3.69 111.613 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 30' ' ' THR . 43.1 mtpt -68.7 -25.81 64.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.643 -0.66 . . . . 7.38 110.622 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 29' ' ' LYS . 12.7 m 70.08 -52.93 0.63 Allowed 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.596 -0.69 . . . . 4.57 111.646 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 54.57 64.6 1.76 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.971 -1.081 . . . . 8.82 110.884 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 57.45 -98.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.372 -0.83 . . . . 7.82 109.831 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -90.07 113.1 55.95 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.765 -1.209 . . . . 7.61 109.878 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -85.63 52.84 3.23 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.113 1.059 . . . . 6.7 110.734 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.53 -113.68 0.85 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.04 -1.624 . . . . 5.33 109.04 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.8 t0 50.03 41.64 23.58 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.61 -0.935 . . . . 6.62 111.77 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 37' ' ' VAL . 48.4 t 41.7 55.15 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 CA-C-O 121.13 0.49 . . . . 4.89 112.196 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.98 161.02 31.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.53 -0.731 . . . . 5.23 109.906 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -151.17 -49.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.749 . . . . 5.15 110.568 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.31 -52.16 2.44 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.279 -1.528 . . . . 1.61 109.279 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.16 -46.48 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.564 -0.963 . . . . 2.49 109.387 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 11' ' ' LEU . 96.1 t -62.48 -42.24 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.803 -0.56 . . . . 1.72 110.154 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -60.03 -39.29 85.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 2.92 110.524 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.97 -43.17 95.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.726 -0.609 . . . . 2.25 110.32 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -84.3 -29.35 26.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.382 -0.824 . . . . 0.88 110.054 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.79 -44.68 96.51 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.347 -0.846 . . . . 1.17 110.327 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.3 p -76.49 -38.53 55.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 1.59 110.949 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -136.46 158.24 44.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.493 -0.755 . . . . 1.19 110.49 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.66 123.96 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.765 . . . . 1.19 109.551 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.1 m -80.0 147.39 31.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.9 110.596 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -82.04 153.82 25.96 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.345 0.593 . . . . 1.04 110.383 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.99 -37.67 80.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 1.25 110.381 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -59.56 -40.82 88.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.553 -0.717 . . . . 1.43 111.181 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.08 -40.0 86.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 1.58 110.257 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.35 -41.18 93.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.861 . . . . 0.86 109.625 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.34 -40.02 89.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.682 -0.636 . . . . 2.07 110.284 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -60.41 -46.2 90.85 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.536 -0.727 . . . . 1.93 109.639 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -62.16 -32.38 72.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.661 -0.649 . . . . 1.87 110.429 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 t -89.15 63.66 6.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.576 -0.702 . . . . 1.24 109.365 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.6 m120 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 118.014 -0.993 . . . . 2.56 110.234 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.043 0.449 . . . . 4.65 110.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.98 160.04 41.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 O-C-N 121.667 -0.646 . . . . 4.16 110.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -152.88 81.58 1.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.572 0.701 . . . . 3.31 109.794 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -83.38 -174.21 5.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.815 -0.553 . . . . 2.99 109.763 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.404 ' CE1' HG13 ' A' ' 49' ' ' ILE . 90.8 m-70 -73.93 142.11 45.94 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.52 -0.737 . . . . 1.56 110.258 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.98 100.92 12.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.544 -0.723 . . . . 1.84 110.314 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 t -150.57 178.27 9.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.76 -0.588 . . . . 1.38 109.645 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.61 -141.86 41.48 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.718 -1.353 . . . . 1.5 109.718 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 m -73.1 -26.61 61.31 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.439 -1.036 . . . . 2.26 111.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -61.87 -40.15 94.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.323 -0.86 . . . . 2.63 109.988 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.42 -40.02 89.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.581 -0.699 . . . . 2.07 110.269 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -61.02 -50.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.591 -0.693 . . . . 1.43 110.057 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.99 -41.33 91.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.7 -0.625 . . . . 2.23 110.635 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.83 -49.86 75.78 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.643 -0.661 . . . . 0.64 111.159 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.06 -49.81 76.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.321 -0.862 . . . . 1.31 111.194 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.365 -0.835 . . . . 3.19 111.081 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.29 -41.68 76.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 1.38 111.245 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' ALA . 70.4 t -70.48 -49.98 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.321 -0.862 . . . . 1.3 110.524 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -76.13 -56.42 4.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.533 -0.729 . . . . 1.27 110.379 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.03 23.34 63.68 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.015 -1.234 . . . . 1.5 110.015 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -139.57 150.41 45.0 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.371 -1.076 . . . . 3.9 110.621 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -96.79 17.03 17.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.664 -0.648 . . . . 5.04 110.307 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.03 96.53 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 121.348 -0.845 . . . . 2.42 111.344 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -76.77 129.63 36.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.259 -1.142 . . . . 2.65 111.032 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -78.96 -38.36 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.482 0.658 . . . . 4.5 110.044 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.15 44.17 25.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.589 -0.694 . . . . 2.39 110.314 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -78.63 144.36 64.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.544 -0.722 . . . . 3.59 110.212 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.43 147.66 59.03 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.312 1.164 . . . . 3.69 110.876 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -70.0 -39.97 75.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.656 -0.653 . . . . 7.38 111.174 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 34' ' ' PRO . 7.4 m 66.62 -63.42 0.26 Allowed 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.822 -0.549 . . . . 4.57 110.734 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 49.99 -144.49 0.5 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.384 -0.823 . . . . 8.82 110.804 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -60.01 -31.43 69.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.952 -1.092 . . . . 7.82 110.42 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -76.06 146.02 78.09 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 7.61 109.718 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' O ' HG23 ' A' ' 30' ' ' THR . 45.1 Cg_endo -71.25 -46.64 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.484 1.255 . . . . 6.7 111.012 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.17 -111.74 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.545 -1.422 . . . . 5.33 109.545 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -162.19 126.87 3.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.691 -0.887 . . . . 6.62 110.198 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 38' ' ' LYS . 61.7 t -71.41 -49.96 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.749 . . . . 4.89 109.304 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 37' ' ' VAL . 48.5 mttp -152.75 154.73 35.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 5.23 109.51 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HB2' HG22 ' A' ' 42' ' ' VAL . 46.6 mmm-85 -69.8 -39.98 76.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.35 -0.844 . . . . 5.15 109.414 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.57 -48.49 1.68 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.473 -1.451 . . . . 1.61 109.473 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.09 -40.1 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -1.008 . . . . 2.49 110.787 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' HB2' ' A' ' 39' ' ' ARG . 31.8 m -68.33 -39.97 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.518 -0.738 . . . . 1.72 111.668 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.6 pt-20 -67.26 -30.03 69.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.436 -0.79 . . . . 2.92 111.713 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.22 -40.04 95.22 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.217 -0.927 . . . . 2.25 111.078 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -81.81 -26.75 34.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.909 . . . . 0.88 110.496 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.9 m -67.8 -37.89 82.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 1.17 109.366 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.99 -39.99 75.58 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.702 -0.624 . . . . 1.59 110.656 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.7 m -139.92 156.4 46.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 1.19 110.465 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 5' ' ' HIS . 70.5 mt -61.59 123.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 1.19 110.144 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.1 m -87.65 137.49 32.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.9 109.723 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.0 p -80.03 159.29 26.26 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.577 -0.702 . . . . 1.04 110.612 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.99 -39.78 86.89 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.725 -0.609 . . . . 1.25 110.572 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -59.55 -39.97 85.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.544 -0.723 . . . . 1.43 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.97 -39.99 75.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.429 -0.794 . . . . 1.58 110.608 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 70.9 mt -60.0 -46.58 89.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.36 -0.837 . . . . 0.86 109.785 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.633 -0.667 . . . . 2.07 109.525 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -60.39 -44.5 95.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.587 -0.696 . . . . 1.93 109.528 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -60.03 -35.4 74.99 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.42 -0.8 . . . . 1.87 110.161 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.7 m -88.01 -8.54 55.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.696 -0.627 . . . . 1.24 110.604 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.95 -1.024 . . . . 2.56 110.141 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.7 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.998 0.427 . . . . 4.65 109.934 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 26.8 m -72.45 140.11 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.852 0.834 . . . . 4.16 111.51 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.76 54.13 0.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.551 -0.907 . . . . 3.31 108.551 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.96 171.06 13.35 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.61 0.719 . . . . 2.99 111.772 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.19 163.2 27.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.767 -0.583 . . . . 1.56 110.662 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 mp -89.77 0.27 57.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.669 -0.644 . . . . 1.84 111.504 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -87.49 -163.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.296 -0.877 . . . . 1.38 109.18 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.91 -131.59 51.96 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.104 -1.198 . . . . 1.5 110.104 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -72.86 -36.11 67.34 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.315 -1.109 . . . . 2.26 111.779 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.88 -30.45 70.16 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.417 -0.802 . . . . 2.63 111.012 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 8.5 tt -59.96 -50.02 75.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.407 -0.808 . . . . 2.07 110.379 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.74 -48.82 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.631 . . . . 1.43 109.531 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.92 -48.55 81.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.225 0.536 . . . . 2.23 110.99 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.06 -45.69 92.03 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.64 112.141 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.05 -50.0 75.45 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.897 . . . . 1.31 111.96 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.75 -43.91 67.85 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.234 -0.916 . . . . 3.19 112.355 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.202 -0.936 . . . . 1.38 112.102 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 14' ' ' ALA . 77.9 t -68.1 -46.82 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.228 -0.92 . . . . 1.3 110.671 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -70.02 -39.72 75.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 1.27 110.236 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.1 20.04 76.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.453 -1.059 . . . . 1.5 110.453 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -135.32 139.22 44.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.369 -1.077 . . . . 3.9 109.395 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -86.63 -5.94 59.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.459 -0.776 . . . . 5.04 112.4 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.56 52.98 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.925 -1.27 . . . . 2.42 109.925 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -78.33 154.71 30.6 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.561 -0.964 . . . . 2.65 110.882 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -75.33 -57.36 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 4.5 111.385 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 54.9 38.83 31.02 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 2.39 110.162 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 m -83.62 117.01 67.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 3.59 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -86.61 177.71 4.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.168 1.089 . . . . 3.69 110.725 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' C ' HG22 ' A' ' 30' ' ' THR . 27.4 ttpt -67.42 -41.66 84.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.634 -0.666 . . . . 7.38 109.55 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.6 t 36.4 28.73 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 113.962 1.097 . . . . 4.57 113.962 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -69.99 -39.99 75.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.924 -1.11 . . . . 8.82 110.723 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.0 tpt85 -63.45 -55.99 19.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.372 -0.83 . . . . 7.82 111.066 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.68 168.98 11.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.448 -0.783 . . . . 7.61 109.937 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.76 -50.63 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.274 1.144 . . . . 6.7 110.312 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 68.32 0.55 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.964 -1.254 . . . . 5.33 109.964 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 38' ' ' LYS . 66.6 m-20 -76.95 146.88 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.991 . . . . 6.62 109.465 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t 58.91 -80.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.76 -0.588 . . . . 4.89 110.281 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 36' ' ' ASP . 25.4 mttm -80.51 114.29 19.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.059 -1.025 . . . . 5.23 109.85 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -70.04 -39.94 75.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.692 -0.63 . . . . 5.15 110.219 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.58 -46.87 1.15 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.361 -1.496 . . . . 1.61 109.361 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.83 -40.03 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.547 -0.972 . . . . 2.49 109.987 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.15 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.686 -0.633 . . . . 1.72 109.966 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.31 91.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.673 -0.642 . . . . 2.92 111.479 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.18 -40.73 97.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.402 -0.811 . . . . 2.25 110.916 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.7 m -83.69 -28.95 27.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.88 110.255 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.05 -43.35 65.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 1.17 109.959 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.6 m -78.49 -41.12 33.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.718 -0.614 . . . . 1.59 110.13 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.7 m -129.91 168.97 15.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.745 -0.597 . . . . 1.19 109.783 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 84.9 mt -87.03 118.82 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.519 -0.738 . . . . 1.19 110.364 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -76.05 142.38 41.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.9 109.735 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -81.19 144.68 31.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.543 -0.723 . . . . 1.04 110.581 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.02 -32.25 70.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.684 -0.635 . . . . 1.25 110.09 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.88 -40.0 83.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.717 -0.614 . . . . 1.43 110.624 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 93.4 mt-30 -68.5 -42.04 79.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.438 -0.789 . . . . 1.58 110.489 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD11 HD23 ' A' ' 6' ' ' LEU . 86.6 mt -62.52 -42.3 99.43 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.486 -0.758 . . . . 0.86 110.23 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.94 90.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 2.07 110.509 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -65.64 -47.13 76.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 1.93 110.444 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 23.4 m-85 -59.94 -35.03 74.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.348 -0.845 . . . . 1.87 110.503 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.2 60.88 5.53 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.488 0.661 . . . . 1.24 109.557 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.019 -0.991 . . . . 2.56 110.108 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.854 -0.424 . . . . 4.65 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.05 159.93 41.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 O-C-N 121.561 -0.712 . . . . 4.16 110.341 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -162.94 72.5 0.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 3.31 109.023 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -80.0 160.01 26.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.465 -0.569 . . . . 2.99 109.465 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 49' ' ' ILE . 95.9 m-70 -74.65 124.22 26.31 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.173 -0.611 . . . . 1.56 109.784 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.659 ' CD1' HD11 ' A' ' 55' ' ' LEU . 83.9 mt -66.01 93.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.679 -0.809 . . . . 1.84 109.414 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 177.6 9.71 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.367 -0.605 . . . . 1.38 109.367 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.18 -134.39 44.94 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.289 -1.524 . . . . 1.5 109.289 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -74.7 -25.5 59.19 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.225 -1.162 . . . . 2.26 110.764 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -62.61 -39.86 95.12 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.526 -0.734 . . . . 2.63 111.014 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.96 -43.3 95.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.509 -0.744 . . . . 2.07 110.786 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.88 -47.5 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.351 -0.843 . . . . 1.43 109.777 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.0 -39.97 87.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.611 -0.681 . . . . 2.23 109.62 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 6' ' ' LEU . . . -60.04 -40.01 87.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.721 -0.612 . . . . 0.64 110.012 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.15 -40.98 91.76 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.519 -0.738 . . . . 1.31 110.281 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -59.97 -49.87 75.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.498 -0.751 . . . . 3.19 109.742 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.03 -36.8 75.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.789 -0.569 . . . . 1.38 110.819 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' ALA . 52.2 t -69.36 -50.03 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.481 -0.762 . . . . 1.3 110.925 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.0 m -69.95 -40.04 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.509 -0.744 . . . . 1.27 109.63 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -47.8 1.69 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.569 -0.824 . . . . 1.5 111.144 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 30.6 mp0 -129.98 149.07 51.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -1.096 . . . . 3.9 111.105 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -73.22 -6.0 43.03 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 5.04 111.22 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.09 -24.0 4.3 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.119 -0.988 . . . . 2.42 112.086 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 21' ' ' GLU . 15.6 p90 -73.52 141.64 46.74 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 118.956 1.378 . . . . 2.65 110.58 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.01 -33.56 44.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 4.5 111.108 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.79 68.56 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.466 -0.771 . . . . 2.39 110.311 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 t -148.07 68.24 10.36 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.611 -0.681 . . . . 3.59 109.98 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.05 159.95 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.492 1.259 . . . . 3.69 109.957 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -66.2 -38.28 87.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.656 -0.652 . . . . 7.38 111.0 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 32' ' ' ARG . 19.4 m 50.45 49.91 19.8 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 4.57 110.294 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 46.19 -89.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.908 -0.495 . . . . 8.82 111.184 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 30' ' ' THR . 13.7 ptt180 -82.63 154.17 25.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.992 -1.068 . . . . 7.82 109.946 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 98.6 m-85 -77.91 -42.77 2.27 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 7.61 111.89 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 33' ' ' TYR . 53.7 Cg_endo -81.14 160.1 20.49 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 122.721 0.853 . . . . 6.7 110.531 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.18 132.2 5.8 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.401 -1.479 . . . . 5.33 109.401 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.553 ' O ' HG12 ' A' ' 37' ' ' VAL . 36.1 p-10 -153.81 -179.96 8.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.87 -0.782 . . . . 6.62 110.763 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ASP . 9.9 p 40.63 28.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 112.759 0.651 . . . . 4.89 112.759 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -161.32 29.86 0.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.296 -0.878 . . . . 5.23 109.435 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -72.38 -40.92 66.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 5.15 111.269 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.47 1.87 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 1.61 109.497 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.0 mt -61.65 -44.92 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.034 . . . . 2.49 109.584 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 43' ' ' GLU . 32.9 m -64.91 -40.23 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.834 -0.541 . . . . 1.72 111.186 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 42' ' ' VAL . 83.5 mt-10 -69.39 -39.96 77.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.92 111.445 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -67.93 -40.02 83.4 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.476 -0.765 . . . . 2.25 112.105 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.16 -36.38 61.53 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.88 110.796 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.17 -46.1 90.83 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.29 -0.881 . . . . 1.17 110.473 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.4 m -73.7 -40.0 63.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.475 -0.766 . . . . 1.59 110.9 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.5 p -136.19 158.9 43.32 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.396 -0.815 . . . . 1.19 110.685 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 5' ' ' HIS . 90.8 mt -66.66 135.38 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 1.19 110.446 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.2 m -95.58 142.72 27.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.711 -0.618 . . . . 0.9 109.811 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.0 p -78.58 157.1 28.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.52 -0.737 . . . . 1.04 111.211 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.91 -30.85 68.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 1.25 110.274 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.44 -40.02 85.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.611 -0.68 . . . . 1.43 110.72 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.6 mt-30 -64.22 -39.93 95.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.459 -0.897 . . . . 1.58 109.498 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD11 ' CD1' ' A' ' 6' ' ' LEU . 96.2 mt -63.85 -42.9 97.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.57 -0.706 . . . . 0.86 109.593 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 2.07 110.258 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -65.68 -39.98 91.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.705 -0.622 . . . . 1.93 109.969 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 16.9 m-85 -66.45 -20.01 65.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.69 -0.631 . . . . 1.87 111.417 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.7 t -88.05 6.21 37.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.908 . . . . 1.24 111.097 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 117.998 -1.001 . . . . 2.56 110.061 179.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.874 0.369 . . . . 4.65 110.356 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.0 158.25 42.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 121.535 -0.728 . . . . 4.16 109.727 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.405 ' HB3' HD13 ' A' ' 49' ' ' ILE . 33.5 m120 -155.62 91.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.427 -0.953 . . . . 3.31 108.427 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -79.96 159.88 26.14 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.396 0.617 . . . . 2.99 110.586 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m170 -77.06 157.92 30.82 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.853 -0.53 . . . . 1.56 110.263 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 14' ' ' ALA . 84.4 mt -99.9 95.23 6.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.518 -0.739 . . . . 1.84 110.531 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 28.1 m -150.53 -179.98 7.68 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.379 -0.6 . . . . 1.38 109.379 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.89 -136.69 44.93 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.555 -1.418 . . . . 1.5 109.555 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.4 p -75.4 -25.82 57.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.303 -1.116 . . . . 2.26 110.94 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.81 -39.28 93.8 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.427 -0.796 . . . . 2.63 110.568 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD22 ' CG2' ' A' ' 42' ' ' VAL . 40.6 tp -60.04 -43.29 95.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.735 . . . . 2.07 110.569 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.75 -49.97 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 1.43 109.927 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.0 -40.2 88.39 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.991 -0.684 . . . . 2.23 110.353 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -62.99 -44.73 95.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.64 111.106 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 26' ' ' TYR . 83.8 mt -60.01 -40.59 89.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 1.31 110.813 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -60.44 -43.84 96.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.436 -0.79 . . . . 3.19 110.256 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -70.02 -41.35 74.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.621 -0.674 . . . . 1.38 111.473 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.0 -42.83 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.377 -0.827 . . . . 1.3 110.7 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.5 m -69.99 -40.04 75.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.501 -0.749 . . . . 1.27 110.509 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.77 19.63 69.59 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.312 -1.115 . . . . 1.5 110.312 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.39 138.93 54.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 3.9 110.318 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -60.06 -44.61 94.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.684 -0.635 . . . . 5.04 110.386 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.64 68.53 0.37 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.779 -1.328 . . . . 2.42 109.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.1 p90 -73.71 138.71 44.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.582 -0.952 . . . . 2.65 109.843 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.9 -52.96 8.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.466 -0.771 . . . . 4.5 110.62 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' CE1' HD22 ' A' ' 15' ' ' LEU . 27.6 t80 49.97 40.73 21.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.439 -0.788 . . . . 2.39 110.629 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.0 m -77.02 139.23 65.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 3.59 110.335 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.2 -166.26 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.337 1.177 . . . . 3.69 109.668 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -78.6 52.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 7.38 111.575 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p 40.9 55.66 3.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.559 -0.713 . . . . 4.57 112.915 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -76.55 131.92 39.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.888 . . . . 8.82 110.67 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 97.8 mtt180 -103.81 111.71 24.34 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.568 -0.708 . . . . 7.82 110.146 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 32' ' ' ARG . 1.1 m-85 -152.86 144.88 16.76 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.724 . . . . 7.61 110.106 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -85.38 75.27 3.41 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 O-C-N 123.413 1.217 . . . . 6.7 110.912 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.62 80.17 0.84 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.345 -1.102 . . . . 5.33 110.345 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.26 117.56 20.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.473 -1.016 . . . . 6.62 110.04 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.622 HG12 ' HG3' ' A' ' 38' ' ' LYS . 94.9 t -71.82 -39.8 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.555 -0.716 . . . . 4.89 109.985 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HG3' HG12 ' A' ' 37' ' ' VAL . 94.1 mttt -145.94 159.98 42.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 5.23 110.341 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -68.44 -40.01 81.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.59 -0.694 . . . . 5.15 110.203 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.62 -51.68 0.79 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.988 -1.645 . . . . 1.61 108.988 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.12 -39.98 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.899 . . . . 2.49 109.349 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 43' ' ' GLU . 12.8 p -62.31 -39.0 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.728 -0.608 . . . . 1.72 110.1 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 42' ' ' VAL . 95.9 mt-10 -59.98 -41.06 91.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.596 -0.69 . . . . 2.92 110.336 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -68.03 -39.98 83.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.793 -0.567 . . . . 2.25 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 64.6 m -78.04 -27.58 48.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.539 -0.726 . . . . 0.88 110.627 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.483 -0.761 . . . . 1.17 111.038 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -75.62 -40.01 57.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.326 -0.858 . . . . 1.59 111.186 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 58.2 m -133.53 153.92 51.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.446 -0.784 . . . . 1.19 110.164 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ASN . 86.0 mt -69.25 128.5 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.54 -0.725 . . . . 1.19 109.992 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 25.6 m -80.28 152.87 28.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.59 -0.694 . . . . 0.9 110.091 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.9 p -80.2 156.77 26.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 1.04 110.585 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.03 -39.99 87.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 1.25 110.536 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.02 -42.78 95.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.648 -0.657 . . . . 1.43 110.887 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 38.4 mt-30 -68.88 -41.32 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.431 -0.793 . . . . 1.58 110.617 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 55' ' ' LEU . 84.8 mt -60.27 -50.04 75.23 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.415 -0.803 . . . . 0.86 109.971 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.84 -39.97 91.08 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.446 0.641 . . . . 2.07 110.02 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -63.4 -40.03 96.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.784 -0.573 . . . . 1.93 111.204 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 21.9 m-85 -59.96 -37.09 78.58 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.188 -0.945 . . . . 1.87 111.138 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.99 -7.82 56.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.424 -0.798 . . . . 1.24 110.254 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.013 179.576 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.082 0.468 . . . . 4.65 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.99 159.97 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 121.533 -0.729 . . . . 4.16 110.519 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -153.79 80.14 1.15 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.491 0.662 . . . . 3.31 109.365 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -81.87 170.04 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.818 -0.551 . . . . 2.99 109.824 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -70.22 152.64 44.01 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.832 -0.747 . . . . 1.56 110.433 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -75.25 93.52 2.86 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.508 0.671 . . . . 1.84 110.591 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 172.56 16.01 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.192 0.52 . . . . 1.38 110.288 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.47 -136.51 43.63 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.063 -1.215 . . . . 1.5 110.063 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.2 m -70.92 -34.01 71.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.367 -1.078 . . . . 2.26 111.028 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -59.95 -35.32 74.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.491 -0.756 . . . . 2.63 110.328 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.6 tp -59.98 -45.22 93.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.62 -0.675 . . . . 2.07 110.679 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.9 t -63.29 -53.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.346 -0.846 . . . . 1.43 109.439 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.06 -45.64 92.19 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.341 0.591 . . . . 2.23 110.324 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.98 87.81 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.629 -0.669 . . . . 0.64 111.147 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.407 -0.808 . . . . 1.31 111.142 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.03 -48.44 81.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.219 -0.926 . . . . 3.19 110.053 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.01 -39.94 75.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.721 -0.612 . . . . 1.38 110.61 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.3 t -77.43 -68.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.735 -0.603 . . . . 1.3 110.601 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.3 m -80.04 -69.96 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.192 -0.603 . . . . 1.27 111.074 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.13 20.06 57.71 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.938 -1.265 . . . . 1.5 109.938 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -82.26 146.91 29.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.323 -1.104 . . . . 3.9 110.298 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -60.04 -39.99 87.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.761 -0.587 . . . . 5.04 111.001 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.85 28.42 10.43 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.573 -1.011 . . . . 2.42 110.573 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -75.06 65.5 1.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.363 -1.081 . . . . 2.65 111.417 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 27' ' ' THR . 11.5 p90 -72.57 -24.31 61.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.576 -1.328 . . . . 4.5 110.079 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 53.7 t80 45.72 71.88 0.25 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.577 -0.702 . . . . 2.39 112.37 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 25' ' ' PHE . 40.2 p -141.92 159.92 57.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 3.59 110.224 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.437 1.23 . . . . 3.69 110.372 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -65.56 -22.56 66.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.542 -0.724 . . . . 7.38 110.791 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.4 m 54.63 88.36 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.28 -0.888 . . . . 4.57 110.825 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtp85 -154.89 -48.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.543 -0.723 . . . . 8.82 109.786 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 mtp-105 -60.0 -47.9 83.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.778 -0.577 . . . . 7.82 110.299 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 36' ' ' ASP . 14.4 t80 -161.12 140.0 7.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 7.61 109.995 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.58 96.28 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 O-C-N 123.139 1.073 . . . . 6.7 111.468 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.25 -58.09 4.85 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.885 -1.286 . . . . 5.33 109.885 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 19.0 t0 53.74 42.11 31.89 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.396 -1.061 . . . . 6.62 110.977 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.1 t 55.08 -86.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.855 -0.528 . . . . 4.89 110.358 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 mptt -80.7 113.17 18.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.141 -0.975 . . . . 5.23 109.369 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' A' ' 41' ' ' ILE . 47.2 ttp180 -68.27 -39.31 82.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 5.15 108.915 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.35 -49.15 0.87 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.348 -1.101 . . . . 1.61 110.348 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' A' ' 39' ' ' ARG . 21.0 tt -68.34 -40.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.561 -0.964 . . . . 2.49 110.298 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 43' ' ' GLU . 14.7 p -64.55 -40.68 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.666 -0.646 . . . . 1.72 110.675 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 42' ' ' VAL . 73.6 mm-40 -66.65 -40.01 88.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.406 -0.809 . . . . 2.92 110.91 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.57 -45.86 92.37 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.538 -0.726 . . . . 2.25 111.207 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.02 -26.61 33.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.356 -0.84 . . . . 0.88 111.401 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.45 -40.02 94.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.117 -0.989 . . . . 1.17 109.638 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.0 p -81.37 -43.44 19.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.67 -0.643 . . . . 1.59 110.933 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -125.74 163.01 23.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.636 -0.665 . . . . 1.19 110.263 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 85.8 mt -79.27 136.66 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.641 0.734 . . . . 1.19 111.411 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.9 m -106.06 164.1 12.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.441 -0.577 . . . . 0.9 109.441 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.7 p -78.55 135.12 37.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.78 . . . . 1.04 109.681 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 55' ' ' LEU . 60.7 tp -59.22 -27.42 65.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.658 . . . . 1.25 110.905 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -59.96 -42.41 94.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.284 -0.885 . . . . 1.43 110.205 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 96.9 mt-30 -69.15 -40.0 78.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.437 -0.789 . . . . 1.58 109.376 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 52' ' ' LEU . 98.3 mt -60.55 -43.16 97.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.718 . . . . 0.86 109.7 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -60.51 -40.0 89.82 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.773 -0.579 . . . . 2.07 111.131 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -63.07 -41.58 99.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.487 -0.758 . . . . 1.93 110.606 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CE2' HD11 ' A' ' 41' ' ' ILE . 48.8 m-85 -59.95 -40.04 87.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.376 -0.827 . . . . 1.87 110.699 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.8 -6.17 56.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.684 . . . . 1.24 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 117.952 -1.023 . . . . 2.56 110.216 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.154 0.502 . . . . 4.65 110.069 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.96 160.06 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.586 -0.696 . . . . 4.16 111.048 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' ILE . 74.7 m-20 -156.73 45.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.273 -0.64 . . . . 3.31 109.273 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -80.88 160.74 24.65 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 2.99 110.449 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -79.01 137.65 37.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.735 -0.603 . . . . 1.56 110.296 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -84.42 84.74 7.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 1.84 109.971 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.02 -175.96 5.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.811 -0.556 . . . . 1.38 109.545 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -137.7 42.08 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.599 -1.401 . . . . 1.5 109.599 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -74.33 -24.16 59.16 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.343 -1.092 . . . . 2.26 110.97 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -66.93 -40.06 87.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.42 -0.8 . . . . 2.63 111.735 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.71 -46.17 91.42 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.264 -0.898 . . . . 2.07 111.196 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.43 -49.21 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.423 -0.798 . . . . 1.43 110.487 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -46.37 89.72 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.645 -0.659 . . . . 2.23 111.462 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.81 -53.91 51.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.75 . . . . 0.64 112.377 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.36 -44.46 95.55 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.23 -0.919 . . . . 1.31 112.041 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.53 -40.14 90.39 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.349 -0.845 . . . . 3.19 111.568 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.2 -40.67 82.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.184 -0.947 . . . . 1.38 110.938 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.03 -43.0 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.512 -0.743 . . . . 1.3 110.557 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -70.79 -36.24 72.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.616 -0.678 . . . . 1.27 110.631 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.74 -82.25 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.169 -1.173 . . . . 1.5 110.169 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -55.64 150.09 13.0 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.46 -1.023 . . . . 3.9 110.897 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.6 mtt85 -100.0 10.07 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.601 -0.687 . . . . 5.04 110.993 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.78 -3.19 83.46 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.155 -0.966 . . . . 2.42 111.536 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 32.2 p90 -74.89 139.0 42.8 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 118.858 1.329 . . . . 2.65 110.559 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.33 -40.05 37.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.473 -0.767 . . . . 4.5 110.962 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.412 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 50.8 t80 50.57 35.2 10.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.371 -0.83 . . . . 2.39 110.16 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 p -85.34 118.85 71.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.757 -0.589 . . . . 3.59 110.914 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.2 -160.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.161 1.085 . . . . 3.69 109.315 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' C ' HG22 ' A' ' 30' ' ' THR . 24.8 tptt -64.9 -59.52 4.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 7.38 109.987 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' C ' ' A' ' 29' ' ' LYS . 9.9 t 36.33 39.83 0.1 Allowed 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 113.08 0.77 . . . . 4.57 113.08 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -79.98 -70.0 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 8.82 110.018 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -69.86 -39.97 76.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 7.82 110.288 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 13.8 t80 -154.74 144.22 15.27 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.554 -0.716 . . . . 7.61 110.472 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 42.3 Cg_endo -70.53 -53.95 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.317 1.167 . . . . 6.7 110.543 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.54 104.85 0.17 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.155 -1.178 . . . . 5.33 110.155 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 93.2 m-20 -75.56 154.36 36.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.961 . . . . 6.62 109.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 40.9 t 65.33 -64.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 109.738 -0.467 . . . . 4.89 109.738 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 36' ' ' ASP . 19.9 tptm -78.58 154.2 30.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 5.23 108.87 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -151.44 -36.97 0.13 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.481 -0.762 . . . . 5.15 110.517 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.67 -56.69 0.67 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.097 -1.601 . . . . 1.61 109.097 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 pt -69.99 -23.76 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.777 -0.837 . . . . 2.49 110.539 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.01 -40.0 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.31 -0.869 . . . . 1.72 110.029 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -57.4 -38.07 73.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 2.92 110.585 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -41.07 91.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.61 -0.681 . . . . 2.25 110.369 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.6 m -86.83 -38.98 16.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.487 -0.758 . . . . 0.88 110.561 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.98 -46.17 75.42 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.374 -0.829 . . . . 1.17 111.107 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.1 m -69.97 -41.82 73.96 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.336 -0.853 . . . . 1.59 109.337 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -139.99 154.72 47.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.755 -0.831 . . . . 1.19 108.755 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 ' O ' ' A' ' 3' ' ' ASN . 96.3 mt -67.36 127.08 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.26 -0.9 . . . . 1.19 109.67 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 7.5 m -70.51 140.14 51.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.667 -0.646 . . . . 0.9 110.187 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.8 p -79.93 158.78 26.56 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.53 0.681 . . . . 1.04 110.99 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.01 -40.0 87.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.831 -0.543 . . . . 1.25 110.563 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -59.4 -42.9 92.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.602 -0.686 . . . . 1.43 110.82 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -68.87 -40.03 79.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.487 -0.758 . . . . 1.58 110.227 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.09 -41.54 99.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.86 109.95 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -61.19 -40.04 92.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.714 -0.616 . . . . 2.07 111.017 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -63.98 -41.96 97.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 1.93 110.445 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -62.08 -39.94 94.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.562 -0.711 . . . . 1.87 111.953 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -89.0 -0.64 57.6 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.263 -0.898 . . . . 1.24 111.226 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.997 -1.002 . . . . 2.56 110.117 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.09 0.471 . . . . 4.65 109.993 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.04 159.99 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.557 -0.714 . . . . 4.16 111.288 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -159.44 39.47 0.2 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.893 -0.78 . . . . 3.31 108.893 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -82.23 157.86 23.76 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.404 0.621 . . . . 2.99 110.225 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -79.97 129.99 34.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.798 -0.564 . . . . 1.56 109.844 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.697 HD11 HD11 ' A' ' 55' ' ' LEU . 17.3 mt -73.75 70.59 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 1.84 109.379 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -149.66 -178.86 6.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.509 -0.552 . . . . 1.38 109.509 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.46 -139.74 41.42 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.568 -1.413 . . . . 1.5 109.568 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -75.15 -29.37 60.46 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.346 -1.09 . . . . 2.26 111.167 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -61.39 -36.97 81.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 2.63 110.894 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.9 tm? -59.93 -42.59 94.28 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.78 . . . . 2.07 110.52 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.78 -48.31 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -0.814 . . . . 1.43 109.409 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.96 -39.98 87.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.695 -0.628 . . . . 2.23 109.939 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.29 95.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.812 -0.555 . . . . 0.64 110.893 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.99 -42.04 93.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.405 -0.809 . . . . 1.31 110.69 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.36 -40.01 81.64 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.666 -0.814 . . . . 3.19 110.17 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.03 -46.15 78.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 1.38 111.587 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.36 -57.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.315 -0.865 . . . . 1.3 110.586 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.9 m -73.66 -57.82 3.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 1.27 109.843 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.95 25.7 62.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.797 -0.921 . . . . 1.5 110.797 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -132.57 155.67 48.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 3.9 110.578 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -103.07 -0.88 30.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 5.04 111.278 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -44.48 97.26 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 121.184 -0.947 . . . . 2.42 111.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 45.0 p90 -80.01 128.15 33.13 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.274 -1.133 . . . . 2.65 112.064 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -81.62 -25.33 35.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.66 -0.65 . . . . 4.5 109.787 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 61.16 69.39 0.67 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.383 -0.823 . . . . 2.39 108.878 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.1 m -151.4 127.56 5.13 Favored Pre-proline 0 N--CA 1.485 1.32 0 O-C-N 121.743 -0.598 . . . . 3.59 110.609 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.94 168.27 23.58 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.147 1.078 . . . . 3.69 110.127 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -69.65 -45.07 69.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.412 -0.805 . . . . 7.38 111.93 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 6.4 t -160.37 24.1 0.16 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 4.57 110.84 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -83.72 127.39 33.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.522 -0.736 . . . . 8.82 110.373 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 53.89 50.27 17.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.44 -0.787 . . . . 7.82 111.609 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -77.7 -55.64 1.23 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.369 -0.832 . . . . 7.61 110.23 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.22 71.62 5.08 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.159 1.084 . . . . 6.7 110.299 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.83 104.63 0.29 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.203 -1.559 . . . . 5.33 109.203 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' C ' HG13 ' A' ' 37' ' ' VAL . 50.5 t0 -80.03 105.0 10.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.579 -0.954 . . . . 6.62 110.056 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG13 ' C ' ' A' ' 36' ' ' ASP . 28.1 m -153.56 -162.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 O-C-N 121.65 -0.656 . . . . 4.89 109.834 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -76.6 141.5 41.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.391 -0.818 . . . . 5.23 110.432 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -69.96 -38.5 76.12 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.576 0.703 . . . . 5.15 109.465 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.34 -30.73 2.68 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.765 -1.734 . . . . 1.61 108.765 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.59 -40.84 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.645 -0.915 . . . . 2.49 109.331 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.43 -40.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.688 -1.227 . . . . 1.72 107.688 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -37.03 78.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.447 0.641 . . . . 2.92 109.868 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -59.99 -39.98 87.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.687 -0.633 . . . . 2.25 110.608 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.15 -14.56 59.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.435 -0.791 . . . . 0.88 111.024 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.95 -39.57 75.97 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.02 -1.05 . . . . 1.17 110.568 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.9 p -75.14 -42.8 55.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.386 -0.821 . . . . 1.59 111.309 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.6 p -126.46 -154.34 0.62 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.813 . . . . 1.19 110.08 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.2 mt -120.0 122.94 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.831 . . . . 1.19 110.238 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.506 ' HB2' HD12 ' A' ' 6' ' ' LEU . 89.2 m -82.95 138.06 33.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.778 -0.576 . . . . 0.9 109.447 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.4 p -79.81 161.5 25.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.59 -0.694 . . . . 1.04 111.201 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 55' ' ' LEU . 7.5 tt -57.14 -31.78 65.7 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.776 -0.577 . . . . 1.25 110.507 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -59.97 -40.0 87.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.568 -0.708 . . . . 1.43 110.26 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 92.3 mt-30 -65.61 -39.97 92.12 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.577 -0.702 . . . . 1.58 109.762 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 52' ' ' LEU . 45.0 mt -59.94 -44.12 94.56 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.741 . . . . 0.86 110.189 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.0 -40.98 91.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.694 -0.629 . . . . 2.07 110.684 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.92 -43.94 86.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.562 -0.711 . . . . 1.93 110.31 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 27.6 m-85 -62.96 -29.57 70.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.518 -0.738 . . . . 1.87 110.62 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 t -88.15 -1.83 58.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.57 -0.706 . . . . 1.24 110.947 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 117.959 -1.02 . . . . 2.56 109.977 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.797 -0.445 . . . . 4.65 109.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 O-C-N 121.474 -0.766 . . . . 4.16 111.004 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -154.92 88.74 1.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.554 -0.906 . . . . 3.31 108.554 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -80.02 164.56 23.34 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.591 0.71 . . . . 2.99 110.953 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -75.77 159.46 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.148 0.499 . . . . 1.56 109.972 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 14' ' ' ALA . 83.4 mt -88.26 90.52 8.43 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.012 -0.736 . . . . 1.84 109.012 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -148.29 -176.19 5.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.808 -0.558 . . . . 1.38 110.091 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 52.95 -141.9 28.24 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.226 -1.55 . . . . 1.5 109.226 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.8 m -76.11 -23.94 54.95 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.237 -1.155 . . . . 2.26 110.665 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -62.37 -36.1 81.22 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.494 -0.754 . . . . 2.63 110.974 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 62.6 tp -59.52 -40.04 85.84 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.38 -0.825 . . . . 2.07 110.13 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.18 -50.39 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 1.43 109.788 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.19 -41.76 93.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.483 -0.76 . . . . 2.23 110.952 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.63 -49.28 77.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.682 -0.636 . . . . 0.64 111.442 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -60.02 -48.08 83.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.416 -0.803 . . . . 1.31 110.682 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.0 -50.01 75.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.396 -0.815 . . . . 3.19 109.968 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.82 -40.43 92.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.658 -0.651 . . . . 1.38 110.139 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.6 t -70.03 -42.75 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.651 -0.656 . . . . 1.3 110.604 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -72.03 -44.29 63.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.463 -0.773 . . . . 1.27 111.589 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.83 59.12 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.87 -1.292 . . . . 1.5 109.87 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.93 163.27 12.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.432 -1.04 . . . . 3.9 111.1 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -128.09 92.44 3.46 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.879 -0.786 . . . . 5.04 108.879 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.96 30.91 3.28 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.293 -1.523 . . . . 2.42 109.293 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 35.7 p90 -76.3 140.21 41.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.653 -0.91 . . . . 2.65 110.97 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -83.7 -42.22 16.84 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.6 -0.688 . . . . 4.5 110.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.4 t80 45.72 27.67 0.47 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.522 -0.737 . . . . 2.39 112.207 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 27' ' ' THR . 9.8 t -82.03 114.57 51.71 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 3.59 110.236 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 46.2 Cg_endo -92.2 176.82 1.76 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.771 0.981 . . . . 3.69 110.624 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -78.29 58.78 2.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.516 -0.74 . . . . 7.38 110.504 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -158.5 96.42 1.4 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.066 -0.716 . . . . 4.57 109.066 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -149.31 164.94 33.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.767 -0.583 . . . . 8.82 109.813 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 59.59 18.94 7.51 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.649 -0.657 . . . . 7.82 109.986 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -85.53 139.64 35.83 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 7.61 109.678 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.83 80.84 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.189 1.1 . . . . 6.7 110.371 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.61 85.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.32 -1.512 . . . . 5.33 109.32 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 38' ' ' LYS . 86.8 m-20 -74.4 156.74 36.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -1.007 . . . . 6.62 109.739 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t 64.19 -65.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 122.134 -0.354 . . . . 4.89 110.938 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' ASP . 3.7 pttt -79.82 149.73 30.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.839 . . . . 5.23 110.287 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.45 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.8 -0.563 . . . . 5.15 109.792 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.43 -27.86 2.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.808 -1.317 . . . . 1.61 109.808 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.0 -49.97 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.376 -1.073 . . . . 2.49 110.081 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 43' ' ' GLU . 31.0 m -63.75 -38.9 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.736 -0.602 . . . . 1.72 110.572 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 42' ' ' VAL . 75.3 mm-40 -62.71 -38.95 92.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.535 -0.728 . . . . 2.92 111.24 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.01 -40.58 89.77 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.272 -0.893 . . . . 2.25 110.503 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -83.42 -31.05 26.85 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.629 -0.669 . . . . 0.88 109.841 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.02 -57.91 10.8 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.753 -0.592 . . . . 1.17 111.647 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -70.39 -41.59 72.84 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.311 -0.868 . . . . 1.59 110.5 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.2 m -126.21 142.73 51.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.606 -0.684 . . . . 1.19 109.46 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.58 124.8 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.743 -0.783 . . . . 1.19 109.535 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.9 m -70.34 150.61 46.14 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.069 -0.653 . . . . 0.9 109.242 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.6 p -76.69 140.31 40.83 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.71 0.767 . . . . 1.04 110.899 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.67 -39.54 84.81 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.144 0.497 . . . . 1.25 110.341 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.33 -41.65 85.03 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.569 -0.707 . . . . 1.43 110.862 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.05 -40.0 87.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 1.58 109.712 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.17 -43.92 95.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.602 -0.686 . . . . 0.86 110.379 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.08 -42.2 94.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.585 -0.697 . . . . 2.07 110.706 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.5 -39.78 92.28 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.686 -0.634 . . . . 1.93 110.883 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 1.87 110.775 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 t -89.96 -9.93 46.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.414 -0.804 . . . . 1.24 110.514 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.955 -1.021 . . . . 2.56 110.209 179.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 59.9 t80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.065 0.459 . . . . 4.65 110.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.02 159.96 41.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.536 -0.727 . . . . 4.16 110.437 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -156.41 38.61 0.34 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.569 0.7 . . . . 3.31 109.506 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -82.15 161.8 22.68 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 2.99 110.062 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -78.02 141.32 38.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.704 -0.622 . . . . 1.56 110.09 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' N ' HD12 ' A' ' 6' ' ' LEU . 5.2 mp -102.5 101.23 11.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.482 -0.761 . . . . 1.84 110.011 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 88.0 m -147.93 -165.28 2.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.783 -0.573 . . . . 1.38 109.665 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.84 -144.52 34.63 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.679 -1.368 . . . . 1.5 109.679 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 t -73.86 -28.47 61.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.421 -1.046 . . . . 2.26 111.19 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -62.06 -41.19 97.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.432 -0.793 . . . . 2.63 110.883 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' HG13 ' A' ' 42' ' ' VAL . 62.7 tp -61.05 -42.69 98.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.421 -0.8 . . . . 2.07 110.626 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.17 -47.18 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.444 -0.785 . . . . 1.43 109.318 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.97 -40.14 88.06 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.474 0.654 . . . . 2.23 109.492 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.57 -40.65 95.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.773 -0.579 . . . . 0.64 110.188 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.02 -44.6 94.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.492 -0.755 . . . . 1.31 110.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -62.65 -49.95 73.13 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.889 -0.724 . . . . 3.19 110.377 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.97 -39.99 75.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.619 -0.676 . . . . 1.38 111.134 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 14' ' ' ALA . 53.0 t -69.56 -46.46 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.426 -0.796 . . . . 1.3 110.34 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.5 m -70.75 -39.96 72.96 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -0.809 . . . . 1.27 109.99 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.25 28.56 73.79 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.302 -1.119 . . . . 1.5 110.302 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -145.26 115.27 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -1.037 . . . . 3.9 110.839 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -62.37 -39.96 94.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.622 -0.674 . . . . 5.04 110.388 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 48.67 2.8 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.454 -1.058 . . . . 2.42 110.454 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -75.09 148.87 39.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.471 -1.017 . . . . 2.65 109.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 27' ' ' THR . 39.3 m-85 -80.03 -69.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.235 -0.916 . . . . 4.5 109.823 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 43.1 27.53 0.12 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.804 -0.56 . . . . 2.39 111.984 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 25' ' ' PHE . 47.0 p -83.03 113.95 49.3 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.439 -0.788 . . . . 3.59 109.364 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.31 -176.8 2.46 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.237 1.125 . . . . 3.69 110.448 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.22 -39.98 93.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.612 -0.68 . . . . 7.38 109.244 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 60.8 m 48.76 44.5 21.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.625 -0.672 . . . . 4.57 111.625 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 46.77 -167.63 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.499 -0.751 . . . . 8.82 111.762 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -60.19 -38.06 82.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.728 -0.608 . . . . 7.82 110.308 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CD1' ' HD2' ' A' ' 34' ' ' PRO . 15.2 t80 -150.64 149.12 25.17 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.615 -0.678 . . . . 7.61 109.47 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HB3' HG21 ' A' ' 30' ' ' THR . 43.6 Cg_endo -79.94 74.7 5.42 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.083 1.044 . . . . 6.7 111.025 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.09 79.52 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.159 -1.576 . . . . 5.33 109.159 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -154.85 167.62 29.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.704 -0.88 . . . . 6.62 109.742 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.86 113.54 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.483 -0.76 . . . . 4.89 109.814 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -86.9 103.2 15.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.73 -0.606 . . . . 5.23 110.965 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -89.96 15.87 9.24 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.524 -0.735 . . . . 5.15 109.883 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.75 97.8 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.181 -1.568 . . . . 1.61 109.181 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 42' ' ' VAL . 46.4 pt -71.58 -40.08 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.703 -0.881 . . . . 2.49 109.32 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 41' ' ' ILE . 63.7 t -67.63 -46.78 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.277 -1.008 . . . . 1.72 108.277 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.02 -30.75 69.37 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.097 -0.502 . . . . 2.92 110.443 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -60.05 -39.94 87.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 2.25 110.443 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.69 -21.68 55.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.88 110.082 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.3 m -69.48 -39.97 77.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.285 -0.884 . . . . 1.17 109.431 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.0 p -74.6 -39.97 61.85 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.61 -0.681 . . . . 1.59 109.905 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.2 p -130.89 144.94 51.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.635 -0.666 . . . . 1.19 109.402 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.01 129.45 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.414 -0.804 . . . . 1.19 110.612 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.8 m -92.51 152.73 19.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.9 109.967 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.5 p -79.54 139.73 37.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.421 -0.799 . . . . 1.04 110.85 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 tp -59.97 -33.75 72.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.735 -0.603 . . . . 1.25 110.332 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -59.47 -43.94 93.12 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.591 -0.693 . . . . 1.43 110.535 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 78.0 mt-30 -69.79 -40.04 76.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.506 -0.746 . . . . 1.58 110.173 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.01 -47.73 84.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.547 -0.72 . . . . 0.86 110.107 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -40.08 88.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.74 -0.6 . . . . 2.07 110.443 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.5 -44.47 97.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.669 -0.645 . . . . 1.93 110.744 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.418 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 37.5 m-85 -60.01 -39.97 87.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.481 -0.762 . . . . 1.87 111.053 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.2 t -88.82 -16.45 32.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.747 -0.595 . . . . 1.24 110.695 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 117.966 -1.016 . . . . 2.56 110.331 179.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.122 0.487 . . . . 4.65 110.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.0 159.99 41.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 121.599 -0.688 . . . . 4.16 109.991 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -156.36 40.56 0.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 3.31 110.134 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -80.93 159.98 24.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.872 -0.517 . . . . 2.99 109.778 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.472 ' CE1' HG13 ' A' ' 49' ' ' ILE . 52.4 m-70 -77.94 128.79 34.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.64 -0.662 . . . . 1.56 109.664 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.69 ' CD1' HD11 ' A' ' 55' ' ' LEU . 86.2 mt -84.24 84.52 7.59 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.448 -0.783 . . . . 1.84 109.65 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.418 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.2 179.97 7.67 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.23 -0.656 . . . . 1.38 109.23 -179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.01 -138.68 42.1 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.201 -1.56 . . . . 1.5 109.201 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -74.71 -25.96 59.49 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.17 -1.194 . . . . 2.26 110.67 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -62.39 -37.87 87.42 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.476 -0.765 . . . . 2.63 110.918 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 6' ' ' LEU . 7.6 tt -59.99 -50.04 75.32 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.518 -0.739 . . . . 2.07 111.043 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.21 -48.0 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.363 -0.835 . . . . 1.43 110.042 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -41.81 92.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.724 -0.61 . . . . 2.23 110.767 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -65.45 -41.37 93.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.646 -0.659 . . . . 0.64 111.279 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.02 -49.42 77.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.448 -0.783 . . . . 1.31 111.006 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -60.05 -49.04 79.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.407 -0.808 . . . . 3.19 111.245 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.0 mt -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 1.38 112.025 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' ALA . 98.9 t -72.9 -58.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.277 -0.889 . . . . 1.3 110.452 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.3 m -79.28 -62.15 1.79 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.7 -0.625 . . . . 1.27 110.61 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.9 29.46 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.292 -1.123 . . . . 1.5 110.292 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' ' CE2' ' A' ' 24' ' ' PHE . 98.9 mt-10 -136.97 154.39 50.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.363 -1.081 . . . . 3.9 110.724 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -100.51 10.34 41.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.618 -0.677 . . . . 5.04 111.0 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.98 -47.14 92.45 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.608 -1.397 . . . . 2.42 109.608 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CG ' ' HA ' ' A' ' 59' ' ' CYS . 53.0 p90 -79.23 124.47 28.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.576 -0.955 . . . . 2.65 110.115 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -82.3 -16.41 49.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.535 -0.728 . . . . 4.5 111.65 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 49.43 73.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.192 -0.943 . . . . 2.39 111.042 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.416 ' CG2' ' HD2' ' A' ' 28' ' ' PRO . 11.0 m -153.1 145.01 16.75 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.767 . . . . 3.59 110.202 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 27' ' ' THR . 41.0 Cg_endo -67.39 -168.92 0.19 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.231 1.122 . . . . 3.69 110.407 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -70.04 -35.3 74.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.493 -0.754 . . . . 7.38 111.886 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.9 m -159.74 -86.07 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.873 . . . . 4.57 110.799 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 52.27 40.0 28.21 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.038 -1.039 . . . . 8.82 111.802 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -81.78 77.83 8.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.482 -0.761 . . . . 7.82 109.63 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -148.07 151.91 38.77 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.663 -0.648 . . . . 7.61 110.042 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.12 139.57 8.36 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.313 1.165 . . . . 6.7 110.583 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.57 21.17 45.0 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.679 -0.969 . . . . 5.33 110.679 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' C ' HG23 ' A' ' 37' ' ' VAL . 96.2 m-20 -78.01 150.02 33.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.212 -1.17 . . . . 6.62 110.335 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 36' ' ' ASP . 91.9 t -155.14 67.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.867 -0.79 . . . . 4.89 108.867 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -160.02 158.04 29.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.562 -0.711 . . . . 5.23 109.937 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -155.41 -44.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.422 -0.799 . . . . 5.15 109.713 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.25 -46.9 2.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.925 -1.27 . . . . 1.61 109.925 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' TYR . 86.8 mt -62.12 -46.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.547 -0.972 . . . . 2.49 109.971 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.75 -42.58 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.155 -0.683 . . . . 1.72 109.155 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.7 mp0 -60.3 -39.99 88.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.667 -0.646 . . . . 2.92 110.276 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.01 -45.41 92.86 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.594 . . . . 2.25 111.361 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.9 m -82.19 -29.02 31.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.883 . . . . 0.88 111.06 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.99 -40.07 95.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.245 -0.91 . . . . 1.17 110.489 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -74.08 -48.26 30.94 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.518 -0.739 . . . . 1.59 110.411 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.3 m -129.89 160.72 32.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.635 -0.666 . . . . 1.19 109.737 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.472 HG13 ' CE1' ' A' ' 5' ' ' HIS . 86.0 mt -72.24 122.01 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 1.19 110.013 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -73.57 139.93 45.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.578 -0.701 . . . . 0.9 110.002 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -80.64 165.98 21.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.622 -0.673 . . . . 1.04 110.966 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.96 -37.88 77.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.734 -0.604 . . . . 1.25 109.988 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -59.71 -40.01 86.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.645 -0.659 . . . . 1.43 110.59 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.15 -39.97 90.2 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.471 -0.892 . . . . 1.58 109.445 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 6' ' ' LEU . 92.7 mt -61.56 -39.99 93.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.735 . . . . 0.86 109.506 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.0 -39.72 86.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.784 -0.573 . . . . 2.07 109.799 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -59.96 -44.88 94.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.671 -0.643 . . . . 1.93 109.9 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 20.8 m-85 -60.05 -36.64 77.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.499 -0.751 . . . . 1.87 110.682 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HA ' ' CG ' ' A' ' 24' ' ' PHE . 6.7 m -89.08 -0.02 57.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.606 -0.684 . . . . 1.24 111.314 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 . . . . . 0 N--CA 1.497 1.924 0 CA-C-O 117.993 -1.003 . . . . 2.56 110.006 179.446 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.975 0.417 . . . . 4.65 109.972 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.0 41.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 121.471 -0.768 . . . . 4.16 110.114 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -156.04 92.65 1.37 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.809 -0.811 . . . . 3.31 108.809 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.96 159.15 26.4 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.524 0.678 . . . . 2.99 110.665 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -80.12 146.57 31.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.856 -0.527 . . . . 1.56 110.147 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.742 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.7 mt -84.76 89.54 7.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.461 -0.774 . . . . 1.84 110.174 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 2.2 t -149.72 172.37 15.2 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.513 -0.551 . . . . 1.38 109.513 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.36 -125.7 37.04 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.389 -1.484 . . . . 1.5 109.389 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.9 m -74.94 -30.29 61.2 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.345 -1.091 . . . . 2.26 111.04 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.11 -39.99 93.9 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.449 -0.782 . . . . 2.63 111.712 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 40.5 tp -59.97 -48.32 82.19 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.843 . . . . 2.07 110.874 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.22 -50.74 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.496 -0.752 . . . . 1.43 109.776 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 -46.21 90.32 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.283 0.564 . . . . 2.23 111.175 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -60.93 -47.41 86.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.655 -0.653 . . . . 0.64 111.791 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.02 -42.88 95.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.383 -0.823 . . . . 1.31 110.689 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -62.47 -42.86 99.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.357 -0.839 . . . . 3.19 110.37 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.84 -40.64 83.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.691 . . . . 1.38 110.691 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.07 -63.53 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 1.3 111.236 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.05 -69.94 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.623 -0.673 . . . . 1.27 110.651 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.96 19.3 63.27 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.386 -1.086 . . . . 1.5 110.386 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.24 143.38 45.6 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.253 -1.145 . . . . 3.9 109.675 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' CE1' ' A' ' 24' ' ' PHE . 54.4 mtt180 -64.48 -21.29 66.62 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.711 . . . . 5.04 111.934 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.33 -21.53 12.77 Favored Glycine 0 N--CA 1.497 2.728 0 O-C-N 121.345 -0.847 . . . . 2.42 111.766 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -73.33 77.61 1.35 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.073 -1.251 . . . . 2.65 112.328 -178.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.253 -0.904 . . . . 4.5 109.325 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 55.47 20.99 4.02 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.836 -0.54 . . . . 2.39 111.321 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.5 m -81.69 138.18 47.32 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.849 . . . . 3.59 109.578 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.26 173.12 10.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.223 1.117 . . . . 3.69 111.037 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.96 -23.47 63.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.701 -0.624 . . . . 7.38 110.376 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 30' ' ' THR . 85.5 m 50.0 50.57 18.26 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.293 -0.879 . . . . 4.57 111.531 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -69.99 -40.05 75.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 8.82 110.052 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 73.0 ttt180 -168.97 32.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.294 -0.879 . . . . 7.82 110.506 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.62 82.64 2.37 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.897 -1.127 . . . . 7.61 111.215 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.25 63.72 8.79 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.174 1.091 . . . . 6.7 109.82 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.35 56.33 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.03 -0.828 . . . . 5.33 111.03 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.18 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.246 -1.15 . . . . 6.62 110.873 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.9 t 57.39 -80.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.747 -0.595 . . . . 4.89 111.467 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -76.72 80.54 3.35 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.959 . . . . 5.23 109.557 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -73.88 -34.08 64.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.234 -0.654 . . . . 5.15 109.234 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.7 -50.65 0.96 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.057 -1.217 . . . . 1.61 110.057 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.6 pt -70.87 -31.35 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.938 . . . . 2.49 110.701 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.84 -43.58 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.342 -0.849 . . . . 1.72 109.757 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.33 -22.69 67.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.593 -0.692 . . . . 2.92 111.011 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -60.03 -42.21 93.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 2.25 111.332 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -81.78 -19.31 41.53 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.88 110.738 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.03 -38.12 75.78 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.293 -0.879 . . . . 1.17 111.088 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.2 p -74.74 -22.63 58.7 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.427 -0.795 . . . . 1.59 111.487 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -140.8 -158.43 0.86 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.358 -0.839 . . . . 1.19 110.529 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.19 126.42 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.583 -0.698 . . . . 1.19 109.268 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.8 m -95.18 139.07 32.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.547 -0.721 . . . . 0.9 110.284 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.1 p -80.03 167.11 20.86 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.372 0.606 . . . . 1.04 111.19 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HA ' HD12 ' A' ' 55' ' ' LEU . 15.6 tp -58.97 -38.43 79.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.726 -0.609 . . . . 1.25 109.709 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -57.19 -43.11 82.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.654 -0.654 . . . . 1.43 109.927 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -67.05 -39.94 87.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 1.58 108.706 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 52' ' ' LEU . 95.6 mt -60.31 -40.6 91.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.59 -0.694 . . . . 0.86 109.626 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.02 88.0 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.636 -0.665 . . . . 2.07 110.26 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -63.96 -40.05 95.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 1.93 110.271 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -67.46 -35.12 78.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.618 -0.676 . . . . 1.87 111.416 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.43 -3.22 58.87 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.421 -0.799 . . . . 1.24 110.691 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 118.069 -0.967 . . . . 2.56 110.152 179.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.024 0.44 . . . . 4.65 110.099 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.02 161.52 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.516 -0.74 . . . . 4.16 111.226 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -153.41 92.41 1.59 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.903 -1.147 . . . . 3.31 107.903 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -79.95 166.62 21.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.748 0.785 . . . . 2.99 111.509 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.95 159.85 31.3 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.258 0.552 . . . . 1.56 110.782 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 11' ' ' LEU . 16.6 mt -96.27 87.63 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.718 -0.614 . . . . 1.84 109.73 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.62 -172.99 4.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.512 -0.743 . . . . 1.38 110.261 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.99 -138.3 42.68 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.727 -1.349 . . . . 1.5 109.727 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 t -74.53 -30.84 61.92 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.389 -1.065 . . . . 2.26 111.237 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -62.04 -39.28 91.81 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.462 -0.774 . . . . 2.63 111.613 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 6' ' ' LEU . 42.8 tp -59.91 -48.13 82.97 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.333 -0.854 . . . . 2.07 110.75 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.8 t -60.04 -49.93 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 1.43 109.527 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.98 -41.55 92.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.659 -0.651 . . . . 2.23 110.201 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.77 -43.31 99.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.659 -0.651 . . . . 0.64 110.74 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.0 -47.84 84.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.464 -0.773 . . . . 1.31 110.751 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.3 -43.72 96.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.437 -0.789 . . . . 3.19 110.224 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.81 -39.96 94.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.67 -0.644 . . . . 1.38 111.912 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 14' ' ' ALA . 57.6 t -72.66 -55.52 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.371 -0.831 . . . . 1.3 110.968 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.2 m -75.23 -46.82 31.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.564 -0.71 . . . . 1.27 110.953 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.63 87.66 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.884 -0.886 . . . . 1.5 110.884 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -145.93 158.38 43.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.969 -1.313 . . . . 3.9 110.841 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.38 25.83 10.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.603 -0.686 . . . . 5.04 110.328 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.38 -36.49 91.68 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.699 -0.961 . . . . 2.42 110.699 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -74.35 144.27 44.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.281 -1.129 . . . . 2.65 110.927 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -81.84 -10.74 59.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.665 . . . . 4.5 110.917 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 55.12 86.74 0.05 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.197 -0.939 . . . . 2.39 110.456 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.6 p -140.34 159.98 61.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.673 -0.642 . . . . 3.59 110.773 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.36 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.485 1.008 0 O-C-N 123.565 1.297 . . . . 3.69 110.865 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -69.97 -19.22 63.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.655 -0.653 . . . . 7.38 110.605 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -154.36 101.01 2.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.309 -0.869 . . . . 4.57 109.917 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -147.63 150.45 34.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.282 0.563 . . . . 8.82 109.979 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.4 ttt85 -60.69 -40.03 90.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.63 -0.668 . . . . 7.82 111.232 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.54 90.55 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.401 -0.812 . . . . 7.61 110.222 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.24 -179.31 5.33 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.47 1.247 . . . . 6.7 110.43 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.77 110.38 3.02 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.89 -1.284 . . . . 5.33 109.89 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 49.96 49.95 19.36 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.526 -0.985 . . . . 6.62 110.745 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 39' ' ' ARG . 65.4 t -75.83 148.78 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.701 -0.625 . . . . 4.89 110.201 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -70.0 -36.25 75.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.695 -0.628 . . . . 5.23 109.351 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' H ' HG12 ' A' ' 37' ' ' VAL . 95.7 mtt180 -156.4 -61.13 0.1 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.325 -0.991 . . . . 5.15 108.325 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.93 -88.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.353 -1.099 . . . . 1.61 110.353 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' ARG . 76.2 mt -63.88 -40.65 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.834 -0.803 . . . . 2.49 109.698 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.3 -46.91 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.678 -0.638 . . . . 1.72 110.141 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.72 -29.73 69.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.521 -0.737 . . . . 2.92 111.494 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -50.03 75.36 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.376 -0.828 . . . . 2.25 111.138 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -86.04 -10.94 54.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.84 . . . . 0.88 111.409 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.98 -44.74 68.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.063 -1.023 . . . . 1.17 111.066 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -73.38 -43.84 59.8 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.355 -0.841 . . . . 1.59 110.693 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 m -108.57 -166.99 1.17 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.522 -0.736 . . . . 1.19 110.207 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.87 123.2 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.641 -0.662 . . . . 1.19 109.4 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.5 m -95.98 129.33 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.594 -0.691 . . . . 0.9 109.891 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.9 p -80.18 164.12 23.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.697 -0.627 . . . . 1.04 110.494 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HA ' HD12 ' A' ' 55' ' ' LEU . 38.7 tp -58.62 -37.82 76.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.701 -0.624 . . . . 1.25 110.233 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -58.09 -42.24 85.21 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.721 . . . . 1.43 110.427 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.0 -38.44 82.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.812 -0.81 . . . . 1.58 108.812 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 52' ' ' LEU . 96.0 mt -60.01 -42.23 93.85 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.501 -0.75 . . . . 0.86 109.312 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.89 -40.05 87.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.817 -0.552 . . . . 2.07 110.18 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -59.99 -46.77 88.37 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.706 -0.621 . . . . 1.93 109.862 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.4 -27.37 68.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.71 . . . . 1.87 110.102 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.52 61.08 5.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.566 -0.709 . . . . 1.24 109.972 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 118.002 -0.999 . . . . 2.56 110.186 179.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.977 0.418 . . . . 4.65 109.961 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.03 160.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 O-C-N 121.555 -0.716 . . . . 4.16 110.182 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -157.24 97.92 1.68 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.249 -1.019 . . . . 3.31 108.249 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.0 163.86 23.91 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.516 0.674 . . . . 2.99 110.905 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -74.09 143.3 45.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.798 -0.564 . . . . 1.56 110.444 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.678 HD22 ' CB ' ' A' ' 14' ' ' ALA . 85.6 mt -73.49 84.89 1.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.602 -0.686 . . . . 1.84 109.812 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.31 174.28 13.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.728 -0.607 . . . . 1.38 109.867 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.55 -131.0 46.31 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.317 -1.513 . . . . 1.5 109.317 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m -75.28 -30.6 60.48 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.342 -1.093 . . . . 2.26 111.128 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -63.26 -36.97 85.42 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.418 -0.801 . . . . 2.63 111.444 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 15' ' ' LEU . 7.7 tt -59.98 -43.57 95.05 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.315 -0.866 . . . . 2.07 110.481 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -62.86 -44.82 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 1.43 109.529 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.04 -42.67 94.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.576 -0.703 . . . . 2.23 110.639 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -64.25 -40.11 95.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.64 111.358 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 11' ' ' LEU . 84.4 mt -60.01 -45.77 91.66 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.459 -0.776 . . . . 1.31 110.389 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.04 -49.5 77.42 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.516 -0.74 . . . . 3.19 109.999 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.04 -44.43 94.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.758 -0.588 . . . . 1.38 111.523 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.9 t -69.99 -39.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.564 -0.71 . . . . 1.3 111.062 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.1 m -69.27 -39.98 78.05 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.302 -0.874 . . . . 1.27 111.063 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 49.94 42.67 38.95 Favored Glycine 0 N--CA 1.499 2.9 0 N-CA-C 110.78 -0.928 . . . . 1.5 110.78 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -146.78 156.7 43.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.48 -1.012 . . . . 3.9 110.544 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -85.81 67.19 9.96 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.553 -0.717 . . . . 5.04 109.605 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.76 45.54 0.02 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.396 -1.482 . . . . 2.42 109.396 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -77.81 155.99 30.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.726 -0.867 . . . . 2.65 110.235 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CD2' ' N ' ' A' ' 26' ' ' TYR . 41.7 p90 -160.0 -40.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.454 -0.779 . . . . 4.5 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' N ' ' CD2' ' A' ' 25' ' ' PHE . 51.9 t80 54.99 76.05 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 2.39 111.163 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -145.31 157.97 52.04 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.68 -0.638 . . . . 3.59 109.564 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.73 -167.48 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.423 1.223 . . . . 3.69 110.719 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.99 -36.39 83.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.674 -0.641 . . . . 7.38 109.808 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.4 m 59.54 85.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.681 -0.637 . . . . 4.57 110.795 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -70.01 -40.04 75.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.659 -0.65 . . . . 8.82 110.07 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -144.21 -86.35 0.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.406 -0.809 . . . . 7.82 111.258 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -150.06 97.03 3.44 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.042 -1.036 . . . . 7.61 110.699 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.0 62.13 4.19 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.284 1.15 . . . . 6.7 110.159 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.14 21.64 41.04 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.388 -1.085 . . . . 5.33 110.388 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -79.83 114.56 18.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.308 -1.113 . . . . 6.62 110.284 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t 54.83 -85.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.734 -0.604 . . . . 4.89 111.194 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -146.67 173.32 12.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.062 -1.024 . . . . 5.23 110.06 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -67.37 -40.03 85.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 5.15 109.677 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.57 -46.3 1.19 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.648 -1.381 . . . . 1.61 109.648 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.04 -50.0 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.567 -0.96 . . . . 2.49 110.068 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.47 -42.22 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 1.72 109.487 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -60.89 -40.04 91.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.628 -0.67 . . . . 2.92 110.013 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -65.2 -40.04 93.62 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.561 -0.712 . . . . 2.25 111.012 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.0 m -73.27 -24.79 60.48 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.268 -0.895 . . . . 0.88 109.339 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -39.83 75.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.286 -0.884 . . . . 1.17 109.023 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.0 p -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.624 -0.673 . . . . 1.59 110.141 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -135.23 155.01 51.37 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 1.19 109.742 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.3 mt -76.83 121.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.376 -0.828 . . . . 1.19 110.118 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.5 m -77.77 150.0 34.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.79 -0.569 . . . . 0.9 109.711 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.6 p -78.99 149.38 32.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 1.04 112.099 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.251 0.548 . . . . 1.25 110.337 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.91 -41.46 87.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.605 -0.684 . . . . 1.43 110.522 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.98 -39.93 75.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.58 110.191 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 6' ' ' LEU . 84.8 mt -60.06 -44.3 94.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.351 -0.843 . . . . 0.86 109.725 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.13 -40.0 88.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.841 -0.537 . . . . 2.07 110.498 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -63.05 -39.45 94.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.615 -0.678 . . . . 1.93 110.481 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.442 ' CB ' ' CE1' ' A' ' 26' ' ' TYR . 34.5 m-85 -59.97 -38.37 82.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.499 -0.751 . . . . 1.87 110.224 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 14.9 t -87.59 -15.71 36.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.762 -0.587 . . . . 1.24 110.425 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.043 -0.979 . . . . 2.56 110.083 179.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.142 0.496 . . . . 4.65 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.92 179.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.621 -0.674 . . . . 4.16 109.991 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -153.4 88.14 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.184 -0.673 . . . . 3.31 109.184 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -148.61 164.59 33.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.766 -0.584 . . . . 2.99 109.526 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 46' ' ' CYS . 90.3 m-70 -77.22 139.11 39.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.56 109.927 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 10' ' ' HIS . 30.1 mt -79.97 103.08 9.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.506 -0.746 . . . . 1.84 109.5 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -150.91 -178.22 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.653 -0.655 . . . . 1.38 110.244 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.2 -141.83 36.92 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.965 -1.254 . . . . 1.5 109.965 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -72.76 -28.26 62.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.345 -1.091 . . . . 2.26 110.829 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.491 ' CD2' HD23 ' A' ' 6' ' ' LEU . 68.9 t60 -61.28 -38.05 85.37 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.491 -0.756 . . . . 2.63 110.516 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.95 -40.99 90.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.492 -0.755 . . . . 2.07 110.284 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.87 -43.54 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.493 -0.754 . . . . 1.43 109.821 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.01 -46.43 89.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.613 -0.68 . . . . 2.23 110.746 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.26 -51.66 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.651 -0.656 . . . . 0.64 110.944 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.07 -46.47 89.45 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.46 -0.775 . . . . 1.31 110.473 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -60.0 -49.97 75.58 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.761 -0.587 . . . . 3.19 110.799 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.64 -39.96 88.49 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.455 -0.778 . . . . 1.38 111.871 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.6 t -69.61 -41.76 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.414 -0.804 . . . . 1.3 111.125 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.9 m -72.02 -31.95 66.69 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 1.27 110.846 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.21 -95.24 1.53 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.483 -1.447 . . . . 1.5 109.483 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -61.4 141.66 57.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.466 -1.02 . . . . 3.9 109.616 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttp85 -73.63 61.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 5.04 110.78 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.43 23.46 20.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.21 -1.556 . . . . 2.42 109.21 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -76.89 150.08 36.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.526 -0.985 . . . . 2.65 110.376 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 22.9 p90 -160.6 -44.99 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.609 -0.682 . . . . 4.5 110.707 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 43.94 52.3 6.72 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.33 -0.856 . . . . 2.39 111.239 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.0 p -79.23 120.44 80.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 3.59 110.625 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.2 153.51 28.18 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 O-C-N 123.291 1.153 . . . . 3.69 109.995 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -69.11 -36.8 77.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 7.38 109.662 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 m -159.43 -64.11 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 4.57 109.867 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.1 mmt-85 48.4 -169.39 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.461 -0.774 . . . . 8.82 111.616 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -100.89 151.39 21.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.518 -0.739 . . . . 7.82 110.43 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.44 66.5 15.82 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.632 -0.668 . . . . 7.61 109.944 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 38' ' ' LYS . 47.9 Cg_endo -71.79 -165.26 0.2 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 O-C-N 123.292 1.153 . . . . 6.7 110.184 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.61 -10.09 60.73 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.336 -0.935 . . . . 5.33 110.777 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' C ' HG12 ' A' ' 37' ' ' VAL . 81.7 m-20 -87.2 40.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.956 -1.32 . . . . 6.62 111.998 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG12 ' C ' ' A' ' 36' ' ' ASP . 12.7 p 37.47 59.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.592 0 N-CA-C 112.934 0.716 . . . . 4.89 112.934 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 42.1 tptt -77.79 82.86 4.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 5.23 109.994 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -70.0 -39.97 75.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.458 -0.776 . . . . 5.15 109.268 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.71 -48.23 3.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.595 -1.402 . . . . 1.61 109.595 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.34 -48.18 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.58 -0.953 . . . . 2.49 110.125 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.4 -49.3 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.48 -0.762 . . . . 1.72 109.966 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -60.08 -39.99 87.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.531 -0.73 . . . . 2.92 110.67 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.02 -45.51 92.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.576 -0.703 . . . . 2.25 111.587 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -86.3 -14.88 42.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.135 -0.978 . . . . 0.88 112.201 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -68.87 -43.83 74.55 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.076 -1.015 . . . . 1.17 111.526 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 p -75.52 -37.98 59.7 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.159 -0.963 . . . . 1.59 110.626 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 m -127.19 143.0 51.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.697 -0.627 . . . . 1.19 110.063 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.7 mt -68.46 129.0 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 1.19 109.435 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 48.7 m -86.6 122.44 30.52 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.011 -0.737 . . . . 0.9 109.011 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.8 p -79.12 161.43 26.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.586 0.707 . . . . 1.04 111.391 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.2 tp -57.06 -37.5 71.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.914 -0.491 . . . . 1.25 111.003 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.23 -42.11 85.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.398 -0.814 . . . . 1.43 110.373 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' O ' ' CD2' ' A' ' 58' ' ' TYR . 84.8 mt-30 -70.04 -44.76 68.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.382 -0.824 . . . . 1.58 110.245 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.44 -44.01 96.24 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.509 -0.744 . . . . 0.86 110.901 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.99 -40.07 87.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.474 -0.766 . . . . 2.07 109.978 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.1 -47.67 84.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.789 -0.569 . . . . 1.93 110.698 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 54' ' ' GLN . 51.2 m-85 -63.2 -39.99 96.21 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.165 -0.96 . . . . 1.87 111.254 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 6.0 t -90.36 49.14 1.64 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.455 -0.778 . . . . 1.24 110.842 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 117.936 -1.031 . . . . 2.56 110.04 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.107 0.48 . . . . 4.65 110.061 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.04 160.02 41.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.623 -0.673 . . . . 4.16 110.243 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -154.66 80.72 1.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.476 -0.935 . . . . 3.31 108.476 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -149.23 167.99 24.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.539 -0.541 . . . . 2.99 109.539 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.04 140.94 42.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.578 -0.701 . . . . 1.56 109.722 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.14 108.75 18.46 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.436 -0.79 . . . . 1.84 110.232 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.1 t -150.72 173.2 14.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.808 -0.557 . . . . 1.38 109.69 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.93 -132.99 50.7 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.036 -1.226 . . . . 1.5 110.036 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.9 t -71.75 -34.18 69.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.338 -1.095 . . . . 2.26 111.302 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -60.01 -38.87 83.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.423 -0.798 . . . . 2.63 110.829 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.834 ' CD2' HG23 ' A' ' 42' ' ' VAL . 56.0 tp -59.98 -44.49 94.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.5 -0.75 . . . . 2.07 110.558 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.19 -43.61 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.383 -0.823 . . . . 1.43 110.053 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -46.01 90.82 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.704 -0.622 . . . . 2.23 111.223 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -64.89 -42.09 95.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.463 -0.773 . . . . 0.64 111.03 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.658 HD23 HD22 ' A' ' 55' ' ' LEU . 98.1 mt -60.05 -45.8 91.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 1.31 110.91 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -61.78 -40.26 94.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.401 -0.812 . . . . 3.19 110.383 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.05 -39.68 86.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.507 -0.745 . . . . 1.38 110.558 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.696 HG22 HD12 ' A' ' 52' ' ' LEU . 45.7 t -67.99 -47.57 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.567 -0.708 . . . . 1.3 110.959 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.6 m -70.01 -43.81 70.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.764 . . . . 1.27 110.447 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.08 19.43 23.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.123 -0.791 . . . . 1.5 111.123 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.78 133.57 43.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -1.219 . . . . 3.9 110.801 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 ptt-85 -63.75 -38.95 93.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.696 -0.628 . . . . 5.04 110.996 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.84 46.29 2.71 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.693 -1.363 . . . . 2.42 109.693 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -77.77 135.08 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.573 -0.957 . . . . 2.65 110.297 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -80.03 -65.29 1.02 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.411 -0.805 . . . . 4.5 110.027 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 38.2 t80 49.88 44.04 25.16 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.627 -0.67 . . . . 2.39 110.499 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 96.2 m -74.93 134.68 74.67 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.679 . . . . 3.59 110.311 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.88 153.8 19.67 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.357 1.188 . . . . 3.69 110.328 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -64.43 -39.1 93.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.583 -0.698 . . . . 7.38 109.559 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.453 ' HA ' HG21 ' A' ' 37' ' ' VAL . 27.9 m 59.08 75.4 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.703 -0.623 . . . . 4.57 110.109 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -66.49 -40.01 89.04 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 8.82 109.015 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -95.52 135.39 37.24 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.859 -0.525 . . . . 7.82 109.677 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -77.93 -54.37 1.33 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.492 -0.755 . . . . 7.61 111.035 -179.391 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.4 Cg_endo -72.46 133.24 20.39 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.195 1.103 . . . . 6.7 110.289 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.25 37.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.41 -1.476 . . . . 5.33 109.41 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 50.0 38.29 16.13 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.349 -1.089 . . . . 6.62 110.727 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 38' ' ' LYS . 42.0 t 55.32 170.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.828 -0.545 . . . . 4.89 110.014 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' N ' HG12 ' A' ' 37' ' ' VAL . 56.6 tttt -70.0 -39.96 75.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.015 -1.053 . . . . 5.23 109.249 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -160.61 -40.46 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.843 -0.536 . . . . 5.15 109.709 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.86 -76.92 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.686 -1.365 . . . . 1.61 109.686 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 41' ' ' ILE . 94.7 mt -126.05 9.46 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.709 -0.877 . . . . 2.49 111.025 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.834 HG23 ' CD2' ' A' ' 11' ' ' LEU . 12.5 p -60.82 -41.11 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.134 -0.978 . . . . 1.72 111.119 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' N ' HG13 ' A' ' 42' ' ' VAL . 47.1 mt-10 -60.29 -40.07 89.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.459 -0.776 . . . . 2.92 110.961 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' OE1' HG23 ' A' ' 41' ' ' ILE . 91.7 mt-30 -68.32 -40.04 81.79 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.484 -0.76 . . . . 2.25 111.639 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 66.5 m -83.16 -24.59 32.43 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.366 -0.833 . . . . 0.88 112.176 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.7 m -67.18 -37.96 84.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.17 110.204 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -71.55 -40.98 69.66 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.412 -0.805 . . . . 1.59 110.415 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.1 m -130.86 146.99 52.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.462 -0.774 . . . . 1.19 110.12 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.07 129.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 1.19 109.88 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.58 127.57 38.12 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.227 -0.657 . . . . 0.9 109.227 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 84.5 p -77.54 160.05 28.88 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.521 0.677 . . . . 1.04 110.692 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 18' ' ' VAL . 41.6 tp -59.33 -40.03 85.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.833 -0.542 . . . . 1.25 110.893 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -59.95 -40.05 87.67 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.434 -0.792 . . . . 1.43 110.778 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -68.63 -40.52 80.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 1.58 110.419 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.658 HD22 HD23 ' A' ' 15' ' ' LEU . 99.0 mt -62.6 -40.46 97.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.86 109.552 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' HG3' HG13 ' A' ' 18' ' ' VAL . 98.8 mt-10 -60.06 -39.94 87.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.861 -0.524 . . . . 2.07 110.006 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -61.54 -43.51 98.73 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.092 -0.643 . . . . 1.93 110.585 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.32 -32.14 72.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.163 -0.961 . . . . 1.87 110.075 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.9 56.54 3.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 1.24 110.411 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.018 -0.991 . . . . 2.56 110.134 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.132 0.491 . . . . 4.65 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.01 168.64 22.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 121.568 -0.708 . . . . 4.16 110.654 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -153.45 94.24 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.589 0.709 . . . . 3.31 109.335 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -83.44 -173.57 4.79 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.327 0.584 . . . . 2.99 111.108 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 49' ' ' ILE . 15.9 m-70 -70.93 150.21 45.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.698 -0.626 . . . . 1.56 110.871 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -102.11 95.28 6.23 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.586 -0.696 . . . . 1.84 110.057 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.3 t -150.51 -173.56 4.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.656 -0.653 . . . . 1.38 109.615 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.71 -146.31 34.92 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.743 -1.343 . . . . 1.5 109.743 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.4 t -71.59 -27.22 62.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.426 -1.043 . . . . 2.26 110.756 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -62.47 -39.48 93.54 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.561 -0.712 . . . . 2.63 111.24 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.701 HD21 HG13 ' A' ' 42' ' ' VAL . 65.1 tp -60.03 -49.98 75.54 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.375 -0.828 . . . . 2.07 110.562 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.9 -45.86 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 1.43 108.842 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' HG2' HD11 ' A' ' 17' ' ' LEU . 85.1 tt0 -60.05 -39.94 87.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.84 -0.538 . . . . 2.23 110.18 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.27 -41.21 96.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.589 -0.694 . . . . 0.64 110.498 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.96 -48.89 79.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.4 -0.812 . . . . 1.31 110.073 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -60.77 -39.94 90.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.569 -0.707 . . . . 3.19 109.556 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 ' HG2' ' A' ' 13' ' ' GLU . 81.2 mt -68.93 -40.71 78.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.724 -0.61 . . . . 1.38 111.244 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 14' ' ' ALA . 91.1 t -75.08 -58.14 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.5 -0.75 . . . . 1.3 110.948 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -70.62 -40.01 73.38 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 1.27 110.79 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.54 18.6 61.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.509 -1.036 . . . . 1.5 110.509 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.65 157.61 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 3.9 110.411 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -109.9 17.14 21.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.613 -0.679 . . . . 5.04 110.821 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.32 -47.7 62.24 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.188 -1.165 . . . . 2.42 110.188 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 39.9 p90 -79.31 129.54 34.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.572 -0.958 . . . . 2.65 110.964 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.67 -9.33 59.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.528 -0.733 . . . . 4.5 110.558 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 51.9 t80 60.02 38.28 20.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.227 -0.92 . . . . 2.39 110.742 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.7 m -85.6 119.83 72.45 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.302 -0.874 . . . . 3.59 109.332 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.59 162.11 42.36 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.046 1.024 . . . . 3.69 109.471 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -62.45 -45.12 94.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.487 -0.758 . . . . 7.38 109.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.6 m 63.21 -55.59 0.18 Allowed 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 112.726 0.639 . . . . 4.57 112.726 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.07 -1.019 . . . . 8.82 109.88 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -140.02 132.31 28.28 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.383 -0.599 . . . . 7.82 109.383 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 1.8 m-85 -78.44 -54.78 1.14 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.474 -0.766 . . . . 7.61 111.619 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.8 Cg_endo -69.92 -168.67 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 122.988 0.993 . . . . 6.7 110.988 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.66 -74.59 0.9 Allowed Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.446 -1.062 . . . . 5.33 110.446 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 52.54 56.67 7.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.343 -1.092 . . . . 6.62 110.963 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 38' ' ' LYS . 40.9 t 57.87 169.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.644 -0.66 . . . . 4.89 110.314 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 37' ' ' VAL . 90.0 mttt -145.7 -174.06 4.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 5.23 109.601 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 59.79 37.36 22.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.618 -0.676 . . . . 5.15 109.534 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.75 -51.84 56.12 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.218 -1.953 . . . . 1.61 108.218 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.4 mt -73.79 -40.02 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.962 -0.728 . . . . 2.49 109.393 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 HD21 ' A' ' 11' ' ' LEU . 97.1 t -64.14 -43.24 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.738 -0.601 . . . . 1.72 110.653 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -59.99 -35.37 74.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.517 -0.74 . . . . 2.92 111.623 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -60.04 -39.99 87.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.275 -0.891 . . . . 2.25 110.809 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -76.29 -23.87 54.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.214 -0.929 . . . . 0.88 109.805 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.6 m -70.03 -47.66 61.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 1.17 109.638 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.2 m -74.63 -40.05 61.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 1.59 110.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.8 m -114.29 137.91 51.18 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.584 -0.698 . . . . 1.19 109.56 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 5' ' ' HIS . 85.8 mt -68.65 121.76 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.458 -0.776 . . . . 1.19 110.641 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.2 m -91.44 149.95 21.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.727 -0.608 . . . . 0.9 109.538 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 p -78.08 159.67 28.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.446 -0.784 . . . . 1.04 111.324 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 tp -59.27 -33.2 70.77 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.438 0.637 . . . . 1.25 110.135 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -59.68 -39.97 86.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 1.43 110.513 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.57 -40.03 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.418 -0.801 . . . . 1.58 109.941 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.41 -0.806 . . . . 0.86 109.215 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.41 -38.42 83.97 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 2.07 109.787 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.03 -46.86 88.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.672 -0.643 . . . . 1.93 110.425 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -59.94 -32.01 70.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.391 -0.818 . . . . 1.87 110.686 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.1 t -89.62 59.92 4.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.504 -0.748 . . . . 1.24 110.47 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.996 -1.002 . . . . 2.56 110.129 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 109.728 -0.471 . . . . 4.65 109.728 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.07 159.97 41.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 O-C-N 121.534 -0.729 . . . . 4.16 110.725 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -155.09 86.63 1.11 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.901 -0.778 . . . . 3.31 108.901 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -84.11 168.74 15.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.629 0.728 . . . . 2.99 111.366 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -77.42 139.53 39.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.844 -0.535 . . . . 1.56 110.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 11' ' ' LEU . 59.7 mt -80.91 80.58 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.75 . . . . 1.84 109.849 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' CA ' ' HB2' ' A' ' 11' ' ' LEU . 1.2 t -150.62 172.13 16.02 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 1.38 110.87 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.32 -134.31 48.72 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.834 -1.306 . . . . 1.5 109.834 177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 t -70.62 -32.59 69.97 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -1.045 . . . . 2.26 110.69 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -61.59 -39.24 90.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.632 -0.667 . . . . 2.63 111.285 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 6' ' ' LEU . 44.1 tp -59.9 -49.86 76.03 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.254 -0.904 . . . . 2.07 110.878 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.47 -48.09 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.201 -0.937 . . . . 1.43 109.896 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.0 -51.29 70.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.802 -0.561 . . . . 2.23 112.36 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.22 -48.38 78.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.299 -0.876 . . . . 0.64 111.588 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.03 -48.07 83.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.472 -0.768 . . . . 1.31 111.237 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -59.98 -47.86 84.08 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.32 -0.863 . . . . 3.19 110.476 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.7 -42.27 96.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 1.38 110.884 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -70.16 -49.86 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.394 -0.816 . . . . 1.3 110.476 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.7 m -69.98 -35.84 74.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.689 -0.632 . . . . 1.27 109.96 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.4 -20.93 31.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 111.242 -0.743 . . . . 1.5 111.242 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -165.47 166.86 18.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.109 -1.23 . . . . 3.9 110.997 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -92.36 18.7 7.99 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.79 -0.569 . . . . 5.04 110.733 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.28 72.23 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.124 -1.19 . . . . 2.42 110.124 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -72.43 127.79 33.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.282 -1.128 . . . . 2.65 109.464 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.781 ' HB3' HG23 ' A' ' 27' ' ' THR . 6.8 m-85 -70.77 -39.67 73.07 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 112.713 0.635 . . . . 4.5 112.713 -178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.443 ' OH ' HD13 ' A' ' 41' ' ' ILE . 35.7 t80 55.51 48.76 18.12 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.037 -1.039 . . . . 2.39 108.351 -177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 25' ' ' PHE . 7.2 p -78.28 111.88 21.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.689 -0.632 . . . . 3.59 110.62 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.75 -173.72 0.37 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.24 1.126 . . . . 3.69 110.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -63.19 -35.96 82.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.551 -0.718 . . . . 7.38 109.345 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 30' ' ' THR . 33.4 m 54.15 54.54 9.45 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.734 -0.604 . . . . 4.57 111.873 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -70.21 -34.42 72.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.093 -1.077 . . . . 8.82 108.093 178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -141.36 157.02 45.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.754 -0.592 . . . . 7.82 109.987 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -154.15 61.7 3.45 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.364 -0.835 . . . . 7.61 109.667 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.06 -23.94 7.29 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.519 1.273 . . . . 6.7 111.4 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.45 39.99 3.55 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 108.706 -1.758 . . . . 5.33 108.706 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -80.75 68.05 6.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.761 -0.846 . . . . 6.62 112.026 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 80.5 t 52.69 -89.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.248 -0.907 . . . . 4.89 111.266 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -79.75 146.84 32.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.818 -1.176 . . . . 5.23 110.048 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.95 -30.34 67.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.663 -0.648 . . . . 5.15 109.858 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.05 -59.89 0.67 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.163 -1.575 . . . . 1.61 109.163 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.443 HD13 ' OH ' ' A' ' 26' ' ' TYR . 15.5 tt -68.3 -37.21 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.718 -0.872 . . . . 2.49 110.987 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.76 -27.12 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.335 -0.853 . . . . 1.72 111.009 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.95 -34.8 73.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.56 -0.712 . . . . 2.92 110.528 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.98 -43.54 95.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.567 -0.708 . . . . 2.25 110.576 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.8 m -79.44 -29.84 42.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.423 -0.798 . . . . 0.88 109.935 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.43 -40.07 77.46 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.528 -0.733 . . . . 1.17 110.054 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -74.18 -43.7 56.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.513 -0.742 . . . . 1.59 109.576 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -132.17 150.65 52.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.953 -0.758 . . . . 1.19 108.953 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.5 mt -68.85 126.74 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.205 -0.934 . . . . 1.19 109.449 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.4 m -79.29 156.47 28.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.615 -0.678 . . . . 0.9 110.32 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.9 p -78.08 146.44 35.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.655 -0.653 . . . . 1.04 110.377 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.0 tp -58.69 -39.35 80.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.798 -0.564 . . . . 1.25 111.051 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -59.28 -42.81 92.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.396 -0.815 . . . . 1.43 110.152 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.44 -39.15 81.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.58 109.337 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.04 -43.6 95.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.577 -0.702 . . . . 0.86 109.498 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.08 -39.98 91.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.666 -0.646 . . . . 2.07 110.031 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.83 -40.01 96.11 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.559 -0.713 . . . . 1.93 110.463 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -59.99 -39.84 87.1 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.583 -0.698 . . . . 1.87 110.692 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.69 -15.92 35.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.673 -0.642 . . . . 1.24 110.334 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.958 -1.02 . . . . 2.56 110.157 179.368 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 47.5 t80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.048 0.451 . . . . 4.65 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.99 160.37 41.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 O-C-N 121.57 -0.707 . . . . 4.16 110.438 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -154.79 97.09 1.93 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.769 -0.826 . . . . 3.31 108.769 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -148.62 161.8 40.98 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.462 0.649 . . . . 2.99 110.584 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.425 ' CE1' HG13 ' A' ' 49' ' ' ILE . 96.6 m-70 -78.56 149.91 32.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.845 -0.534 . . . . 1.56 110.434 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.33 72.76 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.559 -0.713 . . . . 1.84 109.672 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -149.25 -173.79 4.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.685 -0.634 . . . . 1.38 109.816 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.65 -141.88 30.98 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.122 -1.591 . . . . 1.5 109.122 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -75.54 -25.15 56.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.261 -1.141 . . . . 2.26 110.73 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -63.01 -34.75 78.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.492 -0.755 . . . . 2.63 111.063 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' A' ' 42' ' ' VAL . 49.2 tp -59.97 -50.0 75.46 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.441 -0.787 . . . . 2.07 110.656 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.76 -46.65 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.326 -0.859 . . . . 1.43 109.623 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.99 -49.56 77.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 2.23 111.766 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.65 -54.71 31.53 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.898 0.703 . . . . 0.64 112.898 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 11' ' ' LEU . 4.2 mm? -60.01 -50.01 75.44 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.274 -0.891 . . . . 1.31 111.797 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.2 -46.45 88.85 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.285 -0.884 . . . . 3.19 111.385 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -66.73 -40.04 88.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.55 -0.718 . . . . 1.38 112.143 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' ALA . 86.8 t -71.28 -52.23 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.24 -0.913 . . . . 1.3 110.851 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -71.23 -40.04 71.3 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.579 -0.701 . . . . 1.27 110.697 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.37 21.04 56.45 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.175 -1.17 . . . . 1.5 110.175 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -159.97 160.01 32.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -1.09 . . . . 3.9 110.077 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.0 mtm-85 -108.8 27.72 9.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 5.04 110.221 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.72 -21.8 76.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.346 -1.101 . . . . 2.42 110.346 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' PHE . 50.0 p90 -71.98 119.95 16.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.261 -1.14 . . . . 2.65 110.632 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -75.34 -29.96 60.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.693 -0.629 . . . . 4.5 110.066 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 56.13 40.64 30.11 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.521 -0.737 . . . . 2.39 109.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' THR . 10.1 t -78.24 120.07 79.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.762 -0.586 . . . . 3.59 110.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.25 99.36 1.16 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.181 1.095 . . . . 3.69 110.699 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.07 56.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.417 -0.802 . . . . 7.38 109.961 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 31' ' ' ARG . 5.1 t -165.96 -37.12 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 4.57 110.771 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 30' ' ' THR . 59.1 mtt85 -151.56 103.28 2.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 8.82 109.909 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -62.68 -40.03 95.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.608 -0.683 . . . . 7.82 110.744 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.03 103.69 1.91 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.457 -0.777 . . . . 7.61 110.008 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.72 -79.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.234 1.123 . . . . 6.7 111.091 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -130.96 40.04 1.7 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.184 -1.167 . . . . 5.33 110.184 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 50.44 -176.94 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.38 -1.07 . . . . 6.62 111.479 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' A' ' 38' ' ' LYS . 74.0 t 45.95 -90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.774 -0.579 . . . . 4.89 111.894 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' HG3' HG12 ' A' ' 37' ' ' VAL . 80.8 mttt -81.17 116.43 21.07 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.903 -1.123 . . . . 5.23 109.701 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -72.39 -39.45 67.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.661 -0.649 . . . . 5.15 110.957 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.62 -40.25 2.57 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.409 -1.877 . . . . 1.61 108.409 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.88 -40.01 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.778 -0.836 . . . . 2.49 108.909 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 11' ' ' LEU . 14.5 p -62.55 -36.15 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.136 -0.69 . . . . 1.72 109.136 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.94 -14.76 63.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.71 -0.619 . . . . 2.92 110.571 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -59.98 -45.72 91.76 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.308 -0.87 . . . . 2.25 110.765 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m -83.52 -16.58 44.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.88 110.738 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.85 -49.99 75.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.131 -0.981 . . . . 1.17 110.693 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 17.0 p -76.72 -40.0 50.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 1.59 111.136 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 m -125.37 155.3 40.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.376 -0.827 . . . . 1.19 110.527 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' CE1' ' A' ' 5' ' ' HIS . 74.7 mt -81.92 123.32 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.437 -0.789 . . . . 1.19 109.925 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -81.91 146.89 29.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.539 -0.726 . . . . 0.9 110.007 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -82.07 156.96 24.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.473 -0.767 . . . . 1.04 111.72 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.07 -39.77 87.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.816 -0.552 . . . . 1.25 110.418 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -55.05 -39.58 69.37 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.504 -0.748 . . . . 1.43 110.07 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -68.27 -39.93 82.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.541 -0.724 . . . . 1.58 109.44 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.02 -41.28 97.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.46 -0.775 . . . . 0.86 109.419 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.03 -40.02 87.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.785 -0.572 . . . . 2.07 110.144 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.32 -41.64 98.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.93 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -67.19 -33.35 75.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.597 -0.69 . . . . 1.87 111.005 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.4 t -89.38 0.77 56.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.537 -0.727 . . . . 1.24 110.938 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.035 -0.984 . . . . 2.56 110.191 179.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.718 -0.475 . . . . 4.65 109.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.0 159.99 41.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 O-C-N 121.474 -0.766 . . . . 4.16 110.549 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -158.57 93.07 1.17 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.968 -0.753 . . . . 3.31 108.968 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -148.59 158.08 43.89 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.001 -0.68 . . . . 2.99 109.959 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -81.63 156.41 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.835 -0.541 . . . . 1.56 110.767 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD13 HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -100.83 18.45 19.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.61 -0.681 . . . . 1.84 110.623 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 28.6 p -103.22 -162.24 0.9 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.626 -0.671 . . . . 1.38 110.278 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.91 -151.04 12.84 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.693 -1.363 . . . . 1.5 109.693 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -70.17 -25.71 63.57 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.29 -1.124 . . . . 2.26 110.066 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -63.01 -27.34 69.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.533 -0.73 . . . . 2.63 109.446 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 3.2 tt -60.05 -49.98 75.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.679 . . . . 2.07 110.153 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.7 -50.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.647 -0.658 . . . . 1.43 109.355 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.607 ' OE2' HD11 ' A' ' 17' ' ' LEU . 53.7 tp10 -59.99 -49.4 77.82 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.381 0.61 . . . . 2.23 110.508 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.7 -48.66 78.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.757 -0.589 . . . . 0.64 112.204 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.7 mt -60.05 -47.5 85.61 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.233 -0.917 . . . . 1.31 111.939 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -64.32 -41.27 96.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.276 -0.89 . . . . 3.19 111.379 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 ' OE2' ' A' ' 13' ' ' GLU . 85.7 mt -69.97 -40.78 75.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 1.38 111.553 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -76.03 -59.72 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.431 -0.793 . . . . 1.3 110.98 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.1 m -71.81 -40.04 69.43 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 1.27 111.383 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.11 86.42 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.444 -1.063 . . . . 1.5 110.444 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.57 120.09 37.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.042 -1.269 . . . . 3.9 110.688 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -82.2 -15.64 52.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.547 -0.721 . . . . 5.04 111.192 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.15 78.53 0.25 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.881 -1.152 . . . . 2.42 111.035 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.98 133.91 36.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.47 -1.018 . . . . 2.65 109.957 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -75.23 -59.97 2.5 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.484 -0.932 . . . . 4.5 108.484 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 43.99 41.48 4.03 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.182 0.438 . . . . 2.39 112.182 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 27' ' ' THR . 6.6 t -73.35 112.72 17.04 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 119.74 -0.784 . . . . 3.59 109.14 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -90.49 -173.77 0.67 Allowed 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.17 1.089 . . . . 3.69 111.24 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HG3' ' A' ' 34' ' ' PRO . 22.7 ttmt -69.95 -31.24 68.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.811 -0.556 . . . . 7.38 110.039 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 m 56.04 63.66 1.95 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.533 -0.729 . . . . 4.57 110.648 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -151.07 149.95 30.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.478 -0.764 . . . . 8.82 110.145 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -84.03 -11.26 57.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.537 -0.727 . . . . 7.82 111.973 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.9 OUTLIER -76.12 -50.6 2.96 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.237 -0.914 . . . . 7.61 111.462 -179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' TYR . 43.2 Cg_endo -70.04 -27.07 25.61 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 122.943 0.97 . . . . 6.7 110.585 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.31 106.47 0.29 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.667 -1.373 . . . . 5.33 109.667 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.7 p-10 -77.42 155.89 31.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.667 -0.902 . . . . 6.62 109.955 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 36' ' ' ASP . 8.2 p 39.21 33.56 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 N-CA-C 112.348 0.499 . . . . 4.89 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -150.31 116.16 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.621 -0.674 . . . . 5.23 109.752 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.717 ' HD2' HG11 ' A' ' 42' ' ' VAL . 90.2 mtt180 -72.23 -40.01 68.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.6 -0.688 . . . . 5.15 109.986 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.89 -48.76 3.52 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.022 -1.631 . . . . 1.61 109.022 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 91.7 mt -66.61 -40.07 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.696 -0.884 . . . . 2.49 109.997 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.717 HG11 ' HD2' ' A' ' 39' ' ' ARG . 28.5 m -65.34 -42.61 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.57 -0.706 . . . . 1.72 110.961 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' N ' HG23 ' A' ' 42' ' ' VAL . 91.3 mt-10 -61.02 -38.65 86.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.438 -0.789 . . . . 2.92 110.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -60.07 -40.08 88.29 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.461 -0.774 . . . . 2.25 109.794 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.5 m -78.78 -31.08 45.92 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.7 t -70.01 -44.3 69.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 1.17 110.318 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.6 m -72.98 -42.14 63.62 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.46 -0.775 . . . . 1.59 109.443 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.7 m -130.62 147.51 52.3 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.731 -0.84 . . . . 1.19 108.731 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.27 127.44 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.269 -0.895 . . . . 1.19 109.815 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 m -78.13 157.34 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.591 -0.693 . . . . 0.9 109.54 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 80.1 p -78.51 161.03 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.759 0.79 . . . . 1.04 111.856 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.6 tp -58.69 -39.18 80.01 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.25 0.548 . . . . 1.25 110.301 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -56.16 -39.98 73.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.555 -0.716 . . . . 1.43 110.247 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.83 -39.98 87.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 1.58 109.484 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD13 ' A' ' 6' ' ' LEU . 94.9 mt -60.4 -40.02 89.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.404 -0.81 . . . . 0.86 109.37 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.97 -40.04 87.69 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.271 0.557 . . . . 2.07 109.728 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.34 -49.93 75.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.681 -0.637 . . . . 1.93 109.716 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -60.02 -28.31 67.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.69 -0.631 . . . . 1.87 110.695 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -88.22 55.97 3.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.495 -0.753 . . . . 1.24 110.424 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.9 m120 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 118.414 -0.803 . . . . 2.56 110.05 179.454 . . . . . . . . 0 0 . 1 stop_ save_